ATC Catalogue;;;;
anatomical_grp;therapeutic_subgrp;pharmacol_subgrp;chem_subgrp;chem_substance
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX13 - silicones
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB07 - cefatrizine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA04 - urofollitropin
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA10 - promethazine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LX - Other antihypertensives and diuretics in ATC;C02LX01 - pinacidil and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA09 - sargramostim
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC23 - cilostazol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX05 - emepronium -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AC - Drugs used in hereditary angioedema;B06AC05 - lanadelumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA01 - androstanolone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA09 - mefenorex
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF09 - emtricitabine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X - OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC;C09XA - Renin-inhibitors;C09XA53 - aliskiren and amlodipine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB10 - imiquimod
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB02 - chloroform
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AC - Nicotinic acid and derivatives -  peripheral vasodilators;C04AC07 - ciclonicate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AA - Acridine derivatives -  antiseptics and disinfectants;D08AA03 - euflavine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB54 - propyphenazone -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AB - Sulfonamides -  intestinal antiinfectives;A07AB04 - succinylsulfathiazole
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC16 - hydrocortisone aceponate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA51 - morphine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA01 - phenylbutazone
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA02 - flumetasone and antiinfectives
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM08 - isoniazid -  sulfamethoxazole -  trimethoprim and pyridoxine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03A - THYROID PREPARATIONS;H03AA - Thyroid hormones;H03AA01 - levothyroxine sodium
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07C - ANTIVERTIGO PREPARATIONS;N07CA - Antivertigo preparations;N07CA01 - betahistine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX15 - copper usnate
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA05 - hexamidine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE14 - bosutinib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EX - Other respiratory system diagnostic radiopharmaceuticals in ATC;V09EX02 - xenon (127Xe) gas
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA04 - theophylline
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB01 - clobetasone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR09 - emtricitabine -  tenofovir disoproxil -  elvitegravir and cobicistat
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC02 - ethulose
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LL - MAO inhibitors and diuretics;C02LL01 - pargyline and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA06 - trospium and analgesics
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA08 - chloramphenicol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA07 - pyrrolnitrin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE17 - axitinib
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX14 - cinepazet
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX11 - mipomersen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AE - Cholera vaccines;J07AE51 - cholera -  combinations with typhoid vaccine -  inactivated -  whole cell
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX05 - bismuth subcitrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC54 - attapulgite -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX30 - trimethyldiphenylpropylamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AA - Enzyme preparations -  digestives;A09AA02 - multienzymes (lipase -  protease etc.)
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA11 - norgestimate and ethinylestradiol
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB02 - polidocanol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BE - Azaspirodecanedione derivatives -  anxiolytics;N05BE01 - buspirone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA17 - temocillin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XA - Iodine I-131 diagnostic radiopharmaceuticals;V09XA03 - iodine (131I) human albumin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX01 - itramin tosilate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX14 - dapoxetine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB05 - aclidinium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB06 - losartan and amlodipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA03 - magnesium peroxide
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA51 - diprophylline -  combinations
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BA - Psoralens for systemic use;D05BA02 - methoxsalen
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK05 - mercury -  metallic
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AB - Progestogens -  endocrine therapy drugs;L02AB01 - megestrol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA04 - nicomorphine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA03 - technetium (99mTc) mertiatide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA08 - cilazapril
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC10 - bifonazole
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA06 - candesartan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX08 - sulglicotide
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BG - Alpha and beta blocking agents and thiazides;C07BG01 - labetalol and thiazides
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX14 - esketamine
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10B - PAIN PALLIATION (BONE SEEKING AGENTS);V10BX - Various pain palliation radiopharmaceuticals;V10BX03 - rhenium (186Re) etidronic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA09 - hemoglobin raffimer
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD12 - mirabegron
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX06 - atorvastatin -  acetylsalicylic acid and ramipril
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD04 - urokinase
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AC - Enzyme and acid preparations -  combinations;A09AC02 - multienzymes and acid preparations
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA03 - pindolol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB08 - tridihexethyl
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC07 - tioconazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB11 - valaciclovir
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB11 - choline fenofibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AC - Strophanthus glycosides used in cardiac therapy;C01AC01 - g-strophanthin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA79 - dipyrocetyl -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA71 - reserpine and diuretics -  combinations with psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD06 - esomeprazole -  amoxicillin and clarithromycin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA15 - methohexital
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG02 - formestane
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA51 - phenylpropanolamine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX10 - maribavir
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA53 - estradiol -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC02 - salbutamol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB19 - anthrax immunoglobulin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB06 - bevantolol and thiazides
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE10 - ethyl hydroxybenzoate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA05 - temafloxacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX04 - nitrofural
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA02 - diphenhydramine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD04 - dofetilide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CB - Gold preparations;M01CB04 - aurothioglucose
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AA - Bile acids and derivatives for bile therapy;A05AA03 - cholic acid
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AR - Arsenic compounds -  for amoebiasis and other protozoal diseases;P01AR53 - glycobiarsol -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA01 - tacrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD01 - epinephrine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK02 - ethambutol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB09 - lonazolac
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB01 - norgestrel and estrogen
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB27 - levodropropizine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA22 - cloxazolam
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC19 - blinatumomab
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG05 - vorozole
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX07 - sodium borate
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA08 - dexetimide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX16 - mitoguazone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA03 - estradiol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03E - ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;G03EA - Androgens and estrogens;G03EA01 - methyltestosterone and estrogen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX03 - altretamine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02D - ANTICESTODALS;P02DA - Salicylic acid derivative anticestodals;P02DA01 - niclosamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK05 - bedaquiline
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CF - Benzodiazepine related hypnotics and sedatives;N05CF04 - eszopiclone
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB03 - amino(diphenylhydantoin) valeric acid
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB01 - idoxuridine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD08 - droperidol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD06 - lormetazepam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF14 - propenidazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XC - Steroid antibacterials;J01XC01 - fusidic acid
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC03 - propamidine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE01 - sulfamethoxazole and trimethoprim
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LG - Hydrazinophthalazine derivatives and diuretics;C02LG03 - picodralazine and diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB04 - megestrol and estrogen
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX01 - calcium hexamine thiocyanate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01B - AMPHENICOLS;J01BA - Amphenicol antibacterials -  systemic;J01BA02 - thiamphenicol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM15 - methylpentynol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XB - Progesterone receptor modulators -  sex hormones and modulators of the genital system;G03XB02 - ulipristal
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FB - Sympathomimetics excl. antiglaucoma preparations;S01FB02 - ephedrine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BK - Varicella zoster vaccines;J07BK01 - varicella -  live attenuated
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF17 - oxiconazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB01 - bromocriptine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM18 - dexmedetomidine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD01 - cefotaxime
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX06 - furazolidone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA06 - chlorotrianisene
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BX - Other anxiolytics in ATC;N05BX03 - etifoxine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AC - Insulins and analogues for injection -  intermediate-acting;A10AC03 - insulin (pork)
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX50 - ixazomib
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX23 - ibalizumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AA - Aminosalicylic acid and derivatives;J04AA03 - calcium aminosalicylate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB04 - norethisterone and ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB16 - palivizumab
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AF - Direct factor Xa inhibitors;B01AF02 - apixaban
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC10 - calcium iopodate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA07 - calcium chloride
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX03 - atorvastatin and amlodipine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD01 - streptokinase
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA54 - troxerutin -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA04 - sulfamethizole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA16 - dienogest and ethinylestradiol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX27 - desloratadine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD04 - aminolevulinic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CD - Taxanes -  antineoplastic;L01CD01 - paclitaxel
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD02 - prednisolone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA12 - dexpanthenol
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BX - Other antithyroid preparations in ATC;H03BX02 - dibromotyrosine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03X - OTHER ANTIANEMIC PREPARATIONS in ATC;B03XA - Other antianemic preparations in ATC;B03XA02 - darbepoetin alfa
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AG - Iodine products -  antiseptics and disinfectants;D08AG04 - diiodohydroxypropane
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ09 - codeine and other non-opioid analgesics
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB13 - talinolol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC53 - phenothrin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE03 - insulin (pork)
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX09 - thymopentin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD06 - nimustine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BM - Papillomavirus vaccines;J07BM01 - papillomavirus (human types 6 -  11 -  16 -  18)
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AX - Other antigout preparations in ATC;M04AX02 - pegloticase
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA10 - ciprofloxacin and metronidazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XE - Nitrofuran derivatives -  antibacterials for systemic use;J01XE01 - nitrofurantoin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CX - Other renal system diagnostic radiopharmaceuticals in ATC;V09CX03 - sodium iothalamate (125I)
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BD - Dibenzo-bicyclo-octadiene derivative anxiolytics;N05BD01 - benzoctamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CB - Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy;G04CB02 - dutasteride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DF - Monobactams;J01DF01 - aztreonam
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB06 - sertraline
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02B - PROTECTIVES AGAINST UV-RADIATION;D02BB - Protectives against UV-radiation for systemic use;D02BB02 - afamelanotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA54 - streptomycin -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA34 - alemtuzumab
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC02 - diclofenamide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB05 - mesna
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB36 - phentolamine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA04 - ferrous carbonate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA15 - ascorbic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA14 - benzylpenicillin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AC - Phenothiazines with piperidine structure -  antipsychotics;N05AC01 - periciazine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CX - Other drugs used in benign prostatic hypertrophy in ATC;G04CX04 - fexapotide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB05 - neomycin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ05 - benzoxonium chloride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA03 - bevonium and analgesics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BG - Thiazolidinediones -  blood glucose lowering drugs;A10BG02 - rosiglitazone
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AA - Ethers for general anesthesia;N01AA02 - vinyl ether
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA17 - erythromycin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB08 - domiodol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AA - Estrogens -  endocrine therapy drugs;L02AA04 - fosfestrol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BB - Corticosteroids and mydriatics in combination;S01BB04 - betamethasone and mydriatics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA05 - oleandomycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB08 - sisomicin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BX - Other local anesthetics in ATC;N01BX04 - capsaicin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CA - Gonadotropin-releasing hormones;H01CA01 - gonadorelin
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC02 - guanethidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB21 - fenpiverinium
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX05 - tazarotene
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CA - Alpha-adrenoreceptor antagonists -  peripherally acting;C02CA01 - prazosin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BB - Folic acid and derivatives as antianemics;B03BB51 - folic acid -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BB - Belladonna alkaloids -  semisynthetic -  quaternary ammonium compounds for functional gastrointestinal disorders;A03BB01 - butylscopolamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX14 - migalastat
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BA - Solutions for parenteral nutrition;B05BA02 - fat emulsions
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX01 - moroxydine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA09 - corifollitropin alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX01 - dextrothyroxine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC10 - cefprozil
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BC - Corticosteroids -  potent -  combinations with antiseptics;D07BC03 - fluocortolone and antiseptics
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA03 - technetium (99mTc) pentavalent succimer
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AC - Iron chelating agents;V03AC02 - deferiprone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE03 - cyclizine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07F - ANTIDIARRHEAL MICROORGANISMS;A07FA - Antidiarrheal microorganisms;A07FA51 - lactic acid producing organisms -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX01 - thioctic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FB - Beta blocking agents and calcium channel blockers;C07FB13 - metoprolol and amlodipine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB01 - flumetasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB08 - gliquidone
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB19 - dexamethasone
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB03 - flumetasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC08 - magnesium pidolate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA13 - halazepam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD14 - rolapitant
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CA - Alpha-adrenoreceptor antagonists -  peripherally acting;C02CA04 - doxazosin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB02 - imiglucerase
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BB - Sulfonamides and potassium in combination -  low-ceiling diruetics -  excluding thiazides;C03BB07 - clofenamide and potassium
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD05 - interferon
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BC - Hepatitis vaccines;J07BC02 - hepatitis A -  inactivated -  whole virus
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB14 - cloprednol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AD - Papaverine and derivatives containing drugs for functional gastrointestinal disorders;A03AD02 - drotaverine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX10 - fumagillin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA07 - amphotericin B
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA57 - ethenzamide -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX04 - linaclotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD01 - scopolamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA03 - amphotericin B
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AA - Anticholinesterase parasympathomimetics;N07AA30 - ambenonium
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB03 - fluoxetine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AB - Methyldopa -  centrally acting adntiadrenergic agents;C02AB02 - methyldopa (racemic)
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC;C05AX02 - bismuth preparations -  combinations
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX52 - calcipotriol -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD11 - metformin and linagliptin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AD - Succinimide derivatives -  antiepileptics;N03AD03 - mesuximide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA07 - cyclopenthiazide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB02 - bisacodyl
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC30 - magnesium (different salts in combination)
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX18 - reboxetine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA06 - technetium (99mTc) arcitumomab
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA15 - butriptyline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD08 - metformin and vildagliptin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX03 - clofoctol
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CA - Diagnostic agents for diabetes testing;V04CA02 - glucose
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE08 - benzathine benzylpenicillin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA08 - cinitapride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CA - Sympathomimetics -  labour repressants;G02CA01 - ritodrine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE02 - sevelamer
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA05 - profenamine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB10 - perazine
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BA - Drugs used in nicotine dependence;N07BA01 - nicotine
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AA - Corticosteroids -  combinations for treatment of acne;D10AA01 - fluorometholone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE32 - cediranib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AB - Acid preparations -  digestives;A09AB02 - betaine hydrochloride
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AE - Benzodiazepine derivative antiepileptics;N03AE01 - clonazepam
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA51 - reserpine and diuretics -  combinations with other drugs
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB03 - technetium (99mTc) millimicrospheres
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA71 - phenprobamate -  combinations with psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR24 - lamivudine -  tenofovir disoproxil and doravirine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD02 - magnesium oxide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC01 - betamethasone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA01 - alfuzosin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BA - Pyrethrines;P03BA01 - cyfluthrin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AE - Iron in other combinations;B03AE02 - iron -  multivitamins and folic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA30 - piperidolate
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD03 - benzocaine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF04 - tranylcypromine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC04 - clopidogrel
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA05 - potassium gluconate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA14 - butizide and potassium-sparing agents
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB04 - crataegus glycosides
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AA - Lung surfactants;R07AA30 - lung surfactant combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA04 - methylpropylpropanediol dinitrate
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB27 - 4-dimethylaminophenol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01B - AMPHENICOLS;J01BA - Amphenicol antibacterials -  systemic;J01BA52 - thiamphenicol -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX05 - antazoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB06 - aloglutamol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE02 - leuprorelin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF07 - isoconazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AE - Indole derivatives -  antipsychotic;N05AE01 - oxypertine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE05 - histrelin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB14 - protamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA01 - ondansetron
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB07 - fructose 1 - 6-diphosphate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02D - ANTICESTODALS;P02DX - Other anticestodals in ATC;P02DX01 - desaspidin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA04 - chymotrypsin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB09 - interferon alfacon-1
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AC - Corticosteroids for local oral treatment;A01AC01 - triamcinolone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB05 - propenidazole
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA02 - biperiden
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX03 - metoprolol and acetylsalicylic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD02 - nicotinic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA12 - triamcinolone
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA04 - methoserpidine and diuretics
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LC - Imidazoline receptor agonists in combination with diuretics;C02LC05 - moxonidine and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC53 - lansoprazole -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BC - Solutions producing osmotic diuresis;B05BC02 - carbamide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA04 - progesterone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD01 - amiodarone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX01 - mercury compounds
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA05 - carindacillin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA02 - trichlormethiazide and potassium-sparing agents
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA06 - mycophenolic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD11 - various other agents for local oral treatment in ATC
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CB - Gold preparations;M01CB01 - sodium aurothiomalate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC29 - bermekimab
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA12 - reposal
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD03 - lansoprazole -  amoxicillin and metronidazole
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC02 - oxyphenbutazone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX05 - dimethylcarbate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC05 - ketorolac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA02 - ciprofloxacin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX15 - zonisamide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA04 - prednisolone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB01 - interferon alfa natural
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AB - Sulfonamides -  ophthalmologic antiinfectives;S01AB02 - sulfafurazole
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CB - Corticosteroids -  moderately potent -  combinations with antibiotics;D07CB03 - fluorometholone and antibiotics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CF - Benzodiazepine related hypnotics and sedatives;N05CF01 - zopiclone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC20 - vitamin D and analog combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH08 - meningococcus A - C - Y - W-135 -  tetravalent purified polysaccharides antigen conjugated
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB06 - alclofenac
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA03 - metamfetamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG10 - docusate sodium -  incl. combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AD - Purine derivatives -  peripheral vasodilators;C04AD02 - xantinol nicotinate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AB - Imidazole derivatives -  antimycotic for systemic use;J02AB02 - ketoconazole
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AA - Curare alkaloid muscle relaxants -  peripherally acting;M03AA01 - alcuronium
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX08 - ethanol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA07 - risedronic acid
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX06 - tetrabenazine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA10 - diphenadione
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA17 - potassium acetate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX68 - feprazone -  combinations
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC04 - fluocinolone acetonide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX60 - talazoparib
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA01 - phenylpropanolamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX03 - policresulen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX08 - heptaminol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FF - Lincosamides;J01FF01 - clindamycin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD03 - flunitrazepam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF11 - ketoconazole
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA09 - dexamethasone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD06 - von Willebrand factor and coagulation factor VIII in combination
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA05 - opium alkaloids with morphine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BX - Other anti-parathyroid agents in ATC;H05BX04 - etelcalcetide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA04 - ammonium chloride
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08B - X-RAY CONTRAST MEDIA -  NON-IODINATED;V08BA - Barium sulfate containing X-ray contrast media;V08BA02 - barium sulfate without suspending agents
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH06 - gemigliptin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE02 - gefitinib
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB11 - tiracizine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BX - Other hormone antagonists and related agents in ATC;L02BX01 - abarelix
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AH - Quinoline derivatives -  antiseptics and disinfectants;D08AH02 - chlorquinaldol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC17 - eberconazole
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC04 - chlormidazole
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BC - Antiarrhythmics -  class Ic;C01BC07 - lorcainide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB13 - pertussis immunoglobulin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CC - Colchicine derivatives -  antineooplastic;L01CC01 - demecolcine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA13 - hydroquinidine
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX11 - sodium chlorite
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB18 - prifinium bromide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB08 - neomycin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05A - PARATHYROID HORMONES AND ANALOGUES;H05AA - Parathyroid hormones and analogues;H05AA02 - teriparatide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AD - Thiocarbamide derivatives for treatment of tuberculosis;J04AD01 - protionamide
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB03 - atenolol and thiazides
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC02 - levocabastine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA04 - tripelennamine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AN - Medical gases;V03AN02 - carbon dioxide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX14 - dibrompropamidine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA06 - gelatin agents
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07F - ANTIDIARRHEAL MICROORGANISMS;A07FA - Antidiarrheal microorganisms;A07FA01 - lactic acid producing organisms
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ02 - cetrimonium
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CG - Alpha and beta blocking agents and other diuretics;C07CG01 - labetalol and other diuretics
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA04 - sodium salicylate
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE17 - dimazole
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DA - Technetium 99m compounds -  hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;V09DA03 - technetium (99mTc) lidofenin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA11 - gentamicin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB02 - bromhexine
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XA - iodine I-131 therapeutic radiopharmaceuticals;V10XA53 - tositumomab/iodine (131I) tositumomab
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CX - Other drugs used in benign prostatic hypertrophy in ATC;G04CX01 - Prunus africanae cortex
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA06 - candesartan and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE46 - encorafenib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AB - Iodine I-123 compounds -  CNS diagnostic radiopharmaceuticals;V09AB03 - iodine ioflupane (123I)
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AB - Preparations containing sulfur -  anti-acne preparations for topical use;D10AB02 - sulfur
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA15 - telithromycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD08 - becaplermin
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS;C08DB - Benzothiazepine derivative selective calcium channel blockers with direct cardiac effects;C08DB01 - diltiazem
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA07 - ethenzamide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AD - Iron in combination with folic acid;B03AD02 - ferrous fumarate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB07 - sulfathiazole
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BX - Other local anesthetics in ATC;N01BX01 - ethyl chloride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA11 - diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BB - Anti-androgen hormone antagonists and related agents;L02BB01 - flutamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA03 - calcium gluconate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX - Other central nervous system diagnostic radiopharmaceuticals in ATC;V09AX05 - florbetapir (18F)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA01 - diphtheria antitoxin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB02 - lidocaine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BB - Anti-androgen hormone antagonists and related agents;L02BB04 - enzalutamide
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CC - Nitrofuran derivatives -  antiprotozoal drugs;P01CC01 - nifurtimox
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EC - Aminosalicylic acid and similar agents;A07EC02 - mesalazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX11 - sodium benzoate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA08 - acetylcysteine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AA - Estrogens -  endocrine therapy drugs;L02AA01 - diethylstilbestrol
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB08 - ibacitabine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA06 - calcium lactate gluconate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE74 - bucetin -  combinations with psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA02 - ceratonia
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AD - Brucellosis vaccines;J07AD01 - brucella antigen
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA51 - acetylsalicylic acid -  combinations excl. psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE09 - tipranavir
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX02 - calcipotriol
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA01 - feather
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB05 - tolazamide
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX08 - framycetin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA04 - digitoxin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX01 - amlexanox
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA03 - butobarbital
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX58 - alverine -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD02 - trifluridine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03X - OTHER DIURETICS in ATC;C03XA - Vasopressin antagonists -  diuretics;C03XA02 - conivaptan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD11 - nabilone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA04 - streptomycin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BB - Sulfonamides and potassium in combination -  low-ceiling diruetics -  excluding thiazides;C03BB04 - chlortalidone and potassium
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09F - THYROID DIAGNOSTIC RADIOPHARMACEUTICALS;V09FX - Various thyroid diagnostic radiopharmaceuticals;V09FX02 - sodium iodide (123I)
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL02 - salbutamol and ipratropium bromide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD08 - cefixime
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG07 - sorbitol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AA - Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases;P01AA05 - tilbroquinol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA59 - doxylamine -  combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CA - Nitroimidazole derivatives -  antiprotozoal agents against leishmaniasis and trypanosomiasis;P01CA03 - fexinidazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE10 - avanafil
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC52 - methadone -  combinations excl. psycholeptics
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA16 - benzalkonium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC31 - methylestrenolone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX15 - pivagabine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA04 - chlorothiazide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CB - Zinc Supplements;A12CB03 - zinc protein complex
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA10 - ketazolam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA53 - loperamide -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ19 - oxycodone and ibuprofen
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CF - Avermectines;P02CF01 - ivermectin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ06 - codeine and paracetamol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01K - SURGICAL AIDS -  OPHTHALMOLOGIC;S01KA - Viscoelastic substances;S01KA51 - hyaluronic acid -  combinations
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA19 - phenol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LK - Alkaloids -  excl. rauwolfia -  in combination with diuretics;C02LK01 - veratrum and diuretics
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA11 - benzalkonium
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB05 - alendronic acid -  calcium and colecalciferol -  sequential
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA22 - ocriplasmin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA01 - dicoumarol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CX - Other gynecologicals in ATC;G02CX01 - atosiban
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX01 - glycerol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD12 - fluticasone furoate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XX - Various diagnostic radiopharmaceuticals;V09XX03 - selenium (75Se) norcholesterol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA03 - famotidine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA02 - sodium apolate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA02 - budesonide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA31 - teriflunomide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BB - Folic acid and derivatives as antianemics;B03BB01 - folic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AJ - Pertussis vaccines;J07AJ52 - pertussis -  purified antigen -  combinations with toxoids
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AP - Typhoid vaccines;J07AP01 - typhoid -  oral -  live attenuated
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM03 - bromisoval
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AA - Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases;P01AA52 - clioquinol -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX24 - epinastine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX19 - dasiprotimut-T
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX03 - BCG vaccine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XA - Antigonadotropins and similar agents;G03XA02 - gestrinone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB04 - theophylline and adrenergics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA04 - alendronic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD15 - macrogol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BJ - Rubella vaccines;J07BJ01 - rubella -  live attenuated
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB56 - senna glycosides -  combinations
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB02 - dexamethasone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01J - DIAGNOSTIC AGENTS -  OPHTHAMOLOGIC;S01JA - Diagnostic -  opthalmologic coloring agents;S01JA02 - rose bengal sodium
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC01 - ditazole
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF01 - isocarboxazid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC07 - conjugated estrogens and bazedoxifene
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA08 - gadobenic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX08 - raltegravir
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB10 - iomeprol
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB17 - droxypropine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA08 - hemophilus influenzae B and hepatitis B
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX02 - tizanidine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE04 - triclosan
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC09 - epinephrine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DC - Other cytotoxic antibiotics in ATC;L01DC04 - ixabepilone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC03 - lansoprazole
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX05 - rhenium (186Re) sulfide colloid
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA04 - simvastatin and fenofibrate
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX15 - mebhydrolin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA04 - megestrol and ethinylestradiol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC07 - bendazac
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX02 - cyproheptadine
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE08 - ticlatone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF04 - miconazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB03 - aluminium phosphate
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB24 - digitalis antitoxin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AB - Non-selective beta-adrenoreceptor agonist inhalants;R03AB02 - isoprenaline
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA02 - dipivefrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA08 - dihexyverine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AA - Butylpyrazolidines -  antiinflammatory and antirheumatic drugs;M01AA06 - kebuzone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA14 - dydrogesterone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA03 - disopyramide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA06 - ornithine oxoglurate
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02C - ANTIADRENAL PREPARATIONS;H02CA - Anticorticosteroids;H02CA01 - trilostane
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC06 - dexlansoprazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB09 - idursulfase
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX12 - fluciclovine (18F)
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BC - Antiarrhythmics -  class Ic;C01BC04 - flecainide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH06 - tebipenem pivoxil
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GB - Ovulation stimulants -  synthetic;G03GB01 - cyclofenil
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CC - Aldehydes and derivatives;N05CC03 - acetylglycinamide chloral hydrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC26 - inotuzumab ozogamicin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH01 - fentanyl
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD09 - mometasone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC06 - thonzylamine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BX - Other antitrematodal agents in ATC;P02BX03 - stibophen
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX16 - eflornithine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA01 - norethisterone and estrogen
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC11 - amcinonide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD12 - lactitol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AX - Other intestinal antiinfectives in ATC;A07AX01 - broxyquinoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD05 - metformin and pioglitazone
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA08 - aluminium chlorohydrate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD10 - quazepam
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA07 - clofenamide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX18 - vinpocetine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA04 - oxytetracycline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD11 - tenecteplase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX13 - rosuvastatin -  perindopril and indapamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA12 - tigecycline
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB02 - nalorphine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX09 - miltefosine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF12 - clevudine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB05 - oxolinic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC14 - trastuzumab emtansine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC06 - fluocortolone and antibiotics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FG - Streptogramins;J01FG01 - pristinamycin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AC - Oxazolidine derivatives -  antiepileptics;N03AC03 - ethadione
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC01 - edrecolomab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP09 - dasabuvir
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX05 - fipexide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC03 - alfacalcidol
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CB - Superparamagnetic contrast media;V08CB02 - ferristene
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AB - Choline derivative muscle relaxants -  peripherally acting;M03AB01 - suxamethonium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR50 - combinations of penicillins
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AC - Triazole derivatives -  systemic antimycotics;J02AC05 - isavuconazole
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA01 - cyanocobalamin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA14 - epinephrine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA21 - cafedrine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX13 - paliperidone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA03 - imipramine oxide
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CH - renal function and ureteral injuries test diagnostic agents;V04CH01 - inulin and other polyfructosans
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA20 - opium alkaloids and derivative combination cough suppressants
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA14 - loteprednol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA04 - cobamamide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB05 - pentoxyverine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD03 - insulin (pork)
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02B - PROTECTIVES AGAINST UV-RADIATION;D02BA - Protectives against UV-radiation for topical use;D02BA02 - octinoxate
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA32 - diphenhydramine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GA - Streptomycins;J01GA02 - streptoduocin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC12 - salmeterol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BC - Carbamate anxiolytics;N05BC01 - meprobamate
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA05 - althea root
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB23 - minocycline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR12 - lamivudine and tenofovir disoproxil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP56 - sofosbuvir -  velpatasvir and voxilaprevir
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC04 - quingestanol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CB - Belladonna and derivatives in combination with psycholeptics;A03CB01 - methylscopolamine and psycholeptics
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CX - Other agents against leishmaniasis and trypanosomiasis in ATC;P01CX03 - eflornithine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX77 - gefarnate -  combinations with psycholeptics
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA02 - procaine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB03 - atenolol
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC03 - fludroxycortide and antibiotics
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA58 - isosorbide dinitrate -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EE - Prostaglandin analogues -  antiglaucoma drugs and miotics;S01EE03 - bimatoprost
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX10 - virginiamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA55 - palonosetron -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB10 - cefacetrile
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BB - Corticosteroids -  moderately potent -  combinations with antiseptics;D07BB03 - triamcinolone and antiseptics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC06 - meloxicam
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC08 - piribedil
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX03 - ataluren
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AX - Other blood products in ATC;B05AX02 - thrombocytes
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA02 - retinol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA26 - nimesulide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX03 - iodine (125I) CC49-monoclonal antibody
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX08 - tenonitrozole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03E - ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;G03EK - Androgens and female sex hormones in combination with other drugs;G03EK01 - methyltestosterone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AG - Triazole derivatives -  gynecological antiinfectives and antiseptics;G01AG02 - terconazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03H - ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03HA - Antiandrogens -  plain;G03HA01 - cyproterone
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AA - Tetracycline and derivatives -  topical antibiotics;D06AA02 - chlortetracycline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB01 - anti-D (rh) immunoglobulin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AC - antacids containing calcium compounds;A02AC01 - calcium carbonate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED54 - metipranolol -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA05 - ipidacrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX08 - alverine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX19 - suloctidil
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CD - pituitary function test diagnostic agents;V04CD04 - corticorelin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED20 - Long-acting sulfonamide combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE05 - sulfadimidine and trimethoprim
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB05 - inosine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD18 - cefteram
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD02 - ceftazidime
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE39 - midostaurin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB08 - nemonoxacin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB53 - oxyphenonium -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ13 - tramadol and paracetamol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB02 - chlorpropamide
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AC - Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases;P01AC03 - etofamide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC05 - bezitramide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD05 - cefmenoxime
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA01 - acetyldigitoxin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BB - Antiarrhythmics -  class Ib;C01BB04 - aprindine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB54 - mephenytoin -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX01 - amsacrine
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01B - ANTIFUNGALS FOR SYSTEMIC USE;D01BA - Antifungals for systemic use;D01BA01 - griseofulvin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA10 - clindamycin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB10 - escitalopram
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA05 - hidrosmin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB18 - ranolazine
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03B - Corticosteroid ophthalmologic and otologic preparations;S03BA - Corticosteroids;S03BA02 - prednisolone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AA - Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases;P01AA02 - clioquinol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA05 - triflupromazine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC06 - etynodiol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA52 - donepezil and memantine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AX - Other antimycotics for systemic use in ATC;J02AX05 - micafungin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX01 - ipriflavone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DA - Actinomycines;L01DA01 - dactinomycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF06 - nafcillin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CX - Other plant alkaloids and natural products in ATC;L01CX01 - trabectedin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AX - Other alkylating agents in ATC;L01AX03 - temozolomide
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC02 - cadmium compounds
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC01 - dibrompropamidine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC11 - cisatracurium
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA08 - pitavastatin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BC - Ethers chemically close to antihistamines -  centrally acting muscle relaxants;M03BC51 - orphenadrine -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA07 - sotalol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB12 - arbekacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX16 - plerixafor
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA08 - diphemanil and psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD52 - ceftazidime and beta-lactamase inhibitor
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DC - Leukotriene receptor antagonists for obstructive airway diseases;R03DC02 - pranlukast
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB02 - risedronic acid and calcium -  sequential
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AE - Iron in other combinations;B03AE01 - iron -  vitamin B12 and folic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CB - Corticosteroids/antiinfectives/mydriatics in combination;S01CB04 - betamethasone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX04 - denosumab
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA21 - amikacin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CB - Non-selective beta-adrenoreceptor agonists for systemic use;R03CB02 - methoxyphenamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB15 - brivudine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB06 - otilonium bromide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX22 - phenibut
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB15 - erdosteine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA11 - indapamide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA01 - acetylsalicylic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA53 - methocarbamol -  combinations excl. psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09B - SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS;V09BA - Technetium 99m compounds -  skeletal system diagnostic radiopharmaceuticals;V09BA02 - technetium (99mTc) medronic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA24 - kanamycin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AD - Organic acids -  Gynecological;G01AD01 - lactic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA03 - valsartan and diuretics
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA05 - ramipril and diuretics
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB07 - pramocaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX05 - inosine pranobex
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX05 - meglutol
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA05 - mangafodipir
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA08 - nitrendipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CB - Podophyllotoxin derivatives -  antineoplastic drugs;L01CB01 - etoposide
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX12 - terfenadine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AB - Alkyl sulfonate alkylating agents;L01AB03 - mannosulfan
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX03 - methotrexate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD04 - streptozocin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC04 - estrone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA05 - trimebutine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB34 - fomepizole
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA01 - lovastatin and nicotinic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB03 - agalsidase alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA09 - metaraminol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB06 - ganciclovir
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB06 - simfibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CB - Beta blocking agents -  selective -  and other diuretics;C07CB03 - atenolol and other diuretics
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH06 - crisaborole
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA07 - technetium (99mTc) hynic-octreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB06 - sacrosidase
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BB - Corticosteroids and mydriatics in combination;S01BB02 - prednisolone and mydriatics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX06 - pomalidomide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA17 - prulifloxacin
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG30 - caffeine and sodium benzoate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL09 - formoterol -  glycopyrronium bromide and beclometasone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AD - Emergency contraceptive drugs;G03AD02 - ulipristal
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE05 - polynoxylin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CA - Corticosteroids -  weak -  combinations with antibiotics;D07CA03 - prednisolone and antibiotics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB06 - senna glycosides
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA03 - silymarin
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB05 - bemegride
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA55 - nifedipine -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB11 - pixantrone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AA - Butylpyrazolidines -  antiinflammatory and antirheumatic drugs;M01AA03 - oxyphenbutazone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA11 - levonorgestrel and estrogen
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA05 - melevodopa and decarboxylase inhibitor
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10B - ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE;D10BA - Retinoids for treatment of acne;D10BA01 - isotretinoin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AG - Opioids in combination with antispasmodics;N02AG03 - pethidine and antispasmodics
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BC - Corticosteroids -  potent -  combinations with antiseptics;D07BC01 - betamethasone and antiseptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH03 - ertapenem
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CC - Tetrahydropyrimidine derivatives -  antinematodal;P02CC01 - pyrantel
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA12 - tropatepine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX10 - bacitracin
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB08 - dimefline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC53 - tegafur -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE01 - buclizine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD15 - metformin and dapagliflozin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA07 - neomycin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC03 - chloropyramine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC06 - magnesium lactate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA07 - theobromine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03A - THYROID PREPARATIONS;H03AA - Thyroid hormones;H03AA04 - tiratricol
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AC - Nicotinic acid and derivatives -  peripheral vasodilators;C04AC02 - nicotinyl alcohol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD18 - metformin and gemigliptin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC12 - bambuterol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF03 - artesunate and amodiaquine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06C - PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION;N06CA - Antidepressants in combination with psycholeptics;N06CA03 - fluoxetine and psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB09 - bisoxatin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB53 - dantron -  combinations
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB52 - nikethamide -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA04 - dexfenfluramine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC03 - tetragalacturonic acid hydroxymethylester
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BG - Thiazolidinediones -  blood glucose lowering drugs;A10BG03 - pioglitazone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC11 - iloprost
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA10 - methoxamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AA - Antibiotics for systemic use;J02AA02 - hachimycin
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AA - 2-amino-1-phenylethanol derivatives;C04AA01 - isoxsuprine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA03 - albendazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DA - Pregnen (4) derivatives -  progestogens;G03DA03 - hydroxyprogesterone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CH - Melatonin receptor agonists -  hypnotics and sedatives;N05CH02 - ramelteon
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA12 - delapril
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BA - Calcitonin preparations;H05BA02 - calcitonin (pork natural)
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA15 - zofenopril
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XB - Methylhydrazines -  antineoplastics;L01XB01 - procarbazine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX03 - mianserin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE01 - hexachlorophene
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC06 - thrombin
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD54 - isotretinoin -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DC - Other cytotoxic antibiotics in ATC;L01DC01 - bleomycin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03B - ANDROGENS;G03BB - 5-androstanon (3) derivatives;G03BB01 - mesterolone
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AG - Iodine products -  antiseptics and disinfectants;D08AG02 - povidone-iodine
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA05 - nifedipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA02 - gadoteric acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM03 - ethambutol and isoniazid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB07 - risedronic acid and colecalciferol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX03 - olmesartan medoxomil -  amlodipine and hydrochlorothiazide
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX52 - emetine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA05 - levofloxacin and ornidazole
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA11 - tuaminoheptane
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP06 - asunaprevir
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA11 - rifaximin
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD07 - pramocaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC01 - diiodohydroxyquinoline
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AE - Ergot alkaloid peripheral vasodilators;C04AE02 - nicergoline
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX06 - potassium permanganate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX10 - mosapramine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BA - Charcoal preparations -  intestinal absorbents;A07BA51 - medicinal charcoal -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA08 - tetracycline and oleandomycin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB02 - benproperine
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA20 - various allergen extracts
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM10 - hexapropymate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EA - Technetium (99mTc) -  inhalants;V09EA03 - technetium (99mTc) nanocolloid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA11 - desonide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors;A10BK04 - ertugliflozin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA03 - potassium hydrogentartrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX10 - immunocyanin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX22 - perampanel
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BA - Anti-estrogens;L02BA01 - tamoxifen
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA02 - potassium iodide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP53 - ombitasvir -  paritaprevir and ritonavir
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX04 - calcium pantothenate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB11 - peginterferon alfa-2a
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA05 - sulfanilamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA05 - palonosetron
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BA - Vasopressin and analogues;H01BA03 - lypressin
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX26 - cetiedil
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD06 - acipimox
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01L - OCULAR VASCULAR DISORDER AGENTS;S01LA - Antineovascularisation agents;S01LA04 - ranibizumab
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA51 - dihydroergotamine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EC - Intermediate-acting sulfonamides;J01EC20 - Intermediate-acting sulfonamide combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA08 - megestrol and estrogen
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CC - Diagnostic agents for bile duct patency testing;V04CC04 - ceruletide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DX - Other anti-dementia drugs in ATC;N06DX30 - Other anti-dementia drug combinations in ATC
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD07 - dronedarone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX07 - nitroxoline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX19 - irinotecan
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED08 - sulfaphenazole
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX05 - mepacrine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD13 - coagulation factor X
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC05 - cefotetan
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA02 - fibrinolysin and desoxyribonuclease
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB03 - ornidazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA10 - cyclobarbital
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC08 - loracarbef
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX09 - eperisone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AC - Interleukins;L03AC01 - aldesleukin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC11 - ipilimumab
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA02 - rescinnamine and diuretics
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CC - Anti-gonadotropin-releasing hormones;H01CC02 - cetrorelix
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC04 - sermorelin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP03 - boceprevir
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EB - High-ceiling diuretics and potassium-sparing agents;C03EB02 - bumetanide and potassium-sparing agents
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB06 - golimumab
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB09 - hydrocortisone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AC - Anthrax vaccines;J07AC01 - anthrax antigen
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC05 - pramipexole
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX41 - eribulin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA13 - iprindole
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC08 - carbasalate calcium
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH05 - etoricoxib
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX04 - lithium succinate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CE - Imidazothiazole derivatives -  antinematodal;P02CE01 - levamisole
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX03 - propanol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AB - Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AB01 - chymopapain
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA04 - chlortalidone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB02 - nalidixic acid
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX15 - pipradrol
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02B - CORTICOSTEROIDS FOR SYSTEMIC USE -  COMBINATIONS;H02BX - Corticosteroids for systemic use -  combinations;H02BX01 - methylprednisolone -  combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX06 - benzyl alcohol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CD - Arsenic compounds -  for leishmaniasis and trypanosomiasis;P01CD01 - melarsoprol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA14 - fentiazac
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE24 - tavaborole
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB03 - dimetindene
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AC - Drugs used in hereditary angioedema;B06AC02 - icatibant
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX07 - prothipendyl
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC04 - attapulgite
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC13 - mometasone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AA - Antifibrinolytic amino acids;B02AA03 - aminomethylbenzoic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA53 - combinations of rauwolfia alkoloids -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA01 - diprophylline
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA02 - tetracycline
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB51 - phenazone -  combinations excl. psycholeptics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB05 - thiopropazate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC19 - olodaterol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA10 - calcium glucoheptonate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC07 - doxacurium chloride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CB - Synthetic estrogens -  plain;G03CB04 - moxestrol
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XA - iodine I-131 therapeutic radiopharmaceuticals;V10XA01 - sodium iodide (131I)
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX08 - avatrombopag
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA13 - calcium citrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE27 - ibrutinib
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA01 - nystatin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR19 - emtricitabine -  tenofovir alafenamide and rilpivirine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB08 - thioproperazine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03B - ANDROGENS;G03BA - 3-oxoandrosten (4) derivatives;G03BA01 - fluoxymesterone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB04 - aclarubicin
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA04 - pecilocin
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AA - Yttrium-90 antiinflammatory radiopharmaceuticals;V10AA03 - yttrium (90Y) silicate colloid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB09 - acetylcholine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XA - Platinum compounds -  antineoplastic drugs;L01XA04 - satraplatin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC03 - magnesium gluconate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC01 - pyrethrum
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX11 - trapidil
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA01 - vinblastine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA06 - ifosfamide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA02 - scopolamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AE - Sulfonamides -  Gynecological;G01AE01 - sulfatolamide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EX - Other antiglaucoma preparations in ATC;S01EX02 - dapiprazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD06 - misoprostol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC02 - salbutamol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AB - Scilla glycosides used in cardiac therapy;C01AB51 - proscillaridin -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB01 - heparin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CX - Other irrigating solutions in ATC;B05CX04 - mannitol
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ08 - benzethonium chloride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA14 - metampicillin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX35 - anagrelide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC16 - guselkumab
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX11 - sodium oxybate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DB - Hydrazinophthalazine derivatives acting on arteriolar smooth muscle;C02DB04 - cadralazine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EA - Prostaglandin cardiac therapy preparations;C01EA01 - alprostadil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BC - Other immunoglobulins in ATC;J06BC01 - nebacumab
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB02 - oxitropium bromide
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC05 - hexoprenaline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX01 - lentinan
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB31 - prussian blue
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB04 - propyphenazone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX22 - agomelatine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL07 - levosulpiride
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB09 - dimercaprol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA03 - valsartan
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AA - Technetium 99m compounds -  central nervous system diagnostic radiopharmaceuticals;V09AA02 - technetium (99mTc) bicisate
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA05 - ramipril
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA09 - chloroprednisone and antiinfectives
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX25 - Hyperici herba
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX21 - diacerein
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA11 - bendazac
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG06 - nefopam
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX07 - roflumilast
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AX - Other drugs for bile therapy in ATC;A05AX03 - cyclobutyrol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA01 - chorionic gonadotrophin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA03 - tocopherol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BH - Rota virus diarrhea vaccines;J07BH02 - rota virus -  pentavalent -  live -  reassorted
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE02 - methylrosaniline
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HB - Indium-111 inflammation and infection detection radiopharmaceuticals;V09HB02 - indium (111In) tropolonate labelled cells
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL06 - olodaterol and tiotropium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CX - Other high-ceiling diuretics in ATC;C03CX01 - etozolin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA06 - phenylephrine
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA05 - tree pollen allergenic extracts
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB16 - idursulfase beta
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA07 - talbutal
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB03 - aluminium clofibrate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD07 - tolterodine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA06 - crofelemer
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA08 - Food allergenic extracts
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB01 - ipecacuanha
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX06 - mupirocin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DA - Aldosterone antagonists;C03DA04 - eplerenone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB09 - levonorgestrel and estrogen
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA02 - levodopa and decarboxylase inhibitor
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA14 - pinazepam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD25 - metformin -  saxagliptin and dapagliflozin
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH03 - cromoglicic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE04 - nelfinavir
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01K - SURGICAL AIDS -  OPHTHALMOLOGIC;S01KA - Viscoelastic substances;S01KA02 - hypromellose
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA04 - aluminium acetotartrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC04 - rilonacept
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC09 - xenysalate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX02 - repaglinide
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AA - ACTH and synthetic analog preparations;H01AA01 - corticotropin
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX23 - aminobenzoate potassium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BF - Poliomyelitis vaccines;J07BF04 - poliomyelitis oral -  bivalent -  live attenuated
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB03 - dantron
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB53 - mepivacaine -  combinations
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM07 - triclofos
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD04 - isotretinoin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB73 - chlorzoxazone -  combinations with psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF07 - rasburicase
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BB - Sulfur-containing imidazole derivatives -  antithyroid preparations;H03BB01 - carbimazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX05 - pramlintide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BB - Sulfonamides and potassium in combination -  low-ceiling diruetics -  excluding thiazides;C03BB02 - quinethazone and potassium
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX07 - vincamine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CD - Corticosteroids -  very potent -  combinations with antibiotics;D07CD01 - clobetasol and antibiotics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02B - CONTRACEPTIVES FOR TOPICAL USE;G02BA - Intrauterine contraceptives;G02BA03 - plastic IUD with progestogen
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA57 - diphenylpyraline -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA35 - begelomab
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA14 - oxyquinoline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX55 - rucaparib
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05F - COUGH SUPPRESSANTS AND EXPECTORANTS -  COMBINATIONS;R05FB - Other cough suppressants and expectorants in ATC;R05FB02 - cough suppressants and expectorants
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AA - Anticholinesterase parasympathomimetics;N07AA03 - distigmine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA06 - triamcinolone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA08 - ethyl biscoumacetate
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CK - pancreatic function test diagnostic agents;V04CK03 - bentiromide
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC11 - tulobuterol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ01 - dihydrocodeine and paracetamol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA07 - calcium chloride
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA03 - mesulfen
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA01 - ambazone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA05 - gas-gangrene sera
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA02 - felodipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC02 - iotroxic acid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BA - Acidifiers;G04BA03 - calcium chloride
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AB - Preparations increasing uric acid excretion;M04AB04 - isobromindione
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA01 - phentermine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA09 - fluticasone furoate
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB12 - delapril and manidipine
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD51 - tretinoin -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD04 - oxybutynin
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03B - ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS;D03BA - Proteolytic enzymes for treatment of wounds and ulcers;D03BA02 - collagenase
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB08 - staphylococcus immunoglobulin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA02 - sodium monofluorophosphate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH04 - quetiapine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX22 - ebastine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AN - Tuberculosis vaccines;J07AN01 - tuberculosis -  live attenuated
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE11 - udenafil
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE15 - terbinafine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB03 - vidarabine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC03 - tegafur
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX38 - vorinostat
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB10 - Aluminium antacid compound combinations
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA04 - iotalamic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AB - Estren derivatives -  systemic;A14AB03 - oxabolone cipionate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC05 - iobenzamic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD01 - carmustine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC07 - frovatriptan
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX18 - letermovir
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA01 - dihydroergotamine
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA12 - Hederae helicis folium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA06 - diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB15 - zipeprol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA04 - methysergide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CE - Phosphodiesterase inhibitors -  cardiac stimulant;C01CE04 - bucladesine
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF51 - clindamycin -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC54 - brinzolamide -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CC - Diagnostic agents for bile duct patency testing;V04CC01 - sorbitol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA51 - naphazoline -  combinations
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA02 - sulfathiazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX06 - miglustat
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX30 - various other anti-acne preparation combinations for topical use in ATC
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XB - Polymyxins;J01XB02 - polymyxin B
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB04 - interferon alfa-2a
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB08 - desonide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC02 - cefuroxime
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AB - Phenylpiperidine derivatives -  opioid analgesics;N02AB02 - pethidine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH05 - anileridine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AX - Other opioids in ATC;N02AX01 - tilidine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX10 - fluoroethyl-L-tyrosine (18F)
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CX - Other capillary stabilizing agents in ATC;C05CX02 - naftazone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA01 - quinidine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AD - Calcineurin inhibitors;L04AD01 - ciclosporin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX02 - emetine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB06 - prednisolone
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03C - Corticosteroids and antiinfectives in combination -  opthalmologic and otologic;S03CA - Corticosteroids and antiinfectives in combination;S03CA02 - prednisolone and antiinfectives
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BA - Charcoal preparations -  intestinal absorbents;A07BA01 - medicinal charcoal
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA05 - potassium clorazepate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CB - Sulfonamides and potassium in combination -  high-ceiling diruetics -  excluding thiazides;C03CB01 - furosemide and potassium
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE03 - argatroban
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC21 - ramucirumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED05 - sulfamethoxypyridazine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA07 - fluorometholone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BA - Aminoquinoline antimalarials;P01BA02 - hydroxychloroquine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG04 - etravirine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB30 - combinations of corticosteroids
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX06 - mephenesin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD19 - magnesium citrate
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03C - Corticosteroids and antiinfectives in combination -  opthalmologic and otologic;S03CA - Corticosteroids and antiinfectives in combination;S03CA05 - fludrocortisone and antiinfectives
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA03 - domperidone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB06 - chlormadinone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX12 - acetylcarnitine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE55 - meclozine -  combinations
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC01 - somatropin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AE - Serotonin receptor antagonists for functional gastrointestinal disorders;A03AE01 - alosetron
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX01 - minoxidil
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX19 - azelastine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA07 - sotalol and thiazides
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA08 - medroxyprogesterone and ethinylestradiol
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF04 - meclocycline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE06 - bivalirudin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH02 - rofecoxib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD03 - metformin and rosiglitazone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H04 - PANCREATIC HORMONES;H04A - GLYCOGENOLYTIC HORMONES;H04AA - Glycogenolytic hormones;H04AA01 - glucagon
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE03 - propicillin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AA - Curare alkaloid muscle relaxants -  peripherally acting;M03AA04 - dimethyltubocurarine
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA06 - triclosan
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA10 - nortriptyline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AB - Ergot alkaloid oxytocics;G02AB03 - ergometrine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA26 - belimumab
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BX - ACE inhibitors -  other combinations in ATC;C09BX02 - perindopril and bisoprolol
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB12 - bibenzonium bromide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA02 - sulfonamides -  combinations with other antibacterials (excl. trimethoprim)
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA02 - clodronic acid
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB02 - choline theophyllinate and adrenergics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA04 - oxymetazoline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE06 - penamecillin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX21 - serelaxin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR16 - lamivudine and raltegravir
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA02 - microparticles of galactose
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AX - Other peripherally acting muscle relaxants in ATC;M03AX01 - botulinum toxin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CE - Piperidinedione derivatives -  hypnotics and sedatives;N05CE01 - glutethimide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX03 - piracetam
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE24 - ponatinib
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CX - Other cardiac stimulants in ATC;C01CX06 - angiotensinamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AC - Triazole derivatives -  systemic antimycotics;J02AC03 - voriconazole
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB05 - iopromide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC04 - ethisterone
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA05 - sulfur hexafluoride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX12 - bismuth subnitrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XY - Combinations of antineoplastic agents;L01XY01 - cytarabine and daunorubicin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC04 - atracurium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CB - Synthetic estrogens -  plain;G03CB01 - dienestrol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA15 - zofenopril and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BF - Alpha glucosidase inhibitors -  blood glucose lowering;A10BF03 - voglibose
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XB - Amino Acids -  I.V. solution additive;B05XB02 - alanyl glutamine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA13 - pegfilgrastim
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA09 - trolnitrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XA - Platinum compounds -  antineoplastic drugs;L01XA01 - cisplatin
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA03 - pravastatin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA10 - Magnesium antacid compound combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB03 - tioguanine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB01 - doxorubicin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BB - Influenza vaccines;J07BB03 - influenza -  live attenuated
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CB - Salt irrigating solutions;B05CB02 - sodium citrate
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA06 - cerivastatin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CX - Other irrigating solutions in ATC;B05CX01 - glucose
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK06 - salmeterol and fluticasone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CX - Other cardiac stimulants in ATC;C01CX09 - angiotensin II
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BC - Bone morphogenetic proteins;M05BC02 - eptotermin alfa
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB19 - physostigmine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA53 - tamsulosin and solifenacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA03 - melphalan
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01B - ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION;M01BA - Antiinflammatory/antirheumatic agents in combination with corticosteroids;M01BA03 - acetylsalicylic acid and corticosteroids
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA53 - tetracaine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX30 - other nasal preparation combinations in ATC
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD01 - emepronium
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DB - Hydrazinophthalazine derivatives acting on arteriolar smooth muscle;C02DB01 - dihydralazine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK09 - formoterol and mometasone
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB06 - thiosulfate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA09 - syrosingopine and diuretics
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD53 - dexamethasone -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX07 - fluorocholine(18F)
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB02 - cinchocaine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX07 - nusinersen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA16 - empegfilgrastim
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC30 - Platelet aggregation inhibitor combinations excl. heparin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02B - Corticosteroid otologicals;S02BA - Corticosteroids;S02BA07 - betamethasone
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AC - Imidazoline receptor agonists;C02AC04 - tolonidine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BA - Thiouracil antithyroid preparations;H03BA01 - methylthiouracil
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA14 - mepindolol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG03 - glafenine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB74 - propyphenazone -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB05 - ramipril and felodipine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB05 - quinisocaine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA07 - lofepramine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA06 - methoserpidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AB - Preparations for biliary tract therapy;A05AB01 - nicotinyl methylamide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC04 - droxicam
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AB - Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AB52 - trypsin -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA05 - technetium (99mTc) furifosmin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AD - antacids containing combinations and complexes of aluminium -  calcium and magnesium compounds;A02AD01 - ordinary salt combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC09 - briakinumab
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KC - MAO inhibitors -  antihypertensives;C02KC01 - pargyline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03H - ANTIANDROGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03HB - Antiandrogens and estrogens;G03HB01 - cyproterone and estrogen
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10B - ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE;D10BX - Other anti-acne preparations for systemic use in ATC;D10BX01 - ichtasol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA12 - delapril and diuretics
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA10 - fimasartan and diuretics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB02 - fluphenazine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX01 - cyclandelate
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AX - Other throat preparations in ATC;R02AX01 - flurbiprofen
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BE - Artemisinin and derivatives -  plain;P01BE03 - artesunate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AB - Scilla glycosides used in cardiac therapy;C01AB01 - proscillaridin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA11 - doxofylline
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AD - Benzomorphan derivative analgesics;N02AD02 - phenazocine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX17 - pimavanserin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA02 - chlortetracycline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE21 - regorafenib
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE05 - propacetamol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA17 - bopindolol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX03 - malathion
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX08 - tyrothricin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX10 - masoprocol
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CA - sulfonamides -  high-ceiling diuretics -  plain;C03CA04 - torasemide
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX12 - gabapentin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA07 - tetracycline
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA01 - dexamethasone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB11 - trimegestone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX12 - lomitapide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH05 - other meningococcal polyvalent purified polysaccharides antigen
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA15 - benidipine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA06 - fenbendazole
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX18 - feprazone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD13 - cinolazepam
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA28 - belatacept
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA11 - magnesium chloride
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX03 - xaliproden
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA16 - ibopamine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC74 - dextropropoxyphene -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX18 - linsidomine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX04 - nedocromil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC06 - methylcellulose
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AF - Antacids with antiflatulents;A02AF01 - magaldrate and antiflatulents
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC11 - oxiconazole
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC06 - diamorphine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA07 - lidocaine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AF - Thioxanthene derivatives -  antipsychotic;N05AF03 - chlorprothixene
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AB - Peripherally acting antiobesity products;A08AB01 - orlistat
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX07 - azelastine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AX - Other intestinal antiinfectives in ATC;A07AX04 - nifurzide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04B - DRUGS FOR TREATMENT OF LEPRA;J04BA - Drugs for treatment of lepra;J04BA03 - aldesulfone sodium
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE04 - fenoprofen
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB08 - reviparin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX13 - protiofate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB21 - regadenoson
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB02 - hydroflumethiazide and potassium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB02 - hydrogen peroxide
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07C - ANTIVERTIGO PREPARATIONS;N07CA - Antivertigo preparations;N07CA52 - cinnarizine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AB - Antibiotic throat preparations;R02AB01 - neomycin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BA - Acidifiers;G04BA01 - ammonium chloride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ01 - exenatide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE07 - suprofen
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AD - local anesthetic throat preparations;R02AD02 - lidocaine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA14 - sodium glycerophosphate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB15 - diphemanil
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AB - Antibiotic throat preparations;R02AB04 - bacitracin
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA14 - clemastine
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AE - Peroxide anti-acne preparations for topical use;D10AE51 - benzoyl peroxide -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AB - Arsenic compounds -  Gynecological;G01AB01 - acetarsol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC14 - sertaconazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ04 - albiglutide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX51 - cromoglicic acid -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC53 - sterculia -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AC - Bile acid sequestrants;C10AC03 - colextran
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AF - Nitrofuran derivatives -  antiseptics and disinfectants;D08AF01 - nitrofural
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AC - Cyclic amines -  direct acting antivirals;J05AC03 - tromantadine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE07 - apomorphine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA22 - proxibarbal
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE51 - ibuprofen -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB05 - polynoxylin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AC - antacids containing calcium compounds;A02AC10 - Calcium antacid compound combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA08 - choriogonadotropin alfa
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK03 - mercuric chloride
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AC - Ethylene imines -  antineoplastic alkylating drugs;L01AC03 - carboquone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA07 - adinazolam
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA12 - levofloxacin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA02 - opium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA05 - oxymetholone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AF - Insulins and analogues for inhalation;A10AF01 - insulin (human)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH02 - other meningococcal monovalent purified polysaccharides antigen
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CH - renal function and ureteral injuries test diagnostic agents;V04CH30 - aminohippuric acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB05 - cefadroxil
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB16 - aceclofenac
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX23 - mitotane
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CA - sulfonamides -  high-ceiling diuretics -  plain;C03CA01 - furosemide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CC - Aryloxyacetic acid derivatives -  high-ceiling diuretics;C03CC02 - tienilic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XA - Glycopeptide antibacterials;J01XA05 - oritavancin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX05 - bacitracin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA03 - antilymphocyte immunoglobulin (horse)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA02 - pivampicillin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA31 - electrolytes in combination with other drugs
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB03 - fluprednidene
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA03 - camylofin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE05 - meclozine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC04 - debrisoquine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA19 - gusperimus
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB01 - alglucerase
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA08 - oxandrolone
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CA - Alpha-adrenoreceptor antagonists -  peripherally acting;C02CA03 - trimazosin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BC - Hepatitis vaccines;J07BC01 - hepatitis B -  purified antigen
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AA - Barbiturates and derivatives;N03AA04 - barbexaclone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD07 - famciclovir
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CA - Beta blocking agents -  non-selective -  and other diuretics;C07CA17 - bopindolol and other diuretics
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH02 - alfentanil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC12 - cefminox
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX03 - sodium phenylbutyrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB10 - hexocyclium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG01 - nevirapine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA09 - cyclothiazide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED02 - sulfalene
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB05 - fluperolone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC15 - aloxiprin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB04 - insulin lispro
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX11 - hydroquinone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BX - Other antithyroid preparations in ATC;H03BX01 - diiodotyrosine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03X - OTHER ANTIANEMIC PREPARATIONS in ATC;B03XA - Other antianemic preparations in ATC;B03XA01 - erythropoietin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA05 - chloramphenicol
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC;C05AX04 - zinc preparations
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA02 - chlordiazepoxide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX06 - tegaserod
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XE - Nitrofuran derivatives -  antibacterials for systemic use;J01XE03 - furazidin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB03 - tetryzoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA02 - pitofenone and analgesics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA08 - carfecillin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD04 - flunisolide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC18 - triflusal
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB08 - fluvoxamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA12 - ciprofloxacin and ornidazole
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX29 - bilastine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD06 - efaproxiral
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX07 - minaprine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD16 - mannitol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF01 - artemether and lumefantrine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CD - Taxanes -  antineoplastic;L01CD03 - paclitaxel poliglumex
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA14 - heparin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03X - OTHER ANTIANEMIC PREPARATIONS in ATC;B03XA - Other antianemic preparations in ATC;B03XA04 - peginesatide
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KB - Tyrosine hydroxylase inhibitors -  antihypertensives;C02KB01 - metirosine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA05 - atorvastatin and ezetimibe
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AC - Phenothiazines with piperidine structure -  antipsychotics;N05AC03 - mesoridazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB07 - netilmicin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA05 - camylofin and analgesics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB38 - andexanet alfa
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA06 - ferrous succinate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA09 - gadobutrol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE05 - insulin detemir
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC01 - acetazolamide
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA03 - nitrofural
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD08 - uramustine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC01 - absorbable gelatin sponge
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BM - Papillomavirus vaccines;J07BM03 - papillomavirus (human types 6 -  11 -  16 -  18 -  31 -  33 -  45 -  52 -  58)
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA10 - trandolapril
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC63 - clenbuterol and ambroxol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA07 - josamycin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AB - Proteinase inhibitors -  antifibrinolytic;B02AB01 - aprotinin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA30 - gonadotropin combinations
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE09 - sulbentine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA23 - natalizumab
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB06 - xylometazoline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX10 - succinimide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC04 - brinzolamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BB - Belladonna alkaloids -  semisynthetic -  quaternary ammonium compounds for functional gastrointestinal disorders;A03BB03 - methylscopolamine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX03 - tiadenol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AA - Alpha- and beta-adrenoreceptor agonist inhalants;R03AA01 - epinephrine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA15 - dienogest and estrogen
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA19 - ampicillin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA03 - diphtheria-rubella-tetanus
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CB - Antimony compounds for treatment of leishmaniasis and trypanosomiasis;P01CB02 - sodium stibogluconate
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX07 - triprolidine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AE - Indole derivatives -  antipsychotic;N05AE03 - sertindole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11A - MULTIVITAMINS -  COMBINATIONS;A11AA - Multivitamins with minerals;A11AA02 - multivitamins and calcium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC01 - allylestrenol
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB02 - iohexol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB06 - fosfocreatine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA03 - tetracaine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA08 - cilazapril and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX42 - panobinostat
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EA - Trimethoprim and derivatives -  systemic antibacterials;J01EA02 - brodimoprim
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AG - Hemophilus influenzae B vaccines;J07AG52 - hemophilus influenzae B -  combinations with pertussis and toxoids
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB07 - secnidazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD11 - fesoterodine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB09 - ubidecarenone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors;A10BK02 - canagliflozin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BC - Solutions producing osmotic diuresis;B05BC01 - mannitol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA06 - etynodiol and estrogen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX45 - carfilzomib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA06 - eluxadoline
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IB - Indium-111 tumour detection radiopharmaceuticals;V09IB02 - indium (111In) satumomab pendetide
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB16 - ethanol
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX02 - dextranomer
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AM - Tetanus vaccines;J07AM01 - tetanus toxoid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AB - Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AB02 - collagenase clostridium histolyticum
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX03 - sitaxentan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA03 - tropisetron
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB01 - etanercept
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE51 - leuprorelin and bicalutamide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB71 - phenazone -  combinations with psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB03 - edetates
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BE - Mumps vaccines;J07BE01 - mumps -  live attenuated
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE31 - nintedanib
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA27 - cloranolol
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE04 - calcium acetate and magnesium carbonate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX05 - methenamine
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AA - Lung surfactants;R07AA02 - natural phospholipids
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX11 - bencyclane
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LC - Imidazoline receptor agonists in combination with diuretics;C02LC51 - clonidine and diuretics -  combinations with other drugs
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA21 - tolmetin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD11 - catridecacog
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AC - Imidazoline receptor agonists;C02AC01 - clonidine
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX08 - tiratricol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE30 - insulins and analogs for injection combinations -  long-acting
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02D - OTHER OTOLOGICALS in ATC;S02DA - Analgesics and anesthetics;S02DA02 - cocaine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA17 - amoxapine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX14 - iloperidone
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA13 - bendroflumethiazide and potassium-sparing agents
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC01 - piroxicam
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE07 - calcium acetate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD04 - magnesium sulfate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB04 - adalimumab
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA02 - technetium (99mTc) tetrofosmin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA09 - ofloxacin and ornidazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA20 - calcium (different salts in combination)
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF06 - iproclozide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AA - Preparations inhibiting uric acid production;M04AA01 - allopurinol
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BA - Drugs used in nicotine dependence;N07BA03 - varenicline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE34 - tivozanib
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AA - Corticosteroids -  combinations for treatment of acne;D10AA03 - dexamethasone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA73 - methocarbamol -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD02 - tetracaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC05 - dequalinium
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB05 - technetium (99mTc) sulfur colloid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AE - Iron in other combinations;B03AE04 - iron -  multivitamins and minerals
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS;C08DA - Phenylalkylamine derivatives -  selective calcium channel blockers with direct cardiac effects;C08DA02 - gallopamil
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA03 - terazosin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BA - Pyrethrines;P03BA03 - decamethrin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA30 - emepronium and psycholeptics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AG - Diphenylbutylpiperidine derivatives -  antipsychotics;N05AG01 - fluspirilene
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD05 - procaine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC10 - magnesium oxide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05F - COUGH SUPPRESSANTS AND EXPECTORANTS -  COMBINATIONS;R05FA - Opium derivatives and expectorants;R05FA02 - opium derivatives and expectorants
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB05 - enoxaparin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA07 - cathine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE17 - dexketoprofen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE01 - ibuprofen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BA - biguanide blood glucose lower drugs;A10BA02 - metformin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX03 - batroxobin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR01 - zidovudine and lamivudine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AH - Peripheral opioid receptor antagonists;A06AH05 - naldemedine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB04 - demecarium
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX01 - cromoglicic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX15 - cloridarol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA13 - prenalterol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA06 - tetryzoline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB08 - pirarubicin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC55 - colecalciferol -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XX - Various therapeutic radiopharmaceuticals;V10XX03 - radium (223Ra) dichloride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA14 - flurithromycin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA12 - acetyldihydrocodeine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD10 - metformin and saxagliptin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA04 - proxymetacaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE10 - benzathine phenoxymethylpenicillin
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC03 - levacetylmethadol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EX - Other antiglaucoma preparations in ATC;S01EX06 - omidenepag
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX08 - policosanol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC06 - guanazodine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC09 - tretoquinol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB07 - fluostigmine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC06 - capecitabine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC09 - desogestrel
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR04 - zidovudine -  lamivudine and abacavir
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB15 - tibezonium iodide
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB08 - celiprolol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA07 - inositol
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ59 - dodeclonium bromide -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB51 - pilocarpine -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD04 - carboprost
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC11 - siltuximab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA01 - erythromycin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC09 - floxuridine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AD - Non-watersoluble X-ray contrast media;V08AD02 - iopydol
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA11 - polymyxin B
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB07 - talastine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA13 - leflunomide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA12 - piperacillin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA14 - gentamicin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE04 - yohimbine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD08 - oxomemazine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX25 - chondroitin sulfate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA07 - alum
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA04 - fluocortolone and antiinfectives
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA17 - fludiazepam
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA22 - tosufloxacin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA05 - follitropin alfa
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD10 - lansoprazole -  amoxicillin and levofloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC14 - sarilumab
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AA - Mineralocorticoids for systemic use -  plain;H02AA03 - desoxycortone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA18 - meclofenamic acid
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX02 - chloramphenicol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BX - Other antimalarials in ATC;P01BX02 - arterolane and piperaquine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XA - Glycopeptide antibacterials;J01XA02 - teicoplanin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA01 - demeclocycline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EC - Intermediate-acting sulfonamides;J01EC02 - sulfadiazine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB02 - metamizole sodium
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL05 - amisulpride
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CB - diagnostic agents for fat absorption testing;V04CB01 - vitamin A concentrates
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA07 - fluorometholone and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL01 - fenoterol and ipratropium bromide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA09 - tetracycline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF04 - stavudine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC06 - cetuximab
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KA - Alkaloids -  excl. rauwolfia -  antihypertensives;C02KA01 - veratrum
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA38 - ozanimod
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB02 - cefaloridine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DB - Other potassium-sparing agents in ATC;C03DB01 - amiloride
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CE - liver functional capacity test diagnostic agents;V04CE02 - sulfobromophthalein
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA01 - phenprobamate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB13 - oxametacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA19 - limbal stem cells -  autologous
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB54 - chlorphenamine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AD - Papaverine and derivatives containing drugs for functional gastrointestinal disorders;A03AD01 - papaverine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA10 - fenetylline
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA12 - barnidipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA05 - vinflunine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CC - Antiinflammatory products for vaginal administration;G02CC03 - benzydamine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC17 - bitolterol
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AE - Peroxide anti-acne preparations for topical use;D10AE01 - benzoyl peroxide
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AB - Thyrotropin Class in ATC;H01AB01 - thyrotropin alfa
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE22 - naftifine
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07C - ANTIVERTIGO PREPARATIONS;N07CA - Antivertigo preparations;N07CA02 - cinnarizine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AC - Iron chelating agents;V03AC01 - deferoxamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XD - Imidazole derivatives -  antibacterial for systemic use;J01XD03 - ornidazole
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX13 - valbenazine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA04 - styramate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE14 - dexibuprofen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DE - Fourth-generation cephalosporins;J01DE03 - cefozopran
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF06 - artesunate and pyronaridine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA04 - lymecycline
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX03 - dibutylphthalate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA09 - bufexamac
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA59 - codeine -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA06 - betaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD15 - cefdinir
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA07 - modafinil
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG06 - tiagabine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA02 - monoxerutin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE06 - dasatinib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AA - Bile acids and derivatives for bile therapy;A05AA01 - chenodeoxycholic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BC - Ethers chemically close to antihistamines -  centrally acting muscle relaxants;M03BC01 - orphenadrine (citrate)
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC08 - fluocinonide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB22 - meprotixol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BB - Antiarrhythmics -  class Ib;C01BB01 - lidocaine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BB - Diphenylmethane derivatives -  anxiolytics;N05BB02 - captodiame
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG02 - betazole
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG05 - methylthioninium chloride
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA09 - dextromethorphan
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB01 - dydrogesterone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BD - Measles vaccines;J07BD51 - measles -  combinations with mumps -  live attenuated
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA02 - levomepromazine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE01 - polystyrene sulfonate
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC06 - thonzylamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA01 - ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF03 - meticillin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED04 - metipranolol
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AB - Imidazoline derivatives -  peripheral vasodilators;C04AB02 - tolazoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA02 - clidinium and psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD62 - cefoperazone and beta-lactamase inhibitor
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX06 - hexobendine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB07 - ioversol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD03 - melperone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD01 - flurazepam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA32 - pantethine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB09 - ferric proteinsuccinylate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BA - Folic acid analogs -  antimetabolites;L01BA03 - raltitrexed
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB07 - bisoprolol and thiazides
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA05 - glycopyrronium bromide and psycholeptics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX13 - glatiramer acetate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA11 - diflunisal
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BX - Other anti-parathyroid agents in ATC;H05BX02 - paricalcitol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA02 - sodium bicarbonate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH04 - alogliptin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA01 - albumin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA07 - lisuride
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD04 - coagulation factor IX
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX06 - phenazopyridine
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC02 - miconazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CE - Selenium supplements;A12CE01 - sodium selenate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA14 - guacetisal
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA06 - chlortalidone and potassium-sparing agents
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BB - Solutions affecting the electrolyte balance;B05BB04 - electrolytes in combination with other drugs
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA09 - azlocillin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX19 - carisbamate
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XC - Corticosteroids -  potent -  other combinations;D07XC03 - mometasone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED51 - timolol -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA02 - donepezil
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AX - Other respiratory system products in ATC;R07AX02 - ivacaftor
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BA - Encephalitis vaccines;J07BA03 - encephalitis -  Japanese -  live attenuated
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX53 - oxyfedrine -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA02 - enalapril and diuretics
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA02 - mepyramine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AR - Arsenic compounds -  for amoebiasis and other protozoal diseases;P01AR01 - arsthinol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB03 - oxyphenonium
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX01 - simvastatin and acetylsalicylic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB12 - glimepiride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH51 - sitagliptin and simvastatin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB02 - tromantadine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR03 - ticarcillin and beta-lactamase inhibitor
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GX - Other cardiovascular system diagnostic radiopharmaceuticals in ATC;V09GX02 - indium (111In) imciromab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX05 - fenoverine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DA - Thiazide derivatives acting on arteriolar smooth muscle;C02DA01 - diazoxide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD01 - omeprazole -  amoxicillin and metronidazole
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB04 - mephenytoin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA51 - potassium chloride -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LC - Imidazoline receptor agonists in combination with diuretics;C02LC01 - clonidine and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC25 - mogamulizumab
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE04 - triptorelin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AN - Medical gases;V03AN01 - oxygen
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB13 - obidoxime
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB08 - interferon beta-1b
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA05 - ajmaline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA09 - sparfloxacin
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AD - Psoralens for topical use;D05AD02 - methoxsalen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA03 - ethisterone and estrogen
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX11 - topiramate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX02 - sotalol and acetylsalicylic acid
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA01 - trihexyphenidyl
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA51 - epinephrine -  combinations
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX18 - diclofenac
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG10 - cannabinoids
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03C - Corticosteroids and antiinfectives in combination -  opthalmologic and otologic;S03CA - Corticosteroids and antiinfectives in combination;S03CA06 - betamethasone and antiinfectives
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE07 - clometocillin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA07 - itopride
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02B - Corticosteroid otologicals;S02BA - Corticosteroids;S02BA01 - hydrocortisone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD07 - metformin and sitagliptin
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA11 - fluocinonide
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX21 - naftidrofuryl
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD01 - niceritrol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AD - Phosphonic acid derivatives -  direct acting antivirals;J05AD01 - foscarnet
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA03 - deserpidine and diuretics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CC - Aldehydes and derivatives;N05CC05 - paraldehyde
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB51 - metronidazole -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE09 - temsirolimus
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX02 - xibornol
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CA - Diagnostic agents for diabetes testing;V04CA01 - tolbutamide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA03 - pamidronic acid
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA04 - procyclidine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA10 - Antiinfective irrigating solution combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX04 - tolperisone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR23 - atazanavir and ritonavir
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX10 - nizofenone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CA - Sympathomimetics -  labour repressants;G02CA03 - fenoterol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC52 - histapyrrodine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH55 - panipenem and betamipron
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA56 - lorazepam -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA06 - ibandronic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD01 - magnesium carbonate
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AZ - Nerve depressant drugs;V03AZ01 - ethanol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP01 - ribavirin
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF02 - erythromycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BA - Immunoglobulins -  normal human;J06BA02 - immunoglobulins -  normal human -  for intravascular adm.
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA06 - norgestrel and ethinylestradiol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AB - Acid preparations -  digestives;A09AB01 - glutamic acid hydrochloride
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA50 - combination of rauwolfia alkaloids and diuretics incl. other combinations
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB02 - technetium (99mTc) microcolloid
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB12 - ioxilan
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB19 - dropropizine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC03 - picotamide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF03 - phenelzine
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CM - fertility disturbances test diagnostic agents;V04CM01 - gonadorelin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC06 - acetylsalicylic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AB - Acid preparations -  digestives;A09AB04 - citric acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01J - DIAGNOSTIC AGENTS -  OPHTHAMOLOGIC;S01JA - Diagnostic -  opthalmologic coloring agents;S01JA51 - fluorescein -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD61 - lactulose -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE01 - buserelin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF06 - ornidazole
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08B - X-RAY CONTRAST MEDIA -  NON-IODINATED;V08BA - Barium sulfate containing X-ray contrast media;V08BA01 - barium sulfate with suspending agents
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX04 - phenindamine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC09 - pranoprofen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB03 - indometacin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK13 - salbutamol and beclometasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB05 - aluminium acetoacetate
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB26 - methionine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AJ - Pertussis vaccines;J07AJ51 - pertussis -  inactivated -  whole cell -  combinations with toxoids
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB12 - hexetidine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB02 - metoprolol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC02 - gallamine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB06 - cinchocaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CG - Beta-lactamase inhibitors -  systemic penicillins;J01CG01 - sulbactam
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA07 - antimony pentasulfide
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX09 - crilanomer
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA11 - miocamycin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB09 - ropivacaine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD02 - promethazine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD01 - dinoprost
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC06 - medroxyprogesterone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CB - Belladonna and derivatives in combination with psycholeptics;A03CB03 - atropine and psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB05 - rifapentine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AE - Ergot alkaloid peripheral vasodilators;C04AE54 - dihydroergocristine -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA07 - acetrizoic acid
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX07 - erenumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AD - antacids containing combinations and complexes of aluminium -  calcium and magnesium compounds;A02AD05 - almasilate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA01 - dexamethasone and antiinfectives
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BB - Influenza vaccines;J07BB01 - influenza -  inactivated -  whole virus
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CC - Antiinflammatory agents -  non-steroids and antiinfectives in combination;S01CC02 - indometacin and antiinfectives
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA04 - potassium iodide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA28 - piketoprofen
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CB - Piperazine and derivatives -  antinematodal agents;P02CB02 - diethylcarbamazine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB05 - betaxolol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG07 - flupirtine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AA - 2-amino-1-phenylethanol derivatives;C04AA31 - bamethan
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL02 - sultopride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB12 - ceftezole
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB03 - lisinopril and amlodipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA10 - sirolimus
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AA - Corticosteroids -  weak (group I);D07AA02 - hydrocortisone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD05 - hydroxyethylpromethazine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AX - Other therapeutic products in ATC;V03AX03 - cobicistat
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX05 - aceneuramic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AD - Iron in combination with folic acid;B03AD01 - ferrous amino acid complex
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX12 - amikacin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB04 - chlorphenamine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA01 - rescinnamine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX33 - celecoxib
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX15 - atorvastatin and perindopril
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DX - Other anti-dementia drugs in ATC;N06DX02 - Ginkgo folium
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA09 - meticrane
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC02 - naratriptan
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX10 - laquinimod
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA23 - theodrenaline
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX07 - oxiracetam
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA05 - opipramol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FB - Beta blocking agents and calcium channel blockers;C07FB02 - metoprolol and felodipine
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XA - iodine I-131 therapeutic radiopharmaceuticals;V10XA02 - iobenguane (131I)
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC03 - trastuzumab
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC07 - tocilizumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF01 - zidovudine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC05 - colecalciferol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX11 - alcaftadine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XA - Platinum compounds -  antineoplastic drugs;L01XA05 - polyplatillen
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC14 - clenbuterol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB05 - zorubicin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX58 - epacadostat
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE11 - tiaprofenic acid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XC - Selective estrogen receptor modulators;G03XC01 - raloxifene
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB51 - brompheniramine -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC03 - levonorgestrel
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AH - Peripheral opioid receptor antagonists;A06AH02 - alvimopan
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR14 - darunavir and cobicistat
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB30 - Specific immunoglobulin combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA01 - cocaine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA03 - methylscopolamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB02 - rifampicin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XC - Selective estrogen receptor modulators;G03XC04 - ormeloxifene
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BX - Other sclerosing agents in ATC;C05BX51 - calcium dobesilate -  combinations
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA03 - ephedrine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA10 - ferrous ascorbate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD05 - insulin aspart
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB01 - pilocarpine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA34 - chlorphenoxamine
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08E - NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08EA - Phenylalkylamine derivatives -  non-selective calcium channel blockers;C08EA02 - bepridil
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA01 - hydrocortisone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AA - Enzyme preparations -  digestives;A09AA04 - tilactase
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB04 - sodium tetradecyl sulfate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB09 - cyclothiazide and potassium
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BX - Other hormone antagonists and related agents in ATC;L02BX02 - degarelix
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AX - Other antithrombotic agents in ATC;B01AX05 - fondaparinux
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX03 - oxyfedrine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX16 - tiopronin
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA04 - prednisolone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DI - Other cephalosporins and penems in ATC;J01DI01 - ceftobiprole medocaril
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AN - Medical gases;V03AN03 - helium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX12 - phloroglucinol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA08 - olmesartan medoxomil
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX03 - acetohydroxamic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA03 - prednisone
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AX - Other parasympathomimetics in ATC;N07AX03 - cevimeline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB03 - sodium feredetate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AX - Other antiobesity drugs in ATC;A08AX01 - rimonabant
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB13 - bevonium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH01 - sitagliptin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX18 - povidone-iodine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB20 - copper sulfate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BB - Solutions affecting the electrolyte balance;B05BB01 - electrolytes
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC51 - ispaghula -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD01 - coagulation factor IX -  II -  VII and X in combination
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA05 - technetium (99mTc) gluconate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AB - Progestogens -  endocrine therapy drugs;L02AB03 - gestonorone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA16 - gatifloxacin
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CX - Other diagnostic agents in ATC;V04CX01 - indocyanine green
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AC - Bile acid sequestrants;C10AC01 - colestyramine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK10 - vilanterol and fluticasone furoate
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB04 - enflurane
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX03 - ketamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB09 - cefradine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CB - Somatostatin and analogues;H01CB03 - lanreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA06 - budesonide
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA04 - triamcinolone and antiinfectives
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH09 - meningococcus B -  multicomponent vaccine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BD - Measles vaccines;J07BD01 - measles -  live attenuated
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE04 - lomefloxacin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX63 - nitrous oxide -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX13 - proquazone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA03 - clofezone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA53 - hydromorphone and naloxone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA03 - metandienone
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB12 - sinecatechins
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AC - Ethylene imines -  antineoplastic alkylating drugs;L01AC01 - thiotepa
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC25 - cangrelor
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX17 - dapivirine
V - VARIOUS DRUG CLASSES IN ATC;V06 - GENERAL NUTRIENTS;V06D - OTHER NUTRIENTS in ATC;V06DC - Carbohydrate nutrients;V06DC02 - fructose
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG03 - aminobutyric acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD12 - cefoperazone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HA - Technetium 99m compounds -  inflammation and infection detection radiopharmaceuticals;V09HA02 - technetium (99mTc) exametazime labelled cells
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA38 - tenitramine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AA - Preparations inhibiting uric acid production;M04AA51 - allopurinol -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA71 - acetylsalicylic acid -  combinations with psycholeptics
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC18 - prednicarbate
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX03 - azelaic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB01 - indometacin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC05 - fluocortolone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA56 - oxycodone and naltrexone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA06 - etofenamate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE07 - moxifloxacin
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BX - Other dopaminergic agents in ATC;N04BX02 - entacapone
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB06 - trichlormethiazide and potassium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA03 - glutamine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX03 - ipratropium bromide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB06 - medroxyprogesterone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DA - Aldosterone antagonists;C03DA01 - spironolactone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX05 - hydroxycarbamide
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX07 - phenacemide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA08 - metildigoxin
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX01 - bosentan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD22 - metformin and evogliptin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03E - ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;G03EA - Androgens and estrogens;G03EA03 - prasterone and estrogen
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA01 - chloramphenicol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG02 - bisacodyl
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA02 - phenindione
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA52 - acetyldigoxin -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA13 - eritrityl tetranitrate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF16 - omoconazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD08 - midazolam
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BB - Oxytocin and analogues;H01BB01 - demoxytocin
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC06 - povidone-iodine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC05 - polihexanide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC01 - daclizumab
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC30 - oxyquinoline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF19 - sertaconazole
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AG - MAO A Inhibitors -  antidepressant drugs;N06AG03 - toloxatone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA06 - mandelic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA26 - riboflavin
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD01 - tretinoin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF04 - calcium levofolinate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BK - Varicella zoster vaccines;J07BK03 - zoster -  purified antigen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB16 - ibuprofen
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA54 - clemastine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB06 - alendronic acid and alfacalcidol -  sequential
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA11 - lorcaserin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB03 - cabergoline
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE - Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE02 - isosorbide dinitrate
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AB - Preparations containing sulfur -  anti-acne preparations for topical use;D10AB03 - tioxolone
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC09 - sulconazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AD - Papaverine and derivatives containing drugs for functional gastrointestinal disorders;A03AD30 - moxaverine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX10 - oxaflozane
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AB - Preparations increasing uric acid excretion;M04AB01 - probenecid
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BB - Drugs used in alcohol dependence;N07BB03 - acamprosate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX52 - venetoclax
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA11 - chlorquinaldol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD55 - hydroxyethylpromethazine -  combinations
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BD - MAO B Inhibitors -  dopaminergic anti-parkinson drugs;N04BD03 - safinamide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB06 - gestodene and ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB18 - raxibacumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX12 - dolutegravir
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB06 - clofarabine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA05 - propranolol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC04 - fenoterol
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AX - Other respiratory system products in ATC;R07AX31 - ivacaftor and tezacaftor
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB05 - rabies immunoglobulin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA53 - phenylephrine -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA09 - neomycin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AC - Ergot alkaloids and oxytocin incl. analogues -  in combination;G02AC01 - methylergometrine and oxytocin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD06 - brinase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX08 - atorvastatin and acetylsalicylic acid
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC52 - chlorhexidine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AG - Fenamates -  antiinflammatory and antirheumatic drugs;M01AG02 - tolfenamic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA07 - ranitidine bismuth citrate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX06 - resorcinol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA04 - clemastine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA51 - phenprobamate -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA51 - cimetidine -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX01 - pizotifen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XB - Progesterone receptor modulators -  sex hormones and modulators of the genital system;G03XB51 - mifepristone -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX48 - sonidegib
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FB - Sympathomimetics excl. antiglaucoma preparations;S01FB51 - phenylephrine and ketorolac
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH01 - loxapine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DC - Leukotriene receptor antagonists for obstructive airway diseases;R03DC53 - montelukast -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB10 - velaglucerase alfa
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD08 - bismuth subcitrate -  tetracycline and metronidazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB13 - penciclovir
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AF - Barbiturates for general anesthesia -  plain;N01AF02 - hexobarbital
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX09 - chlorhexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB13 - asfotase alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA03 - norepinephrine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA05 - digoxin
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE12 - salicylic acid
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CB - Non-selective beta-adrenoreceptor agonists for systemic use;R03CB53 - orciprenaline -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE41 - binimetinib
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC07 - isoetarine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA01 - diphenoxylate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB02 - sulfamethizole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE01 - saquinavir
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK04 - morinamide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA24 - bentazepam
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA07 - diphenylpyraline
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BX - Other chemotherapeutics in ATC;D06BX02 - ingenol mebutate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01B - AMPHENICOLS;J01BA - Amphenicol antibacterials -  systemic;J01BA01 - chloramphenicol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EE - Prostaglandin analogues -  antiglaucoma drugs and miotics;S01EE02 - unoprostone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CX - Other agents against leishmaniasis and trypanosomiasis in ATC;P01CX02 - suramin sodium
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BA - Vasopressin and analogues;H01BA05 - ornipressin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX40 - omacetaxine mepesuccinate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EB - High-ceiling diuretics and potassium-sparing agents;C03EB01 - furosemide and potassium-sparing agents
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX02 - iobenguane (131I)
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX07 - trimetrexate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AB - Chlorine containing product ectoparasiticides;P03AB02 - lindane
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AC - Corticosteroids for local oral treatment;A01AC54 - prednisolone -  combinations
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC02 - fluocinolone acetonide and antibiotics
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA57 - propatylnitrate -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA25 - aceclofenac
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC30 - Local hemostatic combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK07 - thioacetazone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA01 - guaiazulen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB01 - rosoxacin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB04 - pipemidic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA03 - neomycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF11 - telbivudine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC05 - fluocinonide and antibiotics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX - Other topical products for joint and muscular pain in ATC;M02AX03 - dimethyl sulfoxide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX17 - adrafinil
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BB - Corticosteroids -  moderately potent -  combinations with antiseptics;D07BB02 - desonide and antiseptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA10 - colistin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AX - Other blood products in ATC;B05AX01 - erythrocytes
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC07 - apomorphine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX02 - chondrocytes -  autologous
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX08 - pentostatin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC13 - pertuzumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP08 - sofosbuvir
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02B - ANTIADRENERGIC AGENTS -  GANGLION-BLOCKING;C02BB - Secondary and tertiary amines -  ganglion-blocking antiadrenergic;C02BB01 - mecamylamine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB12 - nebivolol and thiazides
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC16 - dinutuximab beta
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AC - Oxazolidine derivatives -  antiepileptics;N03AC02 - trimethadione
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA09 - sodium phosphate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD10 - drotrecogin alfa (activated)
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX12 - atorvastatin -  acetylsalicylic acid and perindopril
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA11 - clomocycline
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BX - Other antipsoriatics for systemic use in ATC;D05BX51 - fumaric acid derivatives -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BX - Other sclerosing agents in ATC;C05BX01 - calcium dobesilate
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX06 - mequinol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX12 - aripiprazole
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB12 - bemiparin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA02 - imipramine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB06 - terguride
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX05 - valsartan and nebivolol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AC - Triazole derivatives -  systemic antimycotics;J02AC04 - posaconazole
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA12 - nadolol
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AE - Ergot alkaloid peripheral vasodilators;C04AE04 - dihydroergocristine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB06 - iotrolan
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX04 - deanol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA34 - propantheline and psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC02 - dihydrotachysterol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX - Other topical products for joint and muscular pain in ATC;M02AX06 - tolperisone
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA13 - tymazoline
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB09 - ibandronic acid and colecalciferol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA13 - rimexolone
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02B - PROTECTIVES AGAINST UV-RADIATION;D02BA - Protectives against UV-radiation for topical use;D02BA01 - aminobenzoic acid
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX24 - cannabidiol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA03 - hydroxocobalamin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB04 - isoaminile
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA01 - tyloxapol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP52 - dasabuvir -  ombitasvir -  paritaprevir and ritonavir
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC03 - chlorquinaldol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GA - Streptomycins;J01GA01 - streptomycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AG - Hemophilus influenzae B vaccines;J07AG53 - hemophilus influenzae B -  combinations with meningococcus C -  conjugated
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP55 - sofosbuvir and velpatasvir
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX06 - becaplermin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA04 - ipecacuanha
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD02 - insulin (beef)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR11 - lamivudine -  tenofovir disoproxil and efavirenz
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB22 - doxycycline
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AE - Ergot alkaloid peripheral vasodilators;C04AE51 - ergoloid mesylates -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA56 - oxedrine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB07 - oxolamine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BA - Anti-estrogens;L02BA03 - fulvestrant
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AX - Other respiratory system products in ATC;R07AX01 - nitric oxide
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA01 - metabutethamine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB04 - tiotropium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB05 - irbesartan and amlodipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA02 - magnesium oxide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX04 - methiosulfonium chloride
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XA - Iodine I-131 diagnostic radiopharmaceuticals;V09XA02 - iodocholesterol (131I)
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX13 - dimethyl sulfoxide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA02 - eprosartan
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB58 - aceclidine -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA07 - benazepril
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA05 - tasosartan
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA02 - technetium (99mTc) succimer
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX13 - nitrous oxide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB08 - valsartan and lercanidipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA05 - magnesium silicate
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BA - Psoralens for systemic use;D05BA01 - trioxysalen
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK04 - merbromin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA13 - mebutizide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA16 - sulbenicillin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC07 - pirbuterol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA03 - hydromorphone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX07 - gefarnate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CA - Alpha-adrenoreceptor antagonists -  peripherally acting;C02CA06 - urapidil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA19 - aspoxicillin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BC - Esters of benzoic acid for local anesthesia;N01BC01 - cocaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA03 - serum gonadotrophin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ57 - octenidine -  combinations
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB01 - halothane
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX04 - clomethiazole -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AC - Drugs used in hereditary angioedema;B06AC04 - conestat alfa
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC22 - prasugrel
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC12 - halometasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX51 - carbenoxolone -  combinations excl. psycholeptics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE02 - papaverine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AD - Emergency contraceptive drugs;G03AD01 - levonorgestrel
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X - OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC;C09XA - Renin-inhibitors;C09XA52 - aliskiren and hydrochlorothiazide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF08 - adefovir dipivoxil
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA01 - levodopa
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM07 - rifampicin -  ethambutol and isoniazid
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AA - Mineralocorticoids for systemic use -  plain;H02AA01 - aldosterone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BB - biguanide antimalarials;P01BB51 - proguanil -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AB - Sulfonamides -  intestinal antiinfectives;A07AB03 - sulfaguanidine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB53 - aminophenazone -  combinations excl. psycholeptics
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AA - Acridine derivatives -  antiseptics and disinfectants;D08AA02 - aminoacridine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA08 - clobenzorex
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA16 - feprazone
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA01 - prednisolone and antiinfectives
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE13 - afatinib
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC15 - beclometasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA03 - proxyphylline
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA04 - chlorhexidine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB08 - aceclidine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR08 - emtricitabine -  tenofovir disoproxil and rilpivirine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC05 - magnesium aspartate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB19 - sodium perborate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX13 - efloxate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA03 - vindesine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC01 - ispaghula (psylla seeds)
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA07 - ciprofloxacin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CX - Other irrigating solutions in ATC;B05CX10 - Other irrigating solution combinations in ATC
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA01 - bendroflumethiazide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC09 - rocuronium bromide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EB - Technetium (99mTc) -  particles for injection;V09EB02 - technetium (99mTc) microspheres
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC04 - fenoterol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA10 - gestodene and ethinylestradiol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AA - Enzyme preparations -  digestives;A09AA01 - diastase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX10 - alipogene tiparvovec
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA06 - mepartricin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE16 - crizotinib
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB01 - monoethanolamine oleate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE04 - sunitinib
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BX - Other anxiolytics in ATC;N05BX02 - gedocarnil
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05A - PARATHYROID HORMONES AND ANALOGUES;H05AA - Parathyroid hormones and analogues;H05AA01 - parathyroid gland extract
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AC - Insulins and analogues for injection -  intermediate-acting;A10AC02 - insulin (beef)
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA21 - octenidine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB15 - ropeginterferon alfa-2b
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC19 - efinaconazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XB - Progesterone receptor modulators -  sex hormones and modulators of the genital system;G03XB01 - mifepristone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB55 - diclofenac -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FB - Sympathomimetics excl. antiglaucoma preparations;S01FB01 - phenylephrine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB13 - acadesine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA30 - Adrenergic and dopaminergic agents combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA03 - sodium chloride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX05 - nifuratel
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA03 - phenylephrine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA03 - nitrofural
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA07 - noscapine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA53 - diosmin -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA06 - potassium phosphate -  incl. combinations with other potassium salts
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD52 - promethazine -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD08 - coagulation factor VIIa
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AF - Direct factor Xa inhibitors;B01AF01 - rivaroxaban
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BC - Hepatitis vaccines;J07BC20 - Hepatitis vaccine combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD03 - anistreplase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX05 - rosuvastatin and acetylsalicylic acid
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10B - PAIN PALLIATION (BONE SEEKING AGENTS);V10BX - Various pain palliation radiopharmaceuticals;V10BX02 - samarium (153Sm) lexidronam
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED02 - betaxolol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AC - Enzyme and acid preparations -  combinations;A09AC01 - pepsin and acid preparations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA08 - hemoglobin crosfumaril
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC10 - drospirenone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB15 - mumps immunoglobulin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AA - Aminosalicylic acid and derivatives;J04AA02 - sodium aminosalicylate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA70 - organic nitrates in combination with psycholeptics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB03 - levonorgestrel and ethinylestradiol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC06 - tiabendazole
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX21 - retigabine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB10 - clofibride
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC04 - flurbiprofen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AC - antacids containing calcium compounds;A02AC02 - calcium silicate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA02 - oxprenolol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CB - Gold preparations;M01CB03 - auranofin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CB - Corticosteroids -  moderately potent -  combinations with antibiotics;D07CB05 - flumetasone and antibiotics
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA04 - altizide and potassium-sparing agents
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG01 - aminoglutethimide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD05 - omeprazole -  amoxicillin and clarithromycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AA - Bile acids and derivatives for bile therapy;A05AA02 - ursodeoxycholic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD03 - bunaftine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX03 - zinc compounds
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA65 - carbasalate calcium combinations excl. psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02B - ANTIADRENERGIC AGENTS -  GANGLION-BLOCKING;C02BA - Sulfonium derivatives -  ganglion-blocking adreneregic;C02BA01 - trimetaphan
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB08 - etodolac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK01 - pyrazinamide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC18 - pembrolizumab
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB26 - nepinalone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA04 - enoxacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AB - Sulfonamides -  ophthalmologic antiinfectives;S01AB04 - sulfacetamide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG04 - letrozole
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AC - Strophanthus glycosides used in cardiac therapy;C01AC03 - cymarin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB52 - metoprolol and thiazides -  combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BA - Quinoline derivatives and related substances -  antitrematodals;P02BA02 - oxamniquine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB02 - phenytoin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CF - Benzodiazepine related hypnotics and sedatives;N05CF03 - zaleplon
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD07 - benperidol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD05 - triazolam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF13 - azanidazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB05 - demegestone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB03 - chlormadinone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AD - Purine derivatives -  peripheral vasodilators;C04AD04 - etofylline nicotinate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA12 - fluindione
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB10 - adenosine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03C - MUSCLE RELAXANTS -  DIRECTLY ACTING AGENTS;M03CA - Dantrolene and derivatives -  muscle relaxants -  direct acting;M03CA01 - dantrolene
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LG - Hydrazinophthalazine derivatives and diuretics;C02LG02 - hydralazine and diuretics
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB13 - deflazacort
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA06 - paromomycin
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA10 - clioquinol
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB02 - hydrocortisone butyrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC09 - catumaxomab
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA12 - alprazolam
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA02 - technetium (99mTc) antimelanoma antibody
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD13 - casopitant
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09F - THYROID DIAGNOSTIC RADIOPHARMACEUTICALS;V09FX - Various thyroid diagnostic radiopharmaceuticals;V09FX04 - sodium iodide (124I)
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CH - Melatonin receptor agonists -  hypnotics and sedatives;N05CH03 - tasimelteon
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC31 - avelumab
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA05 - technetium (99mTc) depreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX03 - lubiprostone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA02 - natamycin
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA18 - hexamidine
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX21 - brimonidine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AD - Succinimide derivatives -  antiepileptics;N03AD02 - phensuximide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA06 - trichlormethiazide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX17 - milnacipran
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AF - Carboxamide derivatives -  antiepileptics;N03AF03 - rufinamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB01 - oxyphenisatine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB51 - bupivacaine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX26 - fexofenadine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA15 - chlormadinone and ethinylestradiol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD03 - methyl aminolevulinate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AB - Methyldopa -  centrally acting adntiadrenergic agents;C02AB01 - methyldopa (levorotatory)
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB02 - zimeldine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA51 - albumin tannate -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC;C05AX01 - aluminium preparations
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08E - NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08EX - Other non-selective calcium channel blockers in ATC;C08EX02 - perhexiline
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB12 - nebivolol
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA13 - iodoform
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ08 - codeine and ibuprofen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CB - Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy;G04CB01 - finasteride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE02 - insulin (beef)
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02B - PROTECTIVES AGAINST UV-RADIATION;D02BB - Protectives against UV-radiation for systemic use;D02BB01 - betacarotene
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA33 - vedolizumab
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB05 - paroxetine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC52 - bioallethrin -  combinations
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD01 - beclometasone
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA04 - pentosan polysulfate sodium
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CX - Other renal system diagnostic radiopharmaceuticals in ATC;V09CX02 - sodium iodohippurate (131I)
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA01 - neomycin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA11 - nandrolone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AX - Other antigout preparations in ATC;M04AX01 - urate oxidase
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA10 - typhoid-hepatitis A
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA05 - calcium lactate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA13 - diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB04 - kanamycin
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE19 - tolciclate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX08 - poly ICLC
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD05 - fotemustine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA13 - fusidic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA11 - clobetasone and antiinfectives
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DA - Technetium 99m compounds -  hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;V09DA05 - technetium (99mTc) galtifenin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA03 - ferrous gluconate
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB04 - eprazinone
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB35 - sugammadex
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CX - Other drugs used in benign prostatic hypertrophy in ATC;G04CX03 - mepartricin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ04 - cetrimide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB10 - trandolapril and verapamil
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA16 - rifamycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE08 - atazanavir
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BX - Other local anesthetics in ATC;N01BX03 - phenol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA09 - dipyrocetyl
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AD - Iron in combination with folic acid;B03AD04 - ferric oxide polymaltose complexes
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AA - Ethers for general anesthesia;N01AA01 - diethyl ether
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BG - Thiazolidinediones -  blood glucose lowering drugs;A10BG01 - troglitazone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AA - Estrogens -  endocrine therapy drugs;L02AA03 - ethinylestradiol
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB07 - sobrerol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC01 - norethisterone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB10 - ferric maltol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC01 - betanidine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03X - OTHER DIURETICS in ATC;C03XA - Vasopressin antagonists -  diuretics;C03XA01 - tolvaptan
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA51 - heparinoid -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BA - Solutions for parenteral nutrition;B05BA01 - amino acids
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA02 - metrizoic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BB - Corticosteroids and mydriatics in combination;S01BB03 - fluorometholone and mydriatics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA56 - tropicamide -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX13 - uridine triacetate
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB04 - prilocaine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FB - Beta blocking agents and calcium channel blockers;C07FB12 - nebivolol and amlodipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB07 - glipizide
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CC - Tetrahydropyrimidine derivatives -  antinematodal;P02CC02 - oxantel
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA04 - racecadotril
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD30 - thrombin
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX04 - tacalcitol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AH - Neuraminidase inhibitors -  direct acting antivirals;J05AH03 - peramivir
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX10 - propofol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DB - Hydrazinophthalazine derivatives acting on arteriolar smooth muscle;C02DB03 - endralazine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX21 - duloxetine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB08 - sodium nitrite
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA04 - perindopril
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA10 - ketoprofen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AX - Other drugs for bile therapy in ATC;A05AX02 - hymecromone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AD - antacids containing combinations and complexes of aluminium -  calcium and magnesium compounds;A02AD03 - almagate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA02 - pyridoxine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX24 - vilazodone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CX - Other antinematodals in ATC;P02CX02 - bephenium
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA05 - deserpidine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD58 - fluticasone -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX37 - sitimagene ceradenovec
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AF - Morphinan derivatives -  opiod analgesics;N02AF02 - nalbuphine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AC - Imidazoline receptor agonists;C02AC06 - rilmenidine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG05 - viminol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX06 - seratrodast
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA09 - amitriptyline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AC - Drugs used in hereditary angioedema;B06AC01 - c1-inhibitor -  plasma derived
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE23 - dabrafenib
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX05 - dimeticone
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA19 - bupranolol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB02 - dexchlorpheniramine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA27 - droxidopa
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC03 - crospovidone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX23 - tenidap
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AX - Other throat preparations in ATC;R02AX03 - benzydamine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BE - Artemisinin and derivatives -  plain;P01BE05 - artenimol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA13 - ibuprofen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC03 - vecuronium
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB04 - prochlorperazine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CB - Barbiturates -  combinations;N05CB02 - barbiturates in combination with other drugs
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB07 - acetophenazine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC09 - tyropanoic acid
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE51 - paracetamol -  combinations excl. psycholeptics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC06 - pipecuronium bromide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CB - Synthetic estrogens -  plain;G03CB03 - methallenestril
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AA - Antifibrinolytic amino acids;B02AA02 - tranexamic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA52 - reserpine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR18 - emtricitabine -  tenofovir alafenamide -  elvitegravir and cobicistat
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CA - Vitamin A -  plain;A11CA02 - betacarotene
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CE - Piperidinedione derivatives -  hypnotics and sedatives;N05CE03 - pyrithyldione
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE26 - cabozantinib
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA03 - hachimycin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX10 - dilazep
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC02 - magnesium sulfate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XA - Platinum compounds -  antineoplastic drugs;L01XA03 - oxaliplatin
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA05 - atorvastatin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE54 - bucetin -  combinations excl. psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CA - Beta blocking agents -  non-selective -  and other diuretics;C07CA02 - oxprenolol and other diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03B - ANDROGENS;G03BA - 3-oxoandrosten (4) derivatives;G03BA03 - testosterone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB03 - epirubicin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX07 - lusutrombopag
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BA - Belladonna alkaloids -  tertiary amines for functional gastrointestinal disorders;A03BA04 - belladonna total alkaloids
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX14 - rebamipide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BC - Bone morphogenetic proteins;M05BC01 - dibotermin alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CX - Other cardiac stimulants in ATC;C01CX08 - levosimendan
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BC - Carbamate anxiolytics;N05BC51 - meprobamate -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CX - Other irrigating solutions in ATC;B05CX03 - glycine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA15 - balugrastim
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X - OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC;C09XA - Renin-inhibitors;C09XA02 - aliskiren
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA05 - chlormethine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA01 - atropine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB09 - esmolol
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AA - Yttrium-90 antiinflammatory radiopharmaceuticals;V10AA02 - yttrium (90Y) ferrihydroxide colloid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CB - Salt irrigating solutions;B05CB01 - sodium chloride
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD09 - isothipendyl
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB02 - olmesartan medoxomil and amlodipine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX30 - fenyramidol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EX - Other antiglaucoma preparations in ATC;S01EX01 - guanethidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BB - Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD);A02BB02 - enprostil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA23 - delafloxacin
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA10 - flower allergenic extracts
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB01 - ipratropium bromide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE53 - ketoprofen -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB07 - oxyquinoline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB12 - encephalitis -  tick borne immunoglobulin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH05 - linagliptin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA04 - codeine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ06 - semaglutide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AC - Imidazole derivatives -  intestinal antiinfectives;A07AC01 - miconazole
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA12 - lorajmine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA16 - pheniramine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB17 - tiemonium iodide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA82 - clorexolone -  combinations with psycholeptics
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB08 - sevoflurane
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE56 - naproxen and misoprostol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA01 - prednisolone
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC01 - cromoglicic acid
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC60 - bifonazole -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE09 - vardenafil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA08 - glycyrrhizic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX54 - benziodarone -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD02 - lansoprazole -  tetracycline and metronidazole
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC01 - indometacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX16 - picloxydine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA04 - amoxicillin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA75 - salicylamide -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA01 - hydrochlorothiazide and potassium-sparing agents
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB02 - metoprolol and thiazides
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX17 - nimesulide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA14 - moxifloxacin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA09 - clobazam
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA08 - prajmaline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA01 - ofloxacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AB - Sulfonamides -  ophthalmologic antiinfectives;S01AB01 - sulfamethizole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB20 - contact laxatives in combination
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CB - Corticosteroids -  moderately potent -  combinations with antibiotics;D07CB02 - fluprednidene and antibiotics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH52 - gemigliptin and rosuvastatin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB10 - desogestrel and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BX - Other low-ceiling diuretics in ATC;C03BX03 - cicletanine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC28 - durvalumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD21 - sodium tartrate
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CB - Somatostatin and analogues;H01CB01 - somatostatin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AD - Thiocarbamide derivatives for treatment of tuberculosis;J04AD03 - ethionamide
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX10 - various other nasal preparations in ATC
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB05 - diclofenac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH07 - meningococcus C -  purified polysaccharides antigen conjugated
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX06 - emedastine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC08 - polycarbophil calcium
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE02 - norfloxacin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA09 - rolitetracycline
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX14 - levetiracetam
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA03 - cortisone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BG - Other antiarrhythmics -  class I and III in ATC;C01BG01 - moracizine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA20 - organic nitrates in combination
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE06 - benoxaprofen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AB - Imidazole derivatives -  antimycotic for systemic use;J02AB01 - miconazole
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB04 - chlorothiazide and potassium
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA02 - dexamfetamine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AD - Purine derivatives -  peripheral vasodilators;C04AD01 - pentifylline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB60 - peginterferon alfa-2b -  combinations
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AF - Thioxanthene derivatives -  antipsychotic;N05AF02 - clopenthixol
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XC - Corticosteroids -  potent -  other combinations;D07XC01 - betamethasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB06 - etamiphylline and adrenergics
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX05 - amifampridine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX07 - sodium hypochlorite
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ03 - lixisenatide
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX08 - tafamidis
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA16 - cardioplegia solutions
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC03 - desoximetasone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB23 - tiazotic acid
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AF - Thioxanthene derivatives -  antipsychotic;N05AF05 - zuclopenthixol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX09 - olopatadine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AH - Quinoline derivatives -  antiseptics and disinfectants;D08AH01 - dequalinium
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC16 - flutrimazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC55 - linseed -  combinations
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AB - Antibiotic throat preparations;R02AB03 - fusafungine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE09 - flurbiprofen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX02 - inosine
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AD - local anesthetic throat preparations;R02AD04 - dyclonine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE01 - imatinib
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD11 - triamcinolone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX14 - tianeptine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA03 - hydrochlorothiazide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD51 - cefotaxime and beta-lactamase inhibitor
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA21 - mercaptamine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA23 - netilmicin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB14 - neltenexine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA01 - beclometasone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX06 - romosozumab
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA02 - eprosartan and diuretics
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XX - Various diagnostic radiopharmaceuticals;V09XX02 - cobalt (58Co) cyanocobalamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA02 - ranitidine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA01 - organo-heparinoid
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX - Other central nervous system diagnostic radiopharmaceuticals in ATC;V09AX01 - indium (111In) pentetic acid
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BC - Xanthine derivatives -  psychostimulants -  agents used for ADHD and nootropics;N06BC02 - propentofylline
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF02 - dexrazoxane
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB04 - risedronic acid -  calcium and colecalciferol -  sequential
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX18 - cridanimod
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC54 - dextropropoxyphene -  combinations excl. psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD54 - ceftriaxone -  combinations
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM02 - clomethiazole
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AB - Preparations containing sulfur -  anti-acne preparations for topical use;D10AB01 - bithionol
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AB - Iodine I-123 compounds -  CNS diagnostic radiopharmaceuticals;V09AB02 - iodine iolopride (123I)
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AD - Organic acids -  Gynecological;G01AD03 - ascorbic acid
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ01 - benzalkonium
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX05 - pidotimod
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA03 - choline salicylate
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE16 - amorolfine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA06 - tropicamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA62 - bupropion and naltrexone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD07 - amlexanox
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB03 - varicella/zoster immunoglobulin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX - Other central nervous system diagnostic radiopharmaceuticals in ATC;V09AX04 - flutemetamol (18F)
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA13 - fenquizone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09B - SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS;V09BA - Technetium 99m compounds -  skeletal system diagnostic radiopharmaceuticals;V09BA04 - technetium (99mTc) butedronic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE45 - neratinib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DA - Technetium 99m compounds -  hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;V09DA02 - technetium (99mTc) etifenin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA26 - azithromycin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA10 - natamycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AG - Hemophilus influenzae B vaccines;J07AG51 - hemophilus influenzae B -  combinations with toxoids
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA02 - calcium glubionate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BB - Anti-androgen hormone antagonists and related agents;L02BB03 - bicalutamide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX53 - strontium ranelate and colecalciferol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DB - Quinolone vasodilators used in cardiac diseases;C01DB01 - flosequinan
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB07 - lysozyme
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE73 - phenacetin -  combinations with psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX10 - eliglustat
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB01 - bupivacaine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AB - Other hem products in ATC;B06AB01 - hematin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB07 - flumequine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB06 - sulfanilamide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA06 - salsalate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE05 - amprenavir
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AA - Tetracycline and derivatives -  topical antibiotics;D06AA04 - tetracycline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA05 - loperamide oxide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA03 - digitalis leaves
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA02 - amobarbital
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BD - Xanthine derivatives -  low-ceiling diuretics;C03BD01 - theobromine
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AA - Lung surfactants;R07AA01 - colfosceril palmitate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA01 - albumin tannate
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX01 - fumaric acid
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CD - pituitary function test diagnostic agents;V04CD06 - macimorelin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EC - Aminosalicylic acid and similar agents;A07EC01 - sulfasalazine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX07 - hexamidine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CA - Nitroimidazole derivatives -  antiprotozoal agents against leishmaniasis and trypanosomiasis;P01CA02 - benznidazole
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AA - Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases;P01AA04 - chlorquinaldol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LB - Methyldopa and diuretics in combination;C02LB01 - methyldopa (levorotatory) and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG06 - oil ingredients
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX06 - benfluorex
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD01 - idoxuridine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB04 - glibornuride
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD07 - ceftizoxime
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EC - Aminosalicylic acid and similar agents;A07EC04 - balsalazide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ18 - oxycodone and acetylsalicylic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX52 - ambrisentan and tadalafil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CB - Zinc Supplements;A12CB02 - zinc gluconate
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AB - Ethers chemically close to antihistamines -  anticholinergic;N04AB02 - orphenadrine (chloride)
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA15 - povidone-iodine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA52 - morphine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA03 - natamycin
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA03 - house dust mites
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD10 - dronabinol
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09F - THYROID DIAGNOSTIC RADIOPHARMACEUTICALS;V09FX - Various thyroid diagnostic radiopharmaceuticals;V09FX01 - technetium (99mTc) pertechnetate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BB - Sulfonamides and potassium in combination -  low-ceiling diruetics -  excluding thiazides;C03BB03 - clopamide and potassium
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA07 - chlorproethazine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX03 - fenspiride
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF05 - artenimol and piperaquine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GB - Ovulation stimulants -  synthetic;G03GB03 - epimestrol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH01 - meningococcus A -  purified polysaccharides antigen
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CC - Aldehydes and derivatives;N05CC02 - chloralodol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE54 - undecylenic acid -  combinations
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BB - Adamantane derivatives -  dopaminergic;N04BB01 - amantadine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH05 - biapenem
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD17 - metformin and acarbose
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BX - Other antitrematodal agents in ATC;P02BX02 - niridazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DA - Pregnen (4) derivatives -  progestogens;G03DA02 - medroxyprogesterone
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA07 - cetylpyridinium
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA05 - flubendazole
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC10 - diflorasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD11 - lactulose
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC05 - methapyrilene
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD08 - fluticasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA09 - acefylline piperazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM02 - rifampicin and isoniazid
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC14 - reproterol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE19 - ridaforolimus
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM05 - rifampicin -  pyrazinamide and isoniazid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC13 - abciximab
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01J - DIAGNOSTIC AGENTS -  OPHTHAMOLOGIC;S01JA - Diagnostic -  opthalmologic coloring agents;S01JA01 - fluorescein
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AH - Thiazides -  combinations with psycholeptics and/or analgesics;C03AH02 - hydroflumethiazide -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XX - Various therapeutic radiopharmaceuticals;V10XX02 - ibritumomab tiuxetan (90Y)
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA06 - cetylpyridinium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA06 - etilamfetamine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC05 - adrenalone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB01 - betamethasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB58 - sodium picosulfate -  combinations
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB01 - phenylephrine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE03 - phenol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA68 - metipranolol and thiazides -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC06 - estriol
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB01 - bendroflumethiazide and potassium
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE01 - desirudin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CD - Fluoride supplements;A12CD02 - sodium monofluorophosphate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XA - Antigonadotropins and similar agents;G03XA01 - danazol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX01 - baclofen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD14 - pentaerithrityl
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX05 - trazodone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH52 - meropenem and vaborbactam
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB03 - proxyphylline and adrenergics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC08 - calcium alginate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DC - Other cytotoxic antibiotics in ATC;L01DC03 - mitomycin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BA - Calcitonin preparations;H05BA04 - elcatonin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE56 - insulin degludec and liraglutide
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA03 - pravastatin and fenofibrate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA03 - lynestrenol and ethinylestradiol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA02 - oxprenolol and thiazides
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BC - Antiallergic inhalants for obstructive airway diseases -  excl. corticosteroids;R03BC01 - cromoglicic acid
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE06 - biphenylol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX07 - enfuvirtide
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA07 - ferric ammonium citrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX05 - pirfenidone
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX04 - erbium (169Er) citrate colloid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA19 - garenoxacin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CA - Corticosteroids -  weak -  combinations with antibiotics;D07CA02 - methylprednisolone and antibiotics
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX01 - bamipine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC06 - piroxicam
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE07 - chlorphenesin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC02 - pantoprazole
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA01 - epinephrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA07 - dicycloverine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BC - Antiarrhythmics -  class Ic;C01BC03 - propafenone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA13 - norgestimate and estrogen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CA - Quinolines -  antirheumatic drugs;M01CA03 - oxycinchophen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AA - Butylpyrazolidines -  antiinflammatory and antirheumatic drugs;M01AA05 - clofezone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA04 - clonidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB02 - algeldrate
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB23 - acetylcysteine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC05 - esomeprazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB08 - galsulfase
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA07 - fludrocortisone and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC02 - histapyrrodine
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA11 - bornaprine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA05 - epomediol
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB07 - almitrine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BB - biguanide antimalarials;P01BB02 - cycloguanil embonate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB30 - contact laxatives in combination with belladonna alkaloids
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK02 - phenylmercuric borate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA03 - molgramostim
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX10 - sodium propionate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA15 - alefacept
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XA - Glycopeptide antibacterials;J01XA01 - vancomycin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA16 - ofloxacin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE06 - moxisylyte
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA21 - allobarbital
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB01 - cefalexin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA01 - morphine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA04 - metenolone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XA - Glycopeptide antibacterials;J01XA04 - dalbavancin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX04 - neomycin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB15 - ketorolac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB04 - cefazolin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA11 - grepafloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX22 - alitretinoin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA01 - ampicillin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CC - Aryloxyacetic acid derivatives -  high-ceiling diuretics;C03CC01 - etacrynic acid
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX02 - methaqualone -  combinations
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX07 - gentamicin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA06 - oxytetracycline
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FB - Beta blocking agents and calcium channel blockers;C07FB07 - bisoprolol and amlodipine
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07C - ANTIVERTIGO PREPARATIONS;N07CA - Antivertigo preparations;N07CA04 - acetylleucine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CA - sulfonamides -  high-ceiling diuretics -  plain;C03CA03 - piretanide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX25 - bexarotene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF06 - abacavir
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX03 - spaglumic acid
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX02 - riluzole
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA08 - naphazoline
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD12 - doxefazepam
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX58 - pyrrobutamine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AE - Cholera vaccines;J07AE01 - cholera -  inactivated -  whole cell
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF20 - combinations of imidazole derivatives
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB56 - dexbrompheniramine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH04 - meningococcus A - C - Y - W-135 -  tetravalent purified polysaccharides antigen
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA12 - lisdexamfetamine
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA14 - cilnidipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA11 - gadofosveset
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE11 - pazopanib
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX14 - alirocumab
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC05 - levomethadone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA06 - cinchocaine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA10 - magnesium phosphate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA15 - gepefrine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04B - DRUGS FOR TREATMENT OF LEPRA;J04BA - Drugs for treatment of lepra;J04BA02 - dapsone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AX - Other intestinal antiinfectives in ATC;A07AX03 - nifuroxazide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX12 - ciclopirox
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB07 - parnaparin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE03 - ketoprofen
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA10 - fluocinolone acetonide and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AD - local anesthetic throat preparations;R02AD01 - benzocaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR06 - emtricitabine -  tenofovir disoproxil and efavirenz
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB51 - heparin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB17 - metronidazole
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC51 - pyrethrum -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA13 - hydrochloric acid
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA18 - octopamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA03 - midecamycin
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA13 - dimetindene
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AD - Non-watersoluble X-ray contrast media;V08AD04 - iofendylate
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA01 - ethylmorphine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB22 - obiltoxaximab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CA - Sodium supplements;A12CA02 - sodium sulfate
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC13 - omoconazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA07 - lutropin alfa
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC11 - bromfenac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AC - Cyclic amines -  direct acting antivirals;J05AC02 - rimantadine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AC - Bile acid sequestrants;C10AC02 - colestipol
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB20 - Amide local anesthetic combinations
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AD - Succinimide derivatives -  antiepileptics;N03AD51 - ethosuximide -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX02 - sucralfate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB04 - amphotericin B
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CB - Non-selective beta-adrenoreceptor agonists for systemic use;R03CB01 - isoprenaline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB14 - valganciclovir
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BA - Folic acid analogs -  antimetabolites;L01BA05 - pralatrexate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB11 - isepamicin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA07 - ambutonium and psycholeptics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX15 - mifamurtide
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA51 - rutoside -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA01 - cetylpyridinium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XX - Other sex hormones and modulators of the genital system in ATC;G03XX01 - prasterone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA20 - antibiotics in combination with other drugs
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BA - Encephalitis vaccines;J07BA02 - encephalitis -  Japanese -  inactivated -  whole virus
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB11 - stepronin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CB - Corticosteroids/antiinfectives/mydriatics in combination;S01CB03 - hydrocortisone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX03 - strontium ranelate
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA10 - xipamide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09B - SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS;V09BA - Technetium 99m compounds -  skeletal system diagnostic radiopharmaceuticals;V09BA01 - technetium (99mTc) oxidronic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA04 - perindopril and diuretics
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AR - Arsenic compounds -  for amoebiasis and other protozoal diseases;P01AR03 - glycobiarsol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB05 - propantheline
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX21 - mebicar
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX04 - pinaverium
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DC - Pyrimidine derivatives acting on arteriolar smooth muscle;C02DC01 - minoxidil
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DC - Leukotriene receptor antagonists for obstructive airway diseases;R03DC04 - ibudilast
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA16 - imidazole salicylate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR02 - amoxicillin and beta-lactamase inhibitor
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX07 - proxazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AM - Tetanus vaccines;J07AM52 - tetanus toxoid -  combinations with tetanus immunoglobulin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA04 - galantamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR05 - piperacillin and beta-lactamase inhibitor
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX09 - daptomycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD17 - cefcapene
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE38 - cobimetinib
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC01 - dextromoramide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE04 - sulfamoxole and trimethoprim
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA09 - atomoxetine
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CD - pituitary function test diagnostic agents;V04CD03 - sermorelin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AA - Tetracycline and derivatives -  topical antibiotics;D06AA01 - demeclocycline
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX01 - cadexomer iodine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB04 - podophyllotoxin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB24 - tipepidine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BB - Antiarrhythmics -  class Ib;C01BB03 - tocainide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX09 - methylrosaniline
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC04 - dextropropoxyphene
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB01 - glibenclamide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX05 - glucosamine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA01 - chlorpromazine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA04 - acepromazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA31 - calcium pantothenate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BA - Vitamin K containing hemostatics;B02BA02 - menadione
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BD - Measles vaccines;J07BD53 - measles -  combinations with rubella -  live attenuated
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AC - Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases;P01AC02 - clefamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD04 - ceftriaxone
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA04 - troxerutin
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03B - Corticosteroid ophthalmologic and otologic preparations;S03BA - Corticosteroids;S03BA01 - dexamethasone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE07 - sulfamerazine and trimethoprim
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD64 - cefpodoxime and beta-lactamase inhibitor
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM12 - apronal
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB09 - iodixanol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AG - Hemophilus influenzae B vaccines;J07AG01 - hemophilus influenzae B -  purified antigen conjugated
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AX - Other antimycotics for systemic use in ATC;J02AX04 - caspofungin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD05 - pipamperone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AP - Typhoid vaccines;J07AP10 - typhoid -  combinations with paratyphi types
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX12 - melanoma vaccine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ15 - tramadol and other non-opioid analgesics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB03 - medrogestone
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX59 - dextromethorphan -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DC - Leukotriene receptor antagonists for obstructive airway diseases;R03DC01 - zafirlukast
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BB - Diphenylmethane derivatives -  anxiolytics;N05BB51 - hydroxyzine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB01 - etidronic acid and calcium -  sequential
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED06 - befunolol
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA07 - rosuvastatin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA06 - timolol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC08 - olopatadine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF05 - flucloxacillin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AX - Other alkylating agents in ATC;L01AX02 - pipobroman
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC01 - cetrimide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA40 - cladribine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB13 - peginterferon beta-1a
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA03 - amfepramone
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA11 - spirapril
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CH - Melatonin receptor agonists -  hypnotics and sedatives;N05CH01 - melatonin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AC - Phenothiazines with piperidine structure -  antipsychotics;N05AC04 - pipotiazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB52 - bisacodyl -  combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA02 - tiabendazole
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AC - Nicotinic acid and derivatives -  peripheral vasodilators;C04AC01 - nicotinic acid
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03A - THYROID PREPARATIONS;H03AA - Thyroid hormones;H03AA03 - combinations of levothyroxine and liothyronine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX57 - plitidepsin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AA - Antibiotics for systemic use;J02AA01 - amphotericin B
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD01 - porfimer sodium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA04 - stannous fluoride
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC01 - pancuronium
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA03 - dichlorobenzyl alcohol
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BA - Calcitonin preparations;H05BA01 - calcitonin (salmon synthetic)
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA14 - temocapril
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH06 - clotiapine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX02 - tryptophan
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA13 - norelgestromin and ethinylestradiol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC10 - indobufen
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA01 - gadopentetic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA04 - nicardipine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA05 - thiram
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA07 - nisoldipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA06 - ioglicic acid
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA04 - gadoteridol
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AG - Iodine products -  antiseptics and disinfectants;D08AG01 - iodine/octylphenoxypolyglycolether
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD53 - adapalene -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC03 - methallenestril
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AE - Androgens for topical use;D11AE01 - metandienone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA08 - oxedrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB18 - vestronidase alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB05 - fenofibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CB - Beta blocking agents -  selective -  and other diuretics;C07CB02 - metoprolol and other diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD09 - trospium
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AB - Alkyl sulfonate alkylating agents;L01AB02 - treosulfan
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX11 - astemizole
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE01 - bromochlorosalicylanilide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD03 - semustine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX02 - thalidomide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC05 - gemcitabine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC05 - guanoclor
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH02 - pimecrolimus
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB33 - hydroxocobalamin
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH05 - dupilumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA51 - sodium fluoride -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BB - Corticosteroids and mydriatics in combination;S01BB01 - hydrocortisone and mydriatics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC32 - atezolizumab
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE04 - undecylenic acid
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL08 - vilanterol -  umeclidinium bromide and fluticasone furoate
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB04 - etamivan
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX25 - hydrogen peroxide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AA - Butylpyrazolidines -  antiinflammatory and antirheumatic drugs;M01AA02 - mofebutazone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA10 - norgestrel and estrogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB05 - castor oil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB05 - laronidase
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA04 - melevodopa
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA16 - nordazepam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD14 - metformin and repaglinide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AG - Opioids in combination with antispasmodics;N02AG02 - ketobemidone and antispasmodics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA07 - acenocoumarol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE29 - lenvatinib
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA06 - hydrogen peroxide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH02 - meropenem
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB10 - amrubicin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC52 - fluorouracil -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA06 - etamiphylline
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB11 - prednylidene
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC11 - tulobuterol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC03 - phenothrin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA09 - chlorhexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB08 - sodium picosulfate
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD06 - trifarotene
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF09 - glucarpidase
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06C - PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION;N06CA - Antidepressants in combination with psycholeptics;N06CA02 - melitracen and psycholeptics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM09 - Valerianae radix
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA51 - silver sulfadiazine -  combinations
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC04 - ropinirole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC07 - cefotiam
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX04 - phanquinone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB08 - triamcinolone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AX - Other opioids in ATC;N02AX06 - tapentadol
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BX - Other dopaminergic agents in ATC;N04BX01 - tolcapone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE05 - pheneticillin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX02 - eosin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC07 - dipyridamole
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA12 - doxepin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH04 - parecoxib
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD52 - nicotinic acid -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX08 - cyclobenzaprine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC10 - ofatumumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP02 - telaprevir
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CC - Anti-gonadotropin-releasing hormones;H01CC01 - ganirelix
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC03 - mecasermin
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA01 - reserpine and diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB08 - dienogest
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA05 - alizapride
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX14 - prolintane
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BA - Drugs used in nicotine dependence;N07BA04 - cytisine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA03 - clopamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD65 - macrogol -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BJ - Rubella vaccines;J07BJ51 - rubella -  combinations with mumps -  live attenuated
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX03 - calcium gluconate
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC06 - tesamorelin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP05 - simeprevir
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF06 - sulfacetamide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AB - Capsaicin and similar agents;M02AB01 - capsaicin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB53 - chlorzoxazone -  combinations excl. psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR21 - dolutegravir and rilpivirine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX02 - valsartan and aliskiren
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH07 - polmacoxib
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB14 - fedrilate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA04 - spiramycin and metronidazole
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA10 - metizoline
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AE - Ergot alkaloid peripheral vasodilators;C04AE01 - ergoloid mesylates
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA06 - oxedrine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX05 - isopropanol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BX - Other drugs for obstructive airway diseases -  inhalants in ATC;R03BX01 - fenspiride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA02 - potassium citrate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AL - Pneumococcal vaccines;J07AL52 - pneumococcus purified polysaccharides antigen and haemophilus influenzae -  conjugated
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX55 - thiocolchicoside -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EA - Technetium (99mTc) -  inhalants;V09EA02 - technetium (99mTc) technegas
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA10 - alclometasone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA07 - azithromycin -  fluconazole and secnidazole
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB01 - benzonatate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors;A10BK03 - empagliflozin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA04 - sulfamethizole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA04 - dolasetron
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX08 - teduglutide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EA - Trimethoprim and derivatives -  systemic antibacterials;J01EA03 - iclaprim
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AD - Phosphonic acid derivatives -  direct acting antivirals;J05AD02 - fosfonet
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA09 - chloropyramine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB10 - peginterferon alfa-2b
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AX - Other opioids in ATC;N02AX03 - dezocine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX06 - carvedilol and ivabradine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AD - Calcineurin inhibitors;L04AD03 - voclosporin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CD - Pyrazolone derivatives -  high-ceiling diuretics;C03CD01 - muzolimine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BA - Vasopressin and analogues;H01BA02 - desmopressin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX01 - chiniofon
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD05 - nicotinyl alcohol
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CC - Diagnostic agents for bile duct patency testing;V04CC03 - sincalide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA07 - lynestrenol and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD06 - tedisamil
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA53 - xylometazoline -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX18 - tiazofurine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED07 - sulfamerazine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA09 - clobetasone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BG - Other antiarrhythmics -  class I and III in ATC;C01BG07 - cibenzoline
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB02 - tinidazole
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BC - Mercurial diuretics;C03BC01 - mersalyl
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG06 - doravirine
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BB - Retinoids for treatment of psoriasis;D05BB02 - acitretin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX06 - mandelic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB06 - interferon alfa-n1
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01L - OCULAR VASCULAR DISORDER AGENTS;S01LA - Antineovascularisation agents;S01LA03 - pegaptanib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EB - Antiallergic intestinal antiinflammatory drugs -  excl. corticosteroids;A07EB01 - cromoglicic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC04 - cefaclor
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA07 - lomefloxacin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XC - Corticosteroids -  potent -  other combinations;D07XC02 - desoximetasone
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB56 - glucose -  combinations
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA01 - thonzylamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB02 - glycopyrronium bromide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC27 - selexipag
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX18 - lacosamide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX52 - prenylamine -  combinations
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CB - Somatostatin and analogues;H01CB05 - pasireotide
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB06 - isoflurane
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA03 - fluorocarbon blood substitutes
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AB - Sulfonamides -  ophthalmologic antiinfectives;S01AB05 - sulfafenazol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA01 - captopril and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA02 - ademetionine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AA - Barbiturates and derivatives;N03AA01 - methylphenobarbital
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GB - Iodine I-125 compounds -  cardivascular system diagnostic radiopharmaceuticals;V09GB02 - iodine (125I) human albumin
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX02 - resorcinol
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GX - Other cardiovascular system diagnostic radiopharmaceuticals in ATC;V09GX01 - thallium (201Tl) chloride
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX28 - ifenprodil
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE06 - gatifloxacin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA58 - dihydrocodeine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA08 - felbinac
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BX - Other dopaminergic agents in ATC;N04BX04 - opicapone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GX - Other cardiovascular system diagnostic radiopharmaceuticals in ATC;V09GX04 - rubidium (82Rb) chloride
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB08 - methyclothiazide and potassium
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG05 - progabide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA06 - fencamfamin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX10 - benralizumab
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX02 - dimethylphthalate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX02 - niflumic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB11 - glisoxepide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XC - Corticosteroids -  potent -  other combinations;D07XC05 - fluocortolone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD14 - ceftibuten
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HA - Technetium 99m compounds -  inflammation and infection detection radiopharmaceuticals;V09HA04 - technetium (99mTc) sulesomab
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG01 - cation exchange resins
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE05 - sorafenib
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AX - Other antithrombotic agents in ATC;B01AX07 - caplacizumab
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX05 - dapsone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA05 - carglumic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB03 - tolmetin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB21 - cloperastine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC07 - fludroxycortide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BB - Diphenylmethane derivatives -  anxiolytics;N05BB01 - hydroxyzine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DI - Other cephalosporins and penems in ATC;J01DI03 - faropenem
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG04 - pentagastrin
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AB - Zinc bandages;D09AB02 - zinc bandage with supplements
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA08 - pholcodine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AE - Iron in other combinations;B03AE10 - Iron in various other combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA01 - rutoside
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08G - CALCIUM CHANNEL BLOCKERS AND DIURETICS;C08GA - Calcium channel blockers and diuretics;C08GA02 - amlodipine and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DB - Belladonna and derivatives in combination with analgesics;A03DB04 - butylscopolamine and analgesics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AH - Drugs for treatment of hypoglycemia;V03AH01 - diazoxide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA30 - combinations of different antibiotics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB05 - ferric oxide polymaltose complexes
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AX - Other antimycotics for systemic use in ATC;J02AX01 - flucytosine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF02 - cloxacillin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC05 - spaglumic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11D - VITAMIN B1 -  PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12;A11DA - Vitamin B1 -  plain;A11DA02 - sulbutiamine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA06 - fluorometholone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD02 - trifluperidol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA01 - isopropamide and psycholeptics
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA55 - aminophylline -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX66 - octenidine -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX05 - carbocromen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA04 - otilonium bromide and psycholeptics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD03 - factor VIII inhibitor bypassing activity
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB08 - ferric acetyl transferrin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA10 - benorilate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED03 - levobunolol
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AB - Imidazoline derivatives -  peripheral vasodilators;C04AB01 - phentolamine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AN - Medical gases;V03AN05 - medical air
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB10 - diphtheria immunoglobulin
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC01 - clotrimazole
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX05 - alfaxalone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BX - Other anti-parathyroid agents in ATC;H05BX01 - cinacalcet
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA01 - potassium chloride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH03 - saxagliptin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA08 - pivmecillinam
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BB - Solutions affecting the electrolyte balance;B05BB03 - trometamol
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA05 - mebutizide and potassium-sparing agents
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB30 - combinations of corticosteroids
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH03 - olanzapine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC06 - hexoprenaline
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX09 - gallium (68Ga) edotreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB12 - elosulfase alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA02 - isoprenaline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA57 - conjugated estrogens
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA04 - botulinum antitoxin
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA01 - amlodipine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX21 - tritoqualine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB07 - vaccinia immunoglobulin
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03B - ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS;D03BA - Proteolytic enzymes for treatment of wounds and ulcers;D03BA01 - trypsin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA01 - sodium fluoride
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC06 - eletriptan
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB05 - butanilicaine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE43 - brigatinib
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC09 - tretoquinol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE14 - ciclopirox
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD03 - meladrazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA51 - ampicillin -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB07 - ramipril and amlodipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA03 - iodamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX17 - enisamium iodide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA53 - famotidine -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC04 - adipiodone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX03 - iprazochrome
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA09 - calcium citrate lysine complex
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AB - Estren derivatives -  systemic;A14AB02 - ethylestrenol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA09 - doxylamine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HB - Indium-111 inflammation and infection detection radiopharmaceuticals;V09HB01 - indium (111In) oxinate labelled cells
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL05 - formoterol and aclidinium bromide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD05 - acetylsalicylic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AG - Epoxides -  antineoplastic alkylating drugs;L01AG01 - etoglucid
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA72 - ergotamine -  combinations with psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA56 - oxytetracycline -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB02 - idoxuridine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB02 - bezafibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB01 - practolol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC02 - fluorouracil
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD06 - propiverine
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA04 - mold fungus and yeast fungus allergenic extracts
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA05 - norfenefrine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA07 - deslanoside
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA06 - secobarbital
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB15 - velmanase alfa
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA07 - insect allergenic extracts
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA09 - vinbarbital
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD24 - sitagliptin and ertugliflozin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX07 - lonidamine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX09 - lamotrigine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA03 - loperamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BH - Rota virus diarrhea vaccines;J07BH01 - rota virus -  live attenuated
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB04 - sulfapyridine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE71 - paracetamol -  combinations with psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE03 - ritonavir
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA10 - lenograstim
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BB - Oxytocin and analogues;H01BB03 - carbetocin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BF - Poliomyelitis vaccines;J07BF03 - poliomyelitis -  trivalent -  inactivated -  whole virus
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AA - Corticosteroids -  weak (group I);D07AA01 - methylprednisolone
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AF - Carboxamide derivatives -  antiepileptics;N03AF04 - eslicarbazepine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB52 - lidocaine -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC03 - anakinra
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01K - SURGICAL AIDS -  OPHTHALMOLOGIC;S01KA - Viscoelastic substances;S01KA01 - hyaluronic acid
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX05 - ritiometan
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DA - Aldosterone antagonists;C03DA03 - canrenone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB08 - dydrogesterone and estrogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX01 - guar gum
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX22 - ivermectin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA56 - chlorphenoxamine -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02B - CONTRACEPTIVES FOR TOPICAL USE;G02BA - Intrauterine contraceptives;G02BA02 - plastic IUD with copper
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG04 - glycerol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB05 - metergoline
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM06 - propiomazine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB72 - chlormezanone -  combinations with psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF06 - sodium folinate
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD03 - adapalene
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AC - Oxazolidine derivatives -  antiepileptics;N03AC01 - paramethadione
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CX - Other gynecologicals in ATC;G02CX04 - Cimicifugae rhizoma
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA03 - boric acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA25 - lifitegrast
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC08 - sulfur compounds
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA04 - phenprocoumon
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BD - MAO B Inhibitors -  dopaminergic anti-parkinson drugs;N04BD02 - rasagiline
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CK - pancreatic function test diagnostic agents;V04CK02 - pancreozymin (cholecystokinin)
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC10 - carbuterol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA06 - roxatidine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX54 - niraparib
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA13 - acriflavinium chloride
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA08 - ethacridine lactate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA05 - fluticasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA08 - ciclesonide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA09 - azilsartan medoxomil and diuretics
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AB - Chlorine containing product ectoparasiticides;P03AB51 - clofenotane -  combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA02 - potassium polysulfide
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC01 - iodoxamic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AG - Fenamates -  antiinflammatory and antirheumatic drugs;M01AG04 - meclofenamic acid
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ03 - dihydrocodeine and other non-opioid analgesics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD08 - saruplase
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AB - Preparations containing sulfur -  anti-acne preparations for topical use;D10AB05 - mesulfen
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX12 - bupropion
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05F - COUGH SUPPRESSANTS AND EXPECTORANTS -  COMBINATIONS;R05FB - Other cough suppressants and expectorants in ATC;R05FB01 - cough suppressants and mucolytics
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AA - Anticholinesterase parasympathomimetics;N07AA02 - pyridostigmine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AB - Preparations increasing uric acid excretion;M04AB03 - benzbromarone
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BB - Drugs used in alcohol dependence;N07BB05 - nalmefene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AL - Pneumococcal vaccines;J07AL02 - pneumococcus -  purified polysaccharides antigen conjugated
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA05 - benzododecinium
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF03 - chloramphenicol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB05 - ephedrine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE02 - phenoxymethylpenicillin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA02 - cisapride
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX11 - aniracetam
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03C - Corticosteroids and antiinfectives in combination -  opthalmologic and otologic;S03CA - Corticosteroids and antiinfectives in combination;S03CA04 - hydrocortisone and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD06 - betamethasone
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH51 - fentanyl -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH01 - celecoxib
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE05 - ximelagatran
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD02 - metformin and sulfonylureas
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB11 - pipazetate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA01 - penicillins -  combinations with other antibacterials
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA02 - diphtheria-pertussis-poliomyelitis-tetanus
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB08 - tuaminoheptane
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02D - OTHER OTOLOGICALS in ATC;S02DA - Analgesics and anesthetics;S02DA30 - otologic analgesic and anesthetic combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AB - Ergot alkaloid oxytocics;G02AB02 - ergot alkaloids
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BX - ACE inhibitors -  other combinations in ATC;C09BX01 - perindopril -  amlodipine and indapamide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA25 - eculizumab
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX18 - acrivastine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA06 - timolol and thiazides
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA07 - levonorgestrel and ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AF - Diphtheria vaccines;J07AF01 - diphtheria toxoid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA08 - ferrous tartrate
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX13 - Betulae cortex
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA11 - levoverbenone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA09 - clarithromycin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA03 - xylometazoline
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB01 - diprophylline and adrenergics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA05 - brimonidine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA01 - etidronic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE54 - insulin glargine and lixisenatide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA17 - drospirenone and estrogen
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX02 - samarium (153Sm) hydroxyapatite colloid
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CB - Beta blocking agents -  selective -  and other diuretics;C07CB53 - atenolol and other diuretics -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA05 - diphtheria-hepatitis B-pertussis-tetanus
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BB - Belladonna alkaloids -  semisynthetic -  quaternary ammonium compounds for functional gastrointestinal disorders;A03BB05 - cimetropium bromide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC14 - flomoxef
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX05 - zinc acetate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AR - Typhus (exanthematicus) vaccines;J07AR01 - typhus exanthematicus -  inactivated -  whole cell
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE01 - alprostadil
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CE - Phosphodiesterase inhibitors -  cardiac stimulant;C01CE03 - enoximone
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB05 - dexamethasone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE07 - cetirizine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA01 - silver sulfadiazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX11 - caroverine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CX - Other capillary stabilizing agents in ATC;C05CX01 - tribenoside
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB03 - interferon gamma
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB07 - fluprednidene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XB - Polymyxins;J01XB01 - colistin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD09 - ganciclovir
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF01 - metronidazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED01 - sulfadimethoxine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH04 - phenoperidine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA07 - oxytetracycline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD05 - metopimazine
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03C - Corticosteroids and antiinfectives in combination -  opthalmologic and otologic;S03CA - Corticosteroids and antiinfectives in combination;S03CA01 - dexamethasone and antiinfectives
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BA - Aminoquinoline antimalarials;P01BA01 - chloroquine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KD - Serotonin antagonists -  antihypertensives;C02KD01 - ketanserin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BC - Methanolquinolines -  antimalarial;P01BC02 - mefloquine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG03 - efavirenz
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB05 - paramethasone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX - Other topical products for joint and muscular pain in ATC;M02AX10 - various other intestinal adsorbents in ATC
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB03 - insulin (pork)
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AB - Phenylpiperidine derivatives -  opioid analgesics;N02AB01 - ketobemidone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC01 - cefoxitin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED04 - sulfametoxydiazine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA06 - betamethasone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD18 - sorbitol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX09 - viloxazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB06 - insulin glulisine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX05 - thiocolchicoside
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC23 - elotuzumab
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB03 - chlorzoxazone
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA02 - fusidic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE02 - lepirudin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA04 - oxazepam
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC53 - chloropyramine -  combinations
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX13 - monobenzone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE01 - paracetamol
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE06 - colestilan
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG02 - rimazolium
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA55 - pentaerithrityl tetranitrate -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA23 - indometacin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA55 - streptokinase -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC08 - canakinumab
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BE - Artemisinin and derivatives -  plain;P01BE02 - artemether
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE36 - alectinib
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA01 - chloramphenicol
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CX - Other selective calcium channel blockers with mainly vascular effects in ATC;C08CX01 - mibefradil
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE09 - patiromer calcium
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BA - Thiouracil antithyroid preparations;H03BA03 - benzylthiouracil
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX02 - copper oleinate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE04 - bucetin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB01 - dixyrazine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB07 - technetium (99mTc) phytate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AA - Preparations inhibiting uric acid production;M04AA03 - febuxostat
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX16 - brexpiprazole
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AD - Benzomorphan derivative analgesics;N02AD01 - pentazocine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CC - Penicillamine and similar antirheumatic agents;M01CC01 - penicillamine
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CJ - thyreoidea function test diagnostic agents;V04CJ02 - protirelin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA04 - technetium (99mTc) human albumin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA16 - tertatolol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA10 - bufylline
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CH - renal function and ureteral injuries test diagnostic agents;V04CH04 - alsactide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AG - Diphenylbutylpiperidine derivatives -  antipsychotics;N05AG03 - penfluridol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR15 - atazanavir and cobicistat
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA01 - microspheres of human albumin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX59 - enasidenib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA07 - technetium (99mTc) apcitide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BC - Carbamate anxiolytics;N05BC04 - mebutamate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB04 - iopamidol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AP - Typhoid vaccines;J07AP03 - typhoid -  purified polysaccharide antigen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BF - Alpha glucosidase inhibitors -  blood glucose lowering;A10BF02 - miglitol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB10 - tinzaparin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA05 - benzocaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AC - Triazole derivatives -  systemic antimycotics;J02AC02 - itraconazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC03 - lynestrenol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX02 - pyritinol
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CX - Other magnetic resonance imaging contrast media in ATC;V08CX01 - perflubron
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX57 - collagen -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CG - Beta-lactamase inhibitors -  systemic penicillins;J01CG02 - tazobactam
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XB - Amino Acids -  I.V. solution additive;B05XB01 - arginine hydrochloride
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX08 - galcanezumab
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA02 - lovastatin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AE - Sulfonamides -  Gynecological;G01AE10 - combinations of sulfonamides
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA04 - microspheres of phospholipids
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX09 - azatadine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX11 - troxipide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB02 - mercaptopurine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11A - MULTIVITAMINS -  COMBINATIONS;A11AA - Multivitamins with minerals;A11AA04 - multivitamins and trace elements
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AE - Indole derivatives -  antipsychotic;N05AE05 - lurasidone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CB - Belladonna and derivatives in combination with psycholeptics;A03CB04 - methylhomatropine and psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX71 - carbenoxolone -  combinations with psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IB - Indium-111 tumour detection radiopharmaceuticals;V09IB04 - indium (111In) capromab pendetide
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS;C08DA - Phenylalkylamine derivatives -  selective calcium channel blockers with direct cardiac effects;C08DA51 - verapamil -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB18 - potassium permanganate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA52 - tamsulosin and dutasteride
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA02 - chlorambucil
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX05 - riociguat
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BB - Influenza vaccines;J07BB02 - influenza -  inactivated -  split virus or surface antigen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB05 - fludarabine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA12 - ancestim
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE48 - icotinib
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA08 - isosorbide dinitrate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK05 - reproterol and sodium cromoglicate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DD - Nitroferricyanide derivatives acting on arteriolar smooth muscle;C02DD01 - nitroprusside
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK08 - formoterol and beclometasone
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02D - OTHER OTOLOGICALS in ATC;S02DA - Analgesics and anesthetics;S02DA01 - lidocaine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA52 - procaine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01B - ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION;M01BA - Antiinflammatory/antirheumatic agents in combination with corticosteroids;M01BA02 - dipyrocetyl and corticosteroids
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA10 - follitropin delta
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AC - Synthetic antispasmodics -  amides with tertiary amines for functional gastrointestinal disorders;A03AC02 - dimethylaminopropionylphenothiazine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB01 - lidocaine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX47 - idelalisib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX06 - sodium fluoride (18F)
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB04 - benzocaine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AC - Synthetic antispasmodics -  amides with tertiary amines for functional gastrointestinal disorders;A03AC05 - tiropramide
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02D - OTHER OTOLOGICALS in ATC;S02DA - Analgesics and anesthetics;S02DA04 - cinchocaine
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02B - Corticosteroid otologicals;S02BA - Corticosteroids;S02BA06 - dexamethasone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA19 - amineptine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB04 - perindopril and amlodipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC17 - nivolumab
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB05 - prednisolone and promethazine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA08 - rauwolfia alkaloids -  whole root and diuretics
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB73 - aminophenazone -  combinations with psycholeptics
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CB - Corticosteroid derivatives -  antimigraine drugs;N02CB01 - flumedroxone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA06 - norfloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE40 - olmutinib
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA19 - thiopental
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AF - Barbiturates for general anesthesia -  plain;N01AF01 - methohexital
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CB - Gold preparations;M01CB05 - aurotioprol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE11 - haloprogin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BX - Other chemotherapeutics in ATC;D06BX01 - metronidazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB01 - sulfaisodimidine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX08 - hexamidine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA06 - chlorphenoxamine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG06 - exemestane
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA09 - phenglutarimide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB02 - lynestrenol and estrogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD02 - benzydamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK03 - terizidone
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB28 - dimethoxanate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA23 - tofisopam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD21 - saxagliptin and dapagliflozin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE02 - sulfadiazine and trimethoprim
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX02 - retinol
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CD - pituitary function test diagnostic agents;V04CD01 - metyrapone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AK - Other drugs for treatment of tuberculosis in ATC;J04AK06 - delamanid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB05 - norethisterone and estrogen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03E - ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION;G03EA - Androgens and estrogens;G03EA02 - testosterone and estrogen
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC04 - hexamidine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA07 - estrone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM16 - niaprazine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD07 - temazepam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF15 - butoconazole
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AB - Chlorine containing product ectoparasiticides;P03AB01 - clofenotane
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA10 - sibutramine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB02 - lisuride
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM19 - suvorexant
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AF - Direct factor Xa inhibitors;B01AF03 - edoxaban
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF18 - flutrimazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BX - Other anxiolytics in ATC;N05BX04 - fabomotizole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG01 - sodium phosphate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AC - Insulins and analogues for injection -  intermediate-acting;A10AC04 - insulin lispro
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF03 - calcium folinate
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB15 - trimetazidine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BK - Varicella zoster vaccines;J07BK02 - zoster -  live attenuated
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FB - Sympathomimetics excl. antiglaucoma preparations;S01FB03 - ibopamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB17 - motavizumab
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB05 - desogestrel and ethinylestradiol
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BB - Drugs used in alcohol dependence;N07BB02 - calcium carbimide
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC08 - ketoconazole
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LG - Hydrazinophthalazine derivatives and diuretics;C02LG51 - dihydralazine and diuretics -  combinations with other drugs
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE - Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE01 - glyceryl trinitrate
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX31 - quifenadine
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10B - PAIN PALLIATION (BONE SEEKING AGENTS);V10BX - Various pain palliation radiopharmaceuticals;V10BX01 - strontium (89Sr) chloride
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA05 - taurolidine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AG - MAO A Inhibitors -  antidepressant drugs;N06AG02 - moclobemide
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA10 - myristyl-benzalkonium
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX51 - talimogene laherparepvec
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AJ - Pertussis vaccines;J07AJ02 - pertussis -  purified antigen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB09 - isopropamide
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA52 - pseudoephedrine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX11 - elvitegravir
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AG - Fenamates -  antiinflammatory and antirheumatic drugs;M01AG01 - mefenamic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD05 - fibrinolysin
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX07 - rosuvastatin -  amlodipine and lisinopril
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD13 - desfesoterodine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA27 - cefuroxime
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD07 - lansoprazole -  amoxicillin and clarithromycin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA16 - hexobarbital
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BG - Aromatase inhibitors;L02BG03 - anastrozole
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC52 - miconazole -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB12 - cidofovir
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD05 - ibutilide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX05 - bibrocathol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CB - Corticosteroids/antiinfectives/mydriatics in combination;S01CB01 - dexamethasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC03 - terbutaline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB08 - dienogest and estradiol
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AX - Other respiratory system products in ATC;R07AX30 - ivacaftor and lumacaftor
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB04 - hepatitis B immunoglobulin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC03 - dorzolamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA06 - roxithromycin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB09 - famciclovir
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AG - Drugs for treatment of hypercalcemia;V03AG01 - sodium cellulose phosphate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA04 - ciclonium and analgesics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA22 - abetimus
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA51 - nystatin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX15 - telotristat
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BB - Belladonna alkaloids -  semisynthetic -  quaternary ammonium compounds for functional gastrointestinal disorders;A03BB02 - methylatropine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX02 - probucol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BA - Solutions for parenteral nutrition;B05BA03 - carbohydrates
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX02 - lysozyme
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA53 - heparin -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB09 - dibekacin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB09 - letosteine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA18 - polymyxin B
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HX - Other diagnostic radiopharmaceuticals for inflammation and infection detection in ATC;V09HX01 - gallium (67Ga) citrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA07 - prasterone
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CA - Alpha-adrenoreceptor antagonists -  peripherally acting;C02CA02 - indoramin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE04 - chlorcyclizine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX32 - fasudil
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC03 - guanoxan
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA18 - everolimus
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA04 - technetium (99mTc) votumumab
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AC - Iron chelating agents;V03AC03 - deferasirox
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AA - Barbiturates and derivatives;N03AA03 - primidone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AC - Hydrazides for tuberculosis treatment;J04AC51 - isoniazid -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD06 - vidarabine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA30 - combinations of electrolytes
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB02 - triamcinolone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BB - Organophosphorous compounds -  antitrematodals;P02BB01 - metrifonate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC11 - ceforanide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX02 - anethole trithione
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB02 - nikethamide
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB15 - meprednisone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX11 - nitazoxanide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA08 - kanamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC09 - magnesium orotate
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB04 - fluocortin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA01 - diazepam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD12 - pioglitazone and sitagliptin
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC;C05AX03 - other preparations -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE51 - buclizine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM06 - rifampicin -  pyrazinamide -  ethambutol and isoniazid
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CF - Tuberculosis diagnostics agents;V04CF01 - tuberculin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB04 - citalopram
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA08 - methyclothiazide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX19 - gepirone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX05 - prucalopride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA04 - candicidin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD02 - cerium oxalate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03X - OTHER ANTIANEMIC PREPARATIONS in ATC;B03XA - Other antianemic preparations in ATC;B03XA03 - methoxy polyethylene glycol-epoetin beta
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA01 - tropenzilone and analgesics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA02 - ferrous fumarate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA13 - alteplase
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB02 - naphazoline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XE - Nitrofuran derivatives -  antibacterials for systemic use;J01XE02 - nifurtoinol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD03 - dexamethasone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CX - Other renal system diagnostic radiopharmaceuticals in ATC;V09CX04 - chromium (51Cr) edetate
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX10 - finasteride
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB14 - landiolol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX28 - rupatadine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX06 - nefazodone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA17 - medroxyprogesterone and estradiol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD05 - temoporfin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CD - Taxanes -  antineoplastic;L01CD02 - docetaxel
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD07 - ranimustine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BM - Papillomavirus vaccines;J07BM02 - papillomavirus (human types 16 -  18)
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA15 - dihydrostreptomycin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB37 - idarucizumab
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA05 - ferrous chloride
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB06 - ambroxol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AC - Phenothiazines with piperidine structure -  antipsychotics;N05AC02 - thioridazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB06 - amikacin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DF - Monobactams;J01DF02 - carumonam
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC17 - tirofiban
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB07 - alaproclate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA11 - ciprofloxacin and tinidazole
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC54 - permethrin -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA57 - theobromine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE04 - insulin glargine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA52 - rescinnamine and diuretics -  combinations with other drugs
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB04 - technetium (99mTc) tin colloid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC05 - ticlopidine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF05 - iproniazide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AB - Acid preparations -  digestives;A09AB03 - hydrochloric acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA72 - carisoprodol -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD01 - lidocaine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD03 - magnesium peroxide
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AA - Corticosteroids -  combinations for treatment of acne;D10AA02 - methylprednisolone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE33 - palbociclib
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AE - Iron in other combinations;B03AE03 - iron and multivitamins
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD04 - cinchocaine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX53 - propanol -  combinations
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05F - COUGH SUPPRESSANTS AND EXPECTORANTS -  COMBINATIONS;R05FA - Opium derivatives and expectorants;R05FA01 - opium derivatives and mucolytics
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS;C08DA - Phenylalkylamine derivatives -  selective calcium channel blockers with direct cardiac effects;C08DA01 - verapamil
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA02 - tamsulosin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BA - Pyrethrines;P03BA02 - cypermethrin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB05 - creatinolfosfate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CB - Antimony compounds for treatment of leishmaniasis and trypanosomiasis;P01CB01 - meglumine antimonate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB01 - metrizamide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA05 - pentaerithrityl tetranitrate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AG - Alpha and beta blocking agents;C07AG02 - carvedilol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AC - Corticosteroids for local oral treatment;A01AC02 - dexamethasone
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA07 - benazepril and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors;A10BK01 - dapagliflozin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AE - Gonadotropin releasing hormone analogues -  endocrine therapy drugs;L02AE03 - goserelin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF08 - tioconazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11A - MULTIVITAMINS -  COMBINATIONS;A11AA - Multivitamins with minerals;A11AA01 - multivitamins and iron
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AE - Indole derivatives -  antipsychotic;N05AE02 - molindone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB07 - aluminium glycinate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AA - Serotonin (5HT3) antagonists -  antiemetics and antinauseants;A04AA02 - granisetron
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA01 - alprenolol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD10 - darifenacin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EA - Trimethoprim and derivatives -  systemic antibacterials;J01EA01 - trimethoprim
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB06 - nimorazole
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK02 - isoprenaline and other drugs for obstructive airway diseases
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02D - ANTICESTODALS;P02DX - Other anticestodals in ATC;P02DX02 - dichlorophen
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB15 - naloxone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IB - Indium-111 tumour detection radiopharmaceuticals;V09IB01 - indium (111In) pentetreotide
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD03 - nicofuranose
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LG - Hydrazinophthalazine derivatives and diuretics;C02LG73 - picodralazine and diuretics -  combinations with psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX23 - butalamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA05 - methylnortestosterone and estrogen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX44 - aflibercept
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC54 - rabeprazole -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX04 - bisoprolol and acetylsalicylic acid
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA03 - metixene
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA20 - combinations of xanthines
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX04 - spectinomycin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA52 - glyceryl trinitrate -  combinations
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02B - Corticosteroid otologicals;S02BA - Corticosteroids;S02BA03 - prednisolone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CA - Sympathomimetics -  labour repressants;G02CA02 - buphenine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD10 - von Willebrand factor
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AA - Softeners -  emollients;A06AA02 - docusate sodium
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE03 - lanthanum carbonate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01L - OCULAR VASCULAR DISORDER AGENTS;S01LA - Antineovascularisation agents;S01LA01 - verteporfin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA16 - dosulepin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01K - SURGICAL AIDS -  OPHTHALMOLOGIC;S01KX - Other ophthalmologic surgical aids in ATC;S01KX01 - chymotrypsin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD09 - pioglitazone and alogliptin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA12 - metolazone and potassium-sparing agents
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC02 - pergolide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA01 - technetium (99mTc) sestamibi
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB01 - ethotoin
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX06 - candesartan -  amlodipine and hydrochlorothiazide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB01 - technetium (99mTc) nanocolloid
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX10 - moxisylyte
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF10 - sodium levofolinate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB03 - afelimomab
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AH - Quinoline derivatives -  antiseptics and disinfectants;D08AH30 - clioquinol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC05 - gemtuzumab ozogamicin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF03 - zalcitabine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX01 - fusidic acid
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BX - Other antimalarials in ATC;P01BX01 - halofantrine
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB58 - articaine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB12 - difenpiramide
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CE - liver functional capacity test diagnostic agents;V04CE01 - galactose
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA11 - manidipine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DE - Fourth-generation cephalosporins;J01DE02 - cefpirome
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA03 - methocarbamol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE13 - ibuproxam
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA18 - ciclosporin
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA10 - diodone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX09 - linopirdine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA37 - baricitinib
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA03 - chlortetracycline
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BG - Other antiarrhythmics -  class I and III in ATC;C01BG11 - vernakalant
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX12 - patisiran
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XD - Imidazole derivatives -  antibacterial for systemic use;J01XD02 - tinidazole
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX02 - carbazochrome
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA12 - dimetofrine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA05 - oxymetazoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC01 - pectin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE16 - alminoprofen
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB03 - ecothiopate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB04 - dalteparin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BA - biguanide blood glucose lower drugs;A10BA01 - phenformin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AD - Succinimide derivatives -  antiepileptics;N03AD01 - ethosuximide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CC - Antiinflammatory products for vaginal administration;G02CC02 - naproxen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA04 - vinorelbine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC16 - procaterol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE21 - flucytosine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB07 - mitoxantrone
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF01 - mesna
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA09 - guaiacolsulfonate
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC02 - methadone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EX - Other antiglaucoma preparations in ATC;S01EX05 - netarsudil
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA09 - bendamustine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC07 - iocetamic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA13 - dirithromycin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB11 - s-atenolol
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB08 - articaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02B - CONTRACEPTIVES FOR TOPICAL USE;G02BB - Intravaginal contraceptives;G02BB02 - vaginal ring with progestogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AH - Peripheral opioid receptor antagonists;A06AH04 - naloxone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA03 - tetracaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC08 - etonogestrel
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AB - Choline esters -  parasympathomimetics;N07AB02 - bethanechol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR03 - tenofovir disoproxil and emtricitabine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB14 - benzoxonium chloride
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX05 - eltrombopag
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA11 - dimemorfan
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB06 - neostigmine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC08 - procaterol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB07 - bisoprolol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC08 - decitabine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AD - Non-watersoluble X-ray contrast media;V08AD01 - ethyl esters of iodised fatty acids
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XA - Corticosteroids -  weak -  other combinations;D07XA02 - prednisolone
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB08 - ciprofibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX07 - magnesium pyridoxal 5-phosphate glutamate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA09 - methiodal
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA10 - acetic acid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD03 - gemeprost
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD04 - methdilazine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC10 - secukinumab
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX32 - bortezomib
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE03 - sildenafil
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD07 - mequitazine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC13 - ixekizumab
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA09 - technetium (99mTc) tilmanocept
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA13 - miconazole
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB06 - dexbrompheniramine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA11 - mecillinam
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA06 - pyridoxal phosphate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ58 - benzethonium chloride -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG09 - methoxyflurane
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AG - barbiturates for general anesthesia -  in combination with other drugs;N01AG01 - narcobarbital
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX24 - oxaceprol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA21 - sitafloxacin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC01 - sumatriptan
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA06 - ethylmorphine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA03 - hydrocortisone and antiinfectives
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA17 - niflumic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA06 - fludrocortisone and antiinfectives
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA19 - etizolam
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC04 - rizatriptan
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AA - Mineralocorticoids for systemic use -  plain;H02AA02 - fludrocortisone
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA02 - enalapril
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AH - Neuraminidase inhibitors -  direct acting antivirals;J05AH01 - zanamivir
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB11 - hydrocortisone buteprate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EC - Intermediate-acting sulfonamides;J01EC01 - sulfamethoxazole
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB01 - phenazone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL04 - remoxipride
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CC - Nitrofuran derivatives -  antiprotozoal drugs;P01CC02 - nitrofural
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA09 - iodoheparinate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX12 - trientine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AX - Other nasal preparations in ATC;R01AX09 - hyaluronic acid
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB09 - edoxudine
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03B - ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS;D03BA - Proteolytic enzymes for treatment of wounds and ulcers;D03BA52 - collagenase -  combinations
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB03 - mepivacaine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA01 - diatrizoic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BB - Anti-androgen hormone antagonists and related agents;L02BB05 - apalutamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD09 - cefodizime
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL03 - vilanterol and umeclidinium bromide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB06 - carbutamide
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CA - Gonadotropin-releasing hormones;H01CA02 - nafarelin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07X - OTHER ANTIDIARRHEALS in ATC;A07XA - Other antidiarrheals in ATC;A07XA03 - calcium compounds
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AX - Other antipsoriatics for topical use in ATC;D05AX03 - calcitriol
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA02 - grass pollen
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA04 - barbital
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA05 - polymyxin B
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA55 - salicylamide -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD12 - aprepitant
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09F - THYROID DIAGNOSTIC RADIOPHARMACEUTICALS;V09FX - Various thyroid diagnostic radiopharmaceuticals;V09FX03 - sodium iodide (131I)
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BB - Sulfonamides and potassium in combination -  low-ceiling diruetics -  excluding thiazides;C03BB05 - mefruside and potassium
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX05 - omalizumab
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA11 - prazepam
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC08 - panitumumab
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB12 - rimexolone
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AB - Antibiotic throat preparations;R02AB30 - gramicidin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX08 - mitiglinide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC21 - ulobetasol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD03 - aciclovir
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA01 - technetium (99mTc) antiCarcinoEmbryonicAntigen antibody
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA02 - hydroflumethiazide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX16 - venlafaxine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AA - Thiazides -  plain;C03AA05 - polythiazide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BF - Poliomyelitis vaccines;J07BF01 - poliomyelitis oral -  monovalent -  live attenuated
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AF - Carboxamide derivatives -  antiepileptics;N03AF02 - oxcarbazepine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC04 - permethrin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB09 - gliclazide
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA17 - cetrimonium
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BC - Corticosteroids -  potent -  combinations with antiseptics;D07BC04 - diflucortolone and antiseptics
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA12 - chlorhexidine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM04 - carbromal
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XX - Various diagnostic radiopharmaceuticals;V09XX01 - cobalt (57Co) cyanocobalamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CX - Other gynecologicals in ATC;G02CX02 - flibanserin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD13 - ciclesonide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX02 - carbon dioxide producing drugs
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA01 - nystatin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ07 - codeine and acetylsalicylic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08E - NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08EX - Other non-selective calcium channel blockers in ATC;C08EX01 - lidoflazine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA32 - apremilast
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XX - Various diagnostic radiopharmaceuticals;V09XX04 - ferric (59Fe) citrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE01 - insulin (human)
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA14 - nomegestrol and estradiol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX25 - mizolastine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX04 - pegademase
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CX - Other renal system diagnostic radiopharmaceuticals in ATC;V09CX01 - sodium iodohippurate (123I)
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BA - Heparins or heparinoids for topical use;C05BA03 - heparin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA03 - flunisolide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA10 - inosine
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB03 - carbocisteine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE47 - dacomitinib
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA12 - tobramycin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DA - Technetium 99m compounds -  hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;V09DA04 - technetium (99mTc) mebrofenin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CX - Other drugs used in benign prostatic hypertrophy in ATC;G04CX02 - Sabalis serrulatae fructus
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA07 - telmisartan and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BB - Anti-androgen hormone antagonists and related agents;L02BB02 - nilutamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA12 - diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA04 - calcium carbonate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX - Other central nervous system diagnostic radiopharmaceuticals in ATC;V09AX06 - florbetaben (18F)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA16 - solithromycin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ03 - cetylpyridinium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07F - ANTIDIARRHEAL MICROORGANISMS;A07FA - Antidiarrheal microorganisms;A07FA02 - saccharomyces boulardii
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE18 - tolnaftate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX07 - poly I:C
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB03 - gentamicin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA08 - morpholine salicylate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AC - Hydrazides for tuberculosis treatment;J04AC01 - isoniazid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE07 - fosamprenavir
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AA - Estrogens -  endocrine therapy drugs;L02AA02 - polyestradiol phosphate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ06 - didecyldimethylammonium chloride
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AD - Iron in combination with folic acid;B03AD03 - ferrous sulfate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB08 - sulfathiourea
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BX - Other local anesthetics in ATC;N01BX02 - dyclonine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA02 - tetanus antitoxin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD60 - hydrocortisone -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC04 - rabeprazole
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BC - Antiallergic inhalants for obstructive airway diseases -  excl. corticosteroids;R03BC03 - nedocromil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA09 - difemerine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA05 - norethisterone and ethinylestradiol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX16 - deptropine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BA - Immunoglobulins -  normal human;J06BA01 - immunoglobulins -  normal human -  for extravascular adm.
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB04 - dihydroxialumini sodium carbonate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF05 - econazole
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB25 - flumazenil
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AB - Non-selective beta-adrenoreceptor agonist inhalants;R03AB03 - orciprenaline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CD - Fluoride supplements;A12CD51 - fluoride -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX09 - glycerol phenylbutyrate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA01 - naphazoline
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EA - Sympathomimetics in glaucoma therapy;S01EA03 - apraclonidine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC08 - salicylic acid
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX03 - thenalidine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK12 - salmeterol and budesonide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB02 - camphora
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA08 - fleroxacin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC07 - dexrabeprazole
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB07 - interferon beta-1a
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA04 - sparteine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA02 - glyceryl trinitrate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BX - Other antitrematodal agents in ATC;P02BX04 - triclabendazole
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AD - Psoralens for topical use;D05AD01 - trioxysalen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA02 - hydroxyprogesterone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CE - Phosphodiesterase inhibitors -  cardiac stimulant;C01CE01 - amrinone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC24 - daratumumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA06 - clebopride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD06 - glimepiride and pioglitazone
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX10 - felbamate
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX01 - propranolol and other combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX20 - buflomedil
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CC - Aldehydes and derivatives;N05CC04 - dichloralphenazone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC27 - olaratumab
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA10 - fluocinolone acetonide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AB - Phenylpiperidine derivatives -  opioid analgesics;N02AB52 - pethidine -  combinations excl. psycholeptics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AB - Capsaicin and similar agents;M02AB02 - zucapsaicin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB03 - fluocortolone
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA09 - povidone-iodine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX01 - fosfomycin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA23 - penbutolol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA51 - quinidine -  combinations excl. psycholeptics
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DB - Xanthines and adrenergics;R03DB05 - aminophylline and adrenergics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA05 - tiludronic acid
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA20 - topical antibiotic combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR22 - emtricitabine -  tenofovir alafenamide -  darunavir and cobicistat
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX03 - pridinol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE08 - nilotinib
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE09 - procaine benzylpenicillin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CA - Alpha- and beta-adrenoreceptor agonist -  systemic drugs;R03CA02 - ephedrine
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB18 - prenoxdiazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA09 - diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB11 - iobitridol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AF - Monoamine oxidase inhibitors -  non-selective;N06AF02 - nialamide
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF01 - clindamycin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC02 - cloricromen
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC13 - formoterol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE30 - combination drugs used in erectile dysfunction
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE10 - indoprofen
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA04 - clomipramine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA03 - combinations of rauwolfia alkaloids
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD01 - insulin (human)
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD04 - insulin lispro
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA33 - diphenhydramine methylbromide
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CH - renal function and ureteral injuries test diagnostic agents;V04CH02 - indigo carmine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB01 - cycloserine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XC - Selective estrogen receptor modulators;G03XC03 - lasofoxifene
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC02 - lynestrenol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR13 - lamivudine -  abacavir and dolutegravir
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AH - Peripheral opioid receptor antagonists;A06AH01 - methylnaltrexone bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CA - Beta blocking agents -  non-selective -  and other diuretics;C07CA03 - pindolol and other diuretics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA05 - mecobalamin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA02 - cyclopentamine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA25 - amezinium metilsulfate
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB09 - oxeladin
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA11 - animal allergen extracts
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA10 - azithromycin
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC20 - Imidazole and triazole derivative topical antifungal combinations
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA06 - senega
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP57 - glecaprevir and pibrentasvir
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX06 - oxetorone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AM - Tetanus vaccines;J07AM51 - tetanus toxoid -  combinations with diphtheria toxoid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB11 - various antiinfectives and antiseptics for local oral treatment
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB04 - rifabutin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC05 - megestrol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CB - Belladonna and derivatives in combination with psycholeptics;A03CB02 - belladonna total alkaloids and psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA59 - trolnitrate -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA03 - sodium chloride -  hypertonic
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AD - antacids containing combinations and complexes of aluminium -  calcium and magnesium compounds;A02AD04 - hydrotalcite
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CC - Antiinflammatory agents -  non-steroids and antiinfectives in combination;S01CC01 - diclofenac and antiinfectives
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EE - Prostaglandin analogues -  antiglaucoma drugs and miotics;S01EE04 - travoprost
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD01 - alimemazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11G - ASCORBIC ACID (VITAMIN C) -  INCL. COMBINATIONS;A11GB - vitamin C combinations;A11GB01 - ascorbic acid and calcium
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB04 - acebutolol
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CB - Piperazine and derivatives -  antinematodal agents;P02CB01 - piperazine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CC - Penicillamine and similar antirheumatic agents;M01CC02 - bucillamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB11 - cefroxadine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AX - Other blood products in ATC;B05AX03 - blood plasma
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX04 - drisapersen
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC09 - rotigotine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL01 - sulpiride
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AX - Other antipruritics in ATC;D04AX01 - doxepin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BB - Corticosteroids -  moderately potent -  combinations with antiseptics;D07BB04 - hydrocortisone butyrate and antiseptics
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX09 - dehydroemetine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA27 - dexketoprofen
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX11 - rifaximin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA10 - penimepicycline
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX04 - fludeoxyglucose (18F)
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AX - Other therapeutic products in ATC;V03AX02 - nalfurafine
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC30 - other medicated shampoos in ATC
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CB - Superparamagnetic contrast media;V08CB03 - iron oxide -  nanoparticles
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB11 - sulodexide
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX14 - ozenoxacin
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX14 - rosuvastatin -  amlodipine and perindopril
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA13 - eravacycline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD12 - protein C
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF13 - tenofovir alafenamide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB02 - enalapril and lercanidipine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DX - Other anti-dementia drugs in ATC;N06DX01 - memantine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA08 - metolazone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB06 - cinoxacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA05 - tyrothricin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX06 - citicoline
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX10 - epinastine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC04 - calcitriol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA22 - arbutamine
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA15 - indanazoline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FG - Streptogramins;J01FG02 - quinupristin/dalfopristin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC02 - rituximab
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA19 - fenoldopam
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC17 - fluticasone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EB - Technetium (99mTc) -  particles for injection;V09EB01 - technetium (99mTc) macrosalb
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD11 - cefpiramide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX16 - hexetidine
V - VARIOUS DRUG CLASSES IN ATC;V06 - GENERAL NUTRIENTS;V06D - OTHER NUTRIENTS in ATC;V06DC - Carbohydrate nutrients;V06DC01 - glucose
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA02 - mofebutazone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE03 - ciprofloxacin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX12 - glucosaminoglycan polysulfate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB61 - peginterferon alfa-2a -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AE - Serotonin receptor antagonists for functional gastrointestinal disorders;A03AE03 - cilansetron
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02A - EMOLLIENTS AND PROTECTIVES;D02AE - Carbamide products -  emollients and protectives;D02AE51 - carbamide -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE10 - sodium zirconium cyclosilicate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EX - Other respiratory system diagnostic radiopharmaceuticals in ATC;V09EX03 - xenon (133Xe) gas
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG02 - valpromide
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HA - Technetium 99m compounds -  inflammation and infection detection radiopharmaceuticals;V09HA01 - technetium (99mTc) human immunoglobulin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA05 - aminophylline
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX53 - thenalidine -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA55 - oxycodone and naloxone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA05 - benzydamine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB05 - polythiazide and potassium
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE15 - vemurafenib
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AC - Antracen derivatives -  topical antipsoriatics;D05AC51 - dithranol -  combinations
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA08 - griseofulvin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AX - Other antithrombotic agents in ATC;B01AX04 - dermatan sulfate
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08E - NON-SELECTIVE CALCIUM CHANNEL BLOCKERS;C08EA - Phenylalkylamine derivatives -  non-selective calcium channel blockers;C08EA01 - fendiline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC03 - sterculia
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03D - ANTISPASMODICS IN COMBINATION WITH ANALGESICS;A03DA - Synthetic anticholinergic agents in combination with analgesics;A03DA07 - tiemonium iodide and analgesics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX06 - proglumide
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BC - Perchlorate antithyroid preparations;H03BC01 - potassium perchlorate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AC - Preparations with no effect on uric acid metabolism;M04AC01 - colchicine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX02 - prenylamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX15 - pentosan polysulfate sodium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A09 - DIGESTIVES -  INCL. ENZYMES;A09A - DIGESTIVES -  INCL. ENZYMES;A09AA - Enzyme preparations -  digestives;A09AA03 - pepsin
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB03 - invert sugar
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AX - Other parasympathomimetics in ATC;N07AX02 - choline alfoscerate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB02 - saccharated iron oxide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB07 - candesartan and amlodipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA04 - magnesium hydroxide
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB06 - glycopyrronium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AH - Thiazides -  combinations with psycholeptics and/or analgesics;C03AH01 - chlorothiazide -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA15 - gemifloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02A - HORMONES AND RELATED AGENTS;L02AB - Progestogens -  endocrine therapy drugs;L02AB02 - medroxyprogesterone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB12 - mepenzolate
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA07 - telmisartan
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA04 - technetium (99mTc) gluceptate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA02 - hydrocortisone
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX15 - xenon
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA05 - oxycodone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX09 - acetoxolone
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BA - Psoralens for systemic use;D05BA03 - bergapten
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK06 - thiomersal
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CB - Somatostatin and analogues;H01CB02 - octreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX14 - valethamate
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X - OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC;C09XA - Renin-inhibitors;C09XA54 - aliskiren -  amlodipine and hydrochlorothiazide
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC53 - terbutaline -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC21 - treprostinil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA05 - tixocortol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA08 - dihydrocodeine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB08 - cefapirin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX06 - dipiperonylaminoethanol -  combinations
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA03 - hydrocortisone and antiinfectives
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AA - Quinine and derivatives for DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AA01 - hydroquinine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC24 - ticagrelor
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA02 - stanozolol
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB11 - docosanol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB07 - alglucosidase alfa
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CA - Corticosteroids -  weak -  combinations with antibiotics;D07CA01 - hydrocortisone and antibiotics
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE06 - 2-(4-chlorphenoxy)-ethanol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA01 - arginine glutamate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF02 - clotrimazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AB - antacids containing aluminium compounds;A02AB01 - aluminium hydroxide
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB22 - amyl nitrite
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX29 - denileukin diftitox
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX30 - azapetine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA12 - medroxyprogesterone and estrogen
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA06 - etilevodopa and decarboxylase inhibitor
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA04 - citiolone
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AA - Tertiary amines -  anticholinergic;N04AA10 - mazaticol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA20 - etallobarbital
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB06 - prethcamide
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB09 - mepixanox
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BX - Other antitrematodal agents in ATC;P02BX01 - bithionol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX11 - tedizolid
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF04 - artesunate -  sulphamethopyrazine and pyrimethamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GB - Ovulation stimulants -  synthetic;G03GB02 - clomifene
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA08 - tetracycline
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA06 - dexamethasone and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC01 - mepyramine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA23 - quinupramine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DA - Pregnen (4) derivatives -  progestogens;G03DA01 - gestonorone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03A - THYROID PREPARATIONS;H03AA - Thyroid hormones;H03AA02 - liothyronine sodium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11G - ASCORBIC ACID (VITAMIN C) -  INCL. COMBINATIONS;A11GA - vitamin C products -  plain;A11GA01 - ascorbic acid
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA01 - mebendazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH04 - doripenem
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD16 - metformin and canagliflozin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AG - Opioids in combination with antispasmodics;N02AG04 - hydromorphone and antispasmodics
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03A - THYROID PREPARATIONS;H03AA - Thyroid hormones;H03AA05 - thyroid gland preparations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM01 - streptomycin and isoniazid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD19 - linagliptin and empagliflozin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC13 - clenbuterol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD10 - mineral salts in combination
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LF - Guanidine derivatives and diuretics;C02LF01 - guanethidine and diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DA - Pregnen (4) derivatives -  progestogens;G03DA04 - progesterone
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AA - 2-amino-1-phenylethanol derivatives;C04AA02 - buphenine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AC - Nicotinic acid and derivatives -  peripheral vasodilators;C04AC03 - inositol nicotinate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA04 - ciclobendazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CC - Aldehydes and derivatives;N05CC01 - chloral hydrate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE18 - ruxolitinib
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD07 - tixocortol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC07 - magnesium levulinate
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AC - Substituted ethylene diamines -  systemic antihistamines;R06AC04 - tripelennamine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA08 - bamifylline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA09 - ferrous aspartate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AM - Combinations of drugs for treatment of tuberculosis;J04AM04 - thioacetazone and isoniazid
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA13 - moexipril
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA05 - mazindol
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB53 - pentetrazol -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04B - DRUGS FOR TREATMENT OF LEPRA;J04BA - Drugs for treatment of lepra;J04BA01 - clofazimine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AG - Iodine products -  antiseptics and disinfectants;D08AG03 - iodine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DC - Other cytotoxic antibiotics in ATC;L01DC02 - plicamycin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BB - Sulfur-containing imidazole derivatives -  antithyroid preparations;H03BB52 - thiamazole -  combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03B - ANDROGENS;G03BB - 5-androstanon (3) derivatives;G03BB02 - androstanolone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC07 - collagen
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA16 - imidapril
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BA - Calcitonin preparations;H05BA03 - calcitonin (human synthetic)
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC05 - diethylstilbestrol
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AB - Choline esters -  parasympathomimetics;N07AB01 - carbachol
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE02 - policresulen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB57 - cascara -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XX - Various therapeutic radiopharmaceuticals;V10XX01 - sodium phosphate (32P)
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA05 - chlorhexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB01 - insulin (human)
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA03 - gadodiamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CD - Fluoride supplements;A12CD01 - sodium fluoride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD13 - sodium sulfate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DH - Carbapenems;J01DH51 - imipenem and cilastatin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX04 - nomifensine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AB - Proteinase inhibitors -  antifibrinolytic;B02AB04 - camostat
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA02 - quingestanol and ethinylestradiol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CB - Podophyllotoxin derivatives -  antineoplastic drugs;L01CB02 - teniposide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX04 - lenalidomide
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA02 - simvastatin and ezetimibe
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX13 - loratadine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CA - Benzimidazole derivatives -  antinematodal;P02CA51 - mebendazole -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX06 - omega-3-triglycerides incl. other esters and acids
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX03 - dysprosium (165Dy) colloid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX06 - pleconaril
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA09 - lacidipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA06 - gadoversetamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA06 - rociverine
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX06 - gold (198Au) colloidal
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA18 - pazufloxacin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA54 - disulfiram -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX09 - maraviroc
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB04 - agalsidase beta
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AE - Phenol and derivatives -  antiseptics and disinfectants;D08AE05 - chloroxylenol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BC - Proton pump inhibitors for peptic ulcer and GORD;A02BC01 - omeprazole
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX52 - gamolenic acid -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB21 - chlortetracycline
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX05 - hyaluronic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP54 - elbasvir and grazoprevir
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA04 - potassium hydrogencarbonate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX11 - tasonermin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX23 - brivaracetam
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC56 - acetylsalicylic acid -  combinations with proton pump inhibitors
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR10 - lopinavir and ritonavir
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB10 - expectorant combinations -  excl. combinations with cough suppressants
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AA - Barbiturates and derivatives;N03AA30 - metharbital
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA55 - phenylephrine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB01 - benzilone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA09 - noretynodrel and estrogen
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA03 - guaifenesin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BA - Anti-estrogens;L02BA02 - toremifene
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA15 - fluocinolone acetonide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA52 - ergotamine -  combinations excl. psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC06 - cefonicid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA03 - hyaluronidase
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EE - Prostaglandin analogues -  antiglaucoma drugs and miotics;S01EE01 - latanoprost
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01L - OCULAR VASCULAR DISORDER AGENTS;S01LA - Antineovascularisation agents;S01LA05 - aflibercept
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CX - Other agents against leishmaniasis and trypanosomiasis in ATC;P01CX01 - pentamidine isethionate
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BA - Vasopressin and analogues;H01BA04 - terlipressin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA02 - quinethazone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA24 - nifenazone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD14 - susoctocog alfa
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX01 - iobenguane (123I)
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AX - Other agents against amoebiasis and other protozoal diseases in ATC;P01AX06 - atovaquone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB04 - azanidazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB10 - metahexamide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC01 - betamethasone and antibiotics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED09 - sulfamazone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC12 - brentuximab vedotin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CC - Corticosteroids -  potent -  combinations with antibiotics;D07CC04 - beclometasone and antibiotics
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC05 - mecasermin rinfabate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF10 - entecavir
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MB - Other quinolones in ATC;J01MB03 - piromidic acid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE37 - rociletinib
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB21 - clocortolone
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BB - Corticosteroids -  moderately potent -  combinations with antiseptics;D07BB01 - flumetasone and antiseptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC09 - cefmetazole
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX01 - hyaluronic acid
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC06 - cabergoline
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX05 - magnesium sulfate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX04 - tosylchloramide sodium
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA08 - sodium acetate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP07 - daclatasvir
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX - Other topical products for joint and muscular pain in ATC;M02AX02 - tolazoline
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA05 - mefruside
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX16 - pramiracetam
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA14 - melitracen
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX11 - atorvastatin -  amlodipine and perindopril
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH06 - lumiracoxib
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA06 - cefepime and amikacin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA12 - fenoxazoline
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AD - Corticosteroids -  very potent (group IV);D07AD02 - halcinonide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AX - Other topical products for joint and muscular pain in ATC;M02AX05 - idrocilamide
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB10 - paraoxon
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX11 - zotepine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX04 - valsartan and sacubitril
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DX - Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals in ATC;V09DX01 - selenium (75Se) tauroselcholic acid
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA01 - desipramine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC01 - ergocalciferol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC15 - obinutuzumab
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB08 - zoledronic acid -  calcium and colecalciferol -  sequential
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA74 - theophylline -  combinations with psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP51 - sofosbuvir and ledipasvir
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC02 - clioquinol
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA12 - formocortal
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA02 - cyanocobalamin tannin complex
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB03 - clobutinol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BK - Sodium-glucose co-transporter 2 (SGLT2) inhibitors;A10BK05 - ipragliflozin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX09 - fostamatinib
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA06 - gentamicin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB09 - butaperazine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC08 - fazadinium bromide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB02 - antithrombin III
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC03 - terbutaline
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX12 - molsidomine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BG - Rabies vaccines;J07BG01 - rabies -  inactivated -  whole virus
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR07 - stavudine -  lamivudine and nevirapine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AX - Other antithrombotic agents in ATC;B01AX01 - defibrotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC04 - magnesium citrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB18 - clotrimazole
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB09 - etofibrate
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA57 - bietaserpine -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA02 - vincristine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA01 - dixanthogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AA - antacids containing magnesium compounds;A02AA01 - magnesium carbonate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09X - OTHER DIAGNOSTIC RADIOPHARMACEUTICALS in ATC;V09XA - Iodine I-131 diagnostic radiopharmaceuticals;V09XA01 - iodine (131I) norcholesterol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB03 - stramoni preparations
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB04 - telmisartan and amlodipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA07 - trofosfamide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA01 - losartan
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX12 - phenyl salicylate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX03 - pirenzepine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB05 - nifenazone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA01 - technetium (99mTc) pentetic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA06 - quinapril
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA04 - irbesartan
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC06 - isoetarine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA15 - talampicillin
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AA - Anticholinesterase parasympathomimetics;N07AA51 - neostigmine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB31 - acetohexamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA18 - hetacillin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB20 - Short-acting sulfonamide combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX23 - desvenlafaxine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA10 - hemoglobin glutamer (bovine)
D - DERMATOLOGICALS;D02 - EMOLLIENTS AND PROTECTIVES;D02A - EMOLLIENTS AND PROTECTIVES;D02AE - Carbamide products -  emollients and protectives;D02AE01 - carbamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF07 - tenofovir disoproxil
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CB - Barbiturates -  combinations;N05CB01 - combinations of barbiturates
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA09 - fosinopril
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA02 - human menopausal gonadotrophin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA04 - riboflavin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX22 - morniflumate
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX26 - vortioxetine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC59 - trifluridine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA12 - naproxen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA15 - diclofenac
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AB - Sulfonamides -  intestinal antiinfectives;A07AB02 - phthalylsulfathiazole
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB52 - metamizole sodium -  combinations excl. psycholeptics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB06 - trifluoperazine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX03 - methylpentynol -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AC - Drugs used in hereditary angioedema;B06AC03 - ecallantide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA13 - armodafinil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG20 - Enema combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS;P01CD - Arsenic compounds -  for leishmaniasis and trypanosomiasis;P01CD02 - acetarsol
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LE - Alpha-adrenoreceptor antagonists and diuretics;C02LE01 - prazosin and diuretics
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05A - ANTIPSORIATICS FOR TOPICAL USE;D05AC - Antracen derivatives -  topical antipsoriatics;D05AC01 - dithranol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA02 - choline theophyllinate
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AC - Ethers of tropine or tropine derivatives -  anticholinergic;N04AC01 - benzatropine
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA03 - polymyxin B
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX08 - risperidone
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AA - Antifungal Antibiotics -  Topical;D01AA02 - natamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA30 - Caries prophylactic agent combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE12 - vandetanib
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CC - Magnesium supplements -  alimentary tract and metabolism;A12CC01 - magnesium chloride
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AA - Acridine derivatives -  antiseptics and disinfectants;D08AA01 - ethacridine lactate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB10 - fentiazac
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC14 - methylprednisolone aceponate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX06 - emicizumab
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA09 - tramazoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC05 - diosmectite
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CF - Benzodiazepine related hypnotics and sedatives;N05CF02 - zolpidem
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BA - Bisphosphonate drugs affecting bone structure and mineralization;M05BA08 - zoledronic acid
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX07 - fampridine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BA - Corticosteroids -  weak -  combinations with antiseptics;D07BA04 - hydrocortisone and antiseptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX02 - diisopromine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB07 - bumadizone
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB25 - morclofone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AA - Bile acids and derivatives for bile therapy;A05AA04 - obeticholic acid
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB51 - indometacin -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LG - Hydrazinophthalazine derivatives and diuretics;C02LG01 - dihydralazine and diuretics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FF - Lincosamides;J01FF02 - lincomycin
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX09 - imolamine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM13 - valnoctamide
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02B - ANTITREMATODALS;P02BA - Quinoline derivatives and related substances -  antitrematodals;P02BA01 - praziquantel
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX17 - topotecan
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX03 - sultiame
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11D - VITAMIN B1 -  PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12;A11DA - Vitamin B1 -  plain;A11DA03 - benfotiamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BD - Measles vaccines;J07BD54 - measles -  combinations with mumps -  rubella and varicella -  live attenuated
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA04 - methylphenidate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG11 - sodium lauryl sulfoacetate -  incl. combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB04 - nomegestrol
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AD - Purine derivatives -  peripheral vasodilators;C04AD03 - pentoxifylline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA11 - tioclomarol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX61 - copanlisib
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA20 - various antiseptic throat preparations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AC - Insulins and analogues for injection -  intermediate-acting;A10AC01 - insulin (human)
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE;R01BA - Sympathomimetics;R01BA02 - pseudoephedrine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BX - Other anxiolytics in ATC;N05BX01 - mephenoxalone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10X - OTHER DRUGS USED IN DIABETES in ATC;A10XA - Aldose reductase inhibitors used in diabetes;A10XA01 - tolrestat
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE03 - erlotinib
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB14 - cepeginterferon alfa-2b
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD04 - estazolam
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD06 - bromperidol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AF - Imidazole derivatives -  gyncological antiinfectives;G01AF12 - fenticonazole
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA04 - estriol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA02 - chlorhexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH07 - evogliptin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA06 - normethadone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA05 - magnesium sulfate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AH - Quinoline derivatives -  antiseptics and disinfectants;D08AH03 - oxyquinoline
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC18 - luliconazole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD09 - fluanisone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD07 - coagulation factor XIII
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC05 - isoconazole
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC03 - azelastine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB09 - miconazole
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05A - PARATHYROID HORMONES AND ANALOGUES;H05AA - Parathyroid hormones and analogues;H05AA03 - parathyroid hormone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX21 - pentanedioic acid imidazolyl ethanamide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA10 - expectorant combinations excluding combinations with cough suppressants
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB02 - lynestrenol and ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB14 - measles immunoglobulin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AA - Aminosalicylic acid and derivatives;J04AA01 - 4-aminosalicylic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DI - Other cephalosporins and penems in ATC;J01DI54 - ceftolozane and beta-lactamase inhibitor
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BB - Beta blocking agents -  selective -  and thiazides;C07BB04 - acebutolol and thiazides
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE50 - abemaciclib
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED01 - timolol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD02 - alteplase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX04 - simvastatin -  acetylsalicylic acid and ramipril
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA07 - hydroxyethylstarch
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AD - Thiocarbamide derivatives for treatment of tuberculosis;J04AD02 - tiocarlide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC30 - Other intestinal adsorbent combinations in ATC
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX02 - silver compounds
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01C - SPECIFIC ANTIRHEUMATIC AGENTS;M01CB - Gold preparations;M01CB02 - sodium aurotiosulfate
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BA - Corticosteroids -  weak -  combinations with antiseptics;D07BA01 - prednisolone and antiseptics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC03 - diclofenac
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BD - Antiarrhythmics -  class III;C01BD02 - bretylium tosilate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA06 - bacampicillin
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA03 - epitizide and potassium-sparing agents
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA77 - ethenzamide -  combinations with psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD04 - pantoprazole -  amoxicillin and clarithromycin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX14 - tretinoin
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX16 - pregabalin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA05 - triamcinolone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AB - Sulfonamides -  ophthalmologic antiinfectives;S01AB03 - sulfadicramide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CB - Corticosteroids -  moderately potent -  combinations with antibiotics;D07CB04 - dexamethasone and antibiotics
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX06 - etohexadiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE10 - darunavir
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA03 - pefloxacin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FX - Beta blocking agents -  other combinations;C07FX05 - metoprolol and ivabradine
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AL - Silver compounds -  antiseptics and disinfectants;D08AL01 - silver nitrate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA52 - tetryzoline -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AX - Other opioids in ATC;N02AX02 - tramadol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX07 - sapropterin
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA30 - antiinfectives -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CC - Diagnostic agents for bile duct patency testing;V04CC02 - magnesium sulfate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC03 - cefamandole
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AB - Phenylpiperidine derivatives -  opioid analgesics;N02AB03 - fentanyl
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED06 - sulfaperin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC22 - necitumumab
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA08 - medrysone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AB - Nitroimidazole derivatives -  antiprotozoal agents against amoebiasis and other protozoal diseases;P01AB01 - metronidazole
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AD - Calcineurin inhibitors;L04AD02 - tacrolimus
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX11 - fluoroestradiol (18F)
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX24 - visnadine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AD - Nicotinic acid and derivatives -  lipid modifying -  plain;C10AD04 - aluminium nicotinate
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH06 - remifentanil
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BA - Vasopressin and analogues;H01BA01 - vasopressin (argipressin)
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AX - Other cardiac glycosides in ATC;C01AX02 - peruvoside
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB05 - interferon alfa-2b
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01L - OCULAR VASCULAR DISORDER AGENTS;S01LA - Antineovascularisation agents;S01LA02 - anecortave
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB09 - triamcinolone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA02 - procainamide
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA06 - sulfamerazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA20 - combinations of tetracyclines
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CB - Sulfonamides and potassium in combination -  high-ceiling diruetics -  excluding thiazides;C03CB02 - bumetanide and potassium
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA06 - lorazepam
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC03 - dihydroergocryptine mesylate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BA - Aminoquinoline antimalarials;P01BA03 - primaquine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AX - Other opioids in ATC;N02AX05 - meptazinol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG05 - rilpivirine
D - DERMATOLOGICALS;D05 - ANTIPSORIATICS;D05B - ANTIPSORIATICS FOR SYSTEMIC USE;D05BB - Retinoids for treatment of psoriasis;D05BB01 - etretinate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AA - Curare alkaloid muscle relaxants -  peripherally acting;M03AA02 - tubocurarine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB07 - prednisone
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX13 - idebenone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA04 - bromopride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB07 - promegestone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE07 - dabigatran etexilate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD04 - glimepiride and rosiglitazone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE04 - azidocillin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AC - Somatropin and somatropin agonists;H01AC02 - somatrem
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BX - Other centrally acting agents in ATC;M03BX07 - tetrazepam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA09 - desogestrel and ethinylestradiol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AP - Antivirals for treatment of HCV infections;J05AP04 - faldaprevir
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF05 - nadifloxacin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07D - BETA BLOCKING AGENTS -  THIAZIDES AND OTHER DIURETICS;C07DA - Beta blocking agents -  non-selective -  thiazides and other diuretics;C07DA06 - timolol -  thiazides and other diuretics
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AX - Other antiseptics and disinfectants in ATC;D08AX01 - hydrogen peroxide
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA11 - protriptyline
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AH - Coxibs;M01AH03 - valdecoxib
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX02 - gamolenic acid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA05 - phenylephrine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB01 - ferric sodium citrate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB52 - chlormezanone -  combinations excl. psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR20 - emtricitabine -  tenofovir alafenamide and bictegravir
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC09 - epoprostenol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BX - ACE inhibitors -  other combinations in ATC;C09BX03 - ramipril -  amlodipine and hydrochlorothiazide
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DX - Angiotensin II receptor blockers (ARBs) -  other combinations;C09DX01 - valsartan -  amlodipine and hydrochlorothiazide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD54 - chlorobutanol -  combinations
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB13 - butamirate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA03 - cefuroxime and metronidazole
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB16 - dibunate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EA - Technetium (99mTc) -  inhalants;V09EA01 - technetium (99mTc) pentetic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA07 - diphtheria-hepatitis B-tetanus
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX01 - magnesium hydroxide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA01 - potassium chloride
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB29 - cholinesterase
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CA - Ergot alkaloids -  antimigraine;N02CA02 - ergotamine
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA13 - cineole
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AF - Antiinfectives for treatment of acne;D10AF52 - erythromycin -  combinations
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE09 - levocetirizine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BA - Sulfonamides -  topical;D06BA03 - mafenide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AC - Corticosteroids for local oral treatment;A01AC03 - hydrocortisone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK07 - formoterol and budesonide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CX - Other irrigating solutions in ATC;B05CX02 - sorbitol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA14 - lipegfilgrastim
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA04 - fluvastatin
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AA - Yttrium-90 antiinflammatory radiopharmaceuticals;V10AA01 - yttrium (90Y) citrate colloid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB04 - cladribine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03B - ANDROGENS;G03BA - 3-oxoandrosten (4) derivatives;G03BA02 - methyltestosterone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB02 - daunorubicin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE53 - phenacetin -  combinations excl. psycholeptics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XB - Amino Acids -  I.V. solution additive;B05XB03 - lysine
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AA - Anticholinesterase parasympathomimetics;N07AA01 - neostigmine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BB - Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD);A02BB01 - misoprostol
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03A - ANTIINFECTIVES -  OPHTHALMOLOGIC AND OTOLOGIC;S03AA - Antiinfectives;S03AA30 - antiinfectives -  combinations
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CB - Salt irrigating solutions;B05CB03 - magnesium citrate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX08 - fluoroethylcholine (18F)
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB03 - oxybuprocaine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09X - OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM in ATC;C09XA - Renin-inhibitors;C09XA01 - remikiren
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DB - Angiotensin II receptor blockers (ARBs) and calcium channel blockers;C09DB01 - valsartan and amlodipine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AH - Neuraminidase inhibitors -  direct acting antivirals;J05AH02 - oseltamivir
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC05 - almotriptan
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BB - ACE inhibitors and calcium channel blockers;C09BB06 - enalapril and nitrendipine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA17 - pegteograstim
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA03 - lisinopril
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DB - Hydrazinophthalazine derivatives acting on arteriolar smooth muscle;C02DB02 - hydralazine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG04 - floctafenine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P02 - ANTHELMINTICS;P02C - ANTINEMATODAL AGENTS;P02CX - Other antinematodals in ATC;P02CX01 - pyrvinium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05A - BILE THERAPY DRUGS;A05AX - Other drugs for bile therapy in ATC;A05AX01 - piprozolin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AD - antacids containing combinations and complexes of aluminium -  calcium and magnesium compounds;A02AD02 - magaldrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA01 - nicotinamide
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BE - Anilide analgesics and antipyretics;N02BE03 - phenacetin
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AB - Anesthetics for topical use;D04AB06 - tetracaine
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA04 - rauwolfia alkaloids -  whole root
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AF - Morphinan derivatives -  opiod analgesics;N02AF01 - butorphanol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX36 - oblimersen
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD57 - tixocortol -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AC - Imidazoline receptor agonists;C02AC05 - moxonidine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC05 - lornoxicam
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA26 - ephedrine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA06 - technetium (99mTc) stannous agent labelled cells
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX08 - reslizumab
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA08 - dibenzepin
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA07 - bietaserpine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB01 - brompheniramine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AB - Phenothiazines with piperazine structure -  antipsychotics;N05AB03 - perphenazine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CB - Superparamagnetic contrast media;V08CB01 - ferumoxsil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07B - INTESTINAL ADSORBENTS;A07BC - Other intestinal adsorbents in ATC;A07BC02 - kaolin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE22 - masitinib
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX04 - quassia
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA12 - mepyramine theophyllinacetate
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX02 - phenoxybenzamine
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AX - Other throat preparations in ATC;R02AX02 - ibuprofen
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BE - Artemisinin and derivatives -  plain;P01BE04 - artemotil
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AJ - Pertussis vaccines;J07AJ01 - pertussis -  inactivated -  whole cell
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CA - Vitamin A -  plain;A11CA01 - retinol (vit A)
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CE - Piperidinedione derivatives -  hypnotics and sedatives;N05CE02 - methyprylon
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BD - MAO B Inhibitors -  dopaminergic anti-parkinson drugs;N04BD01 - selegiline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE25 - trametinib
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC08 - sodium iopodate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR17 - emtricitabine and tenofovir alafenamide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AA - Antifibrinolytic amino acids;B02AA01 - aminocaproic acid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CX - Other estrogens in ATC;G03CX01 - tibolone
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA06 - perflubutane polymer microspheres
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX13 - alginic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA53 - hydroxocobalamin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BA - Belladonna alkaloids -  tertiary amines for functional gastrointestinal disorders;A03BA03 - hyoscyamine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XX - Other i.v. solution additives in ATC;B05XX02 - trometamol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XA - Platinum compounds -  antineoplastic drugs;L01XA02 - carboplatin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA11 - calcium pangamate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC05 - hexafluronium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CB - Synthetic estrogens -  plain;G03CB02 - diethylstilbestrol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CX - Other cardiac stimulants in ATC;C01CX07 - xamoterol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AF - Thioxanthene derivatives -  antipsychotic;N05AF04 - tiotixene
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX08 - ketotifen
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC02 - fluclorolone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ02 - liraglutide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB03 - hydrochlorothiazide and potassium
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA01 - amfetamine
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09E - RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09EX - Other respiratory system diagnostic radiopharmaceuticals in ATC;V09EX01 - krypton (81mKr) gas
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB22 - meldonium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AL - Pneumococcal vaccines;J07AL01 - pneumococcus -  purified polysaccharides antigen
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC15 - fluconazole
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AD - local anesthetic throat preparations;R02AD03 - cocaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX01 - clodantoin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE08 - pirprofen
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA15 - potassium lactate
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AB - Antibiotic throat preparations;R02AB02 - tyrothricin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB16 - (2-benzhydryloxyethyl)diethyl-methylammonium iodide
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA15 - bamipine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB06 - domiphen
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE52 - naproxen and esomeprazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BJ - Glucagon-like peptide-1 (GLP-1) analogues;A10BJ05 - dulaglutide
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA03 - hydrocodone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE08 - tadalafil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A05 - BILE AND LIVER THERAPY DRUGS;A05B - LIVER THERAPY -  LIPOTROPICS;A05BA - Liver therapy drugs;A05BA07 - tidiacic arginine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA06 - quinbolone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA10 - trimethobenzamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB19 - timepidium bromide
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB07 - desflurane
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX30 - beclamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB11 - hepatitis A immunoglobulin
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AC - Bile acid sequestrants;C10AC04 - colesevelam
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA13 - trovafloxacin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA08 - bromazepam
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BC - Antiarrhythmics -  class Ic;C01BC08 - encainide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA01 - oxyphencyclimine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BA - Antiarrhythmics -  class Ia;C01BA71 - quinidine -  combinations with psycholeptics
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07C - CORTICOSTEROIDS -  COMBINATIONS WITH ANTIBIOTICS;D07CB - Corticosteroids -  moderately potent -  combinations with antibiotics;D07CB01 - triamcinolone and antibiotics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AX - Other antiinfectives in ATC;S01AX15 - propamidine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX24 - pegaspargase
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA04 - antithymocyte immunoglobulin (rabbit)
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA03 - carbenicillin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB17 - bufexamac
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH03 - meningococcus A - C -  bivalent purified polysaccharides antigen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB06 - cefazedone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB04 - zomepirac
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB12 - nomegestrol and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA16 - clevidipine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE01 - ofloxacin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH06 - meningococcus B -  outer membrane vesicle vaccine
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX09 - mupirocin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA08 - minocycline
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX13 - pheneturide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX27 - arsenic trioxide
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX11 - estramustine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BA - Corticosteroid ophthalmologic antiinflammatory agents -  plain;S01BA02 - hydrocortisone
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX04 - sodium oxybate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX14 - lactobacillus fermentum
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE05 - fenbufen
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB09 - danaparoid
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX05 - lodoxamide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02A - ANTACIDS;A02AF - Antacids with antiflatulents;A02AF02 - ordinary salt combinations and antiflatulents
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC07 - triticum (wheat fibre)
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AF - Thioxanthene derivatives -  antipsychotic;N05AF01 - flupentixol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA29 - tofacitinib
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AC - Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases;P01AC04 - teclozan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EC - Aminosalicylic acid and similar agents;A07EC03 - olsalazine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD06 - latamoxef
S - SENSORY ORGAN DRUGS;S03 - OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS;S03B - Corticosteroid ophthalmologic and otologic preparations;S03BA - Corticosteroids;S03BA03 - betamethasone
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BC - Dopamine agonists;N04BC01 - bromocriptine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07C - BETA BLOCKING AGENTS AND OTHER DIURETICS;C07CA - Beta blocking agents -  non-selective -  and other diuretics;C07CA23 - penbutolol and other diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BB - Sulfonylureas for blood glucose lowering;A10BB03 - tolbutamide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA21 - clotiazepam
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB53 - aciclovir -  combinations
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ17 - oxycodone and paracetamol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA53 - donepezil -  memantine and Ginkgo folium
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA11 - pentamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA02 - nystatin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX02 - asparaginase
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX02 - eprozinol
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA06 - cyamemazine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BD - Diaminopyrimidines -  antimalarials;P01BD51 - pyrimethamine -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AX - Other alkylating agents in ATC;L01AX04 - dacarbazine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA20 - artificial tears and other indifferent preparations
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AC - Medicated shampoos;D11AC03 - selenium compounds
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX02 - aluminium chlorohydrate
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AC - Biguanides and amidines as antiseptics and disinfectants;D08AC02 - chlorhexidine
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AX - Other ectoparasiticides -  incl. scabicides in ATC;P03AX01 - benzyl benzoate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CB - Zinc Supplements;A12CB01 - zinc sulfate
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AB - Ethers chemically close to antihistamines -  anticholinergic;N04AB01 - etanautine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AX - Other antimycotics for systemic use in ATC;J02AX06 - anidulafungin
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX13 - medifoxamine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB09 - norgestimate and ethinylestradiol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX17 - sipuleucel-T
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB13 - bekanamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA09 - pipenzolate and psycholeptics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM01 - methaqualone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA23 - sirolimus
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA22 - micronomicin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB13 - dornase alfa (desoxyribonuclease)
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CB - Corticosteroids/antiinfectives/mydriatics in combination;S01CB05 - fluorometholone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BX - Other drugs affecting bone structure and mineralization in ATC;M05BX05 - burosumab
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA01 - losartan and diuretics
M - MUSCULO-SKELETAL SYSTEM DRUGS;M05 - DRUGS FOR TREATMENT OF BONE DISEASES;M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION;M05BB - Bisphosphonates -  combinations affecting bone structure and mineralization;M05BB03 - alendronic acid and colecalciferol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DC - Leukotriene receptor antagonists for obstructive airway diseases;R03DC03 - montelukast
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD09 - ancrod
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BC - Xanthine derivatives -  psychostimulants -  agents used for ADHD and nootropics;N06BC01 - caffeine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CB - Salt irrigating solutions;B05CB10 - Salt solution combinations
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AB - Iodine I-123 compounds -  CNS diagnostic radiopharmaceuticals;V09AB01 - iodine iofetamine (123I)
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA01 - cimetidine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CB - Non-selective beta-adrenoreceptor agonists for systemic use;R03CB03 - orciprenaline
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA05 - homatropine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BA - Solutions for parenteral nutrition;B05BA10 - Combination solutions for parenteral nutrition
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB07 - methantheline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA01 - calcium phosphate
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA04 - irbesartan and diuretics
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA06 - quinapril and diuretics
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DA - Technetium 99m compounds -  hepatic and reticulo endothelial system diagnostic radiopharmaceuticals;V09DA01 - technetium (99mTc) disofenin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09B - SKELETON DIAGNOSTIC RADIOPHARMACEUTICALS;V09BA - Technetium 99m compounds -  skeletal system diagnostic radiopharmaceuticals;V09BA03 - technetium (99mTc) pyrophosphate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE44 - lorlatinib
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AD - Organic acids -  Gynecological;G01AD02 - acetic acid
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA02 - aloxiprin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AX - Other central nervous system diagnostic radiopharmaceuticals in ATC;V09AX03 - iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA04 - nizatidine
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03B - LOW-CEILING DIURETICS -  EXCL. THIAZIDES;C03BA - sulfonamides -  low-ceiling diuretics -  plain;C03BA12 - clorexolone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK01 - epinephrine and other drugs for obstructive airway diseases
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA25 - azidamfenicol
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB16 - mannitol
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AA - Tetracycline and derivatives -  topical antibiotics;D06AA03 - oxytetracycline
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB06 - penciclovir
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA01 - bromazine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX09 - trepibutone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED55 - carteolol -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB02 - tetanus immunoglobulin
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX17 - vinburnine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AD - Other agents for local oral treatment in ATC;A01AD06 - adrenalone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA04 - difenoxin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA05 - salicylamide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB05 - sulfafurazole
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA30 - local opthalmologic anesthetic combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE06 - sulfadiazine and tetroxoprim
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA02 - acetyldigoxin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA01 - pentobarbital
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AC - Diphenylpropylamine derivative analgesics;N02AC03 - piritramide
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CD - pituitary function test diagnostic agents;V04CD05 - somatorelin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX46 - olaparib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IX - Other diagnostic radiopharmaceuticals for tumour detection in ATC;V09IX05 - fluorodopa (18F)
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AX - Other blood products in ATC;B05AX04 - stem cells from umbilical cord blood
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX04 - macitentan
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AB - Enzymes FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AB03 - bromelains
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB72 - metamizole sodium -  combinations with psycholeptics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB02 - infliximab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX01 - fenpiprane
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AC - Imidazoline receptor agonists;C02AC02 - guanfacine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AC - Synthetic antispasmodics -  amides with tertiary amines for functional gastrointestinal disorders;A03AC04 - nicofetamide
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB04 - pralidoxime
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02L - ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION;C02LA - Rauwolfia alkaloids and diuretics in combination;C02LA07 - bietaserpine and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AA - Softeners -  emollients;A06AA01 - liquid paraffin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01B - ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION;M01BA - Antiinflammatory/antirheumatic agents in combination with corticosteroids;M01BA01 - phenylbutazone and corticosteroids
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA22 - suxibuzone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AB - Tumor necrosis factor alpha (TNF-) inhibitors;L04AB05 - certolizumab pegol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA54 - methylpropylpropanediol dinitrate -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA18 - dimetacrine
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02D - OTHER OTOLOGICALS in ATC;S02DA - Analgesics and anesthetics;S02DA03 - phenazone
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02D - ARTERIOLAR SMOOTH MUSCLE -  AGENTS ACTING ON;C02DG - Guanine derivatives acting on arteriolar smooth muscle;C02DG01 - pinacidil
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AC - Insulins and analogues for injection -  intermediate-acting;A10AC30 - Insulins and analogs for injection -  intermediate-acting combinations
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE05 - sucroferric oxyhydroxide
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX09 - oxaceprol
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AA - Beta blocking agents -  non-selective;C07AA15 - carteolol
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia;V03AE08 - ferric citrate
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BA - Thiouracil antithyroid preparations;H03BA02 - propylthiouracil
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BE - Artemisinin and derivatives -  plain;P01BE01 - artemisinin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD20 - metformin and empagliflozin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE35 - osimertinib
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GA - Technetium 99m compounds -  cardiovascular system diagnostic radiopharmaceuticals;V09GA03 - technetium (99mTc) teboroxime
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AX - Other antipsychotics in ATC;N05AX15 - cariprazine
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02B - Corticosteroid otologicals;S02BA - Corticosteroids;S02BA08 - fluocinolone acetonide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC02 - tenoxicam
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CJ - thyreoidea function test diagnostic agents;V04CJ01 - thyrotropin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BA - Pyrethrines;P03BA04 - tetramethrin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA04 - silodosin
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CH - renal function and ureteral injuries test diagnostic agents;V04CH03 - phenolsulfonphthalein
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09D - HEPATIC AND RETICULO ENDOTHELIAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09DB - Technetium 99m particles and colloid diagnostic radiopharmaceuticals for hepatic and reticulo endothelial system;V09DB06 - technetium (99mTc) rheniumsulfide colloid
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AC - Quinoline gynecological antiinfectives;G01AC06 - broxyquinoline
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AA - Preparations inhibiting uric acid production;M04AA02 - tisopurine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BC - Carbamate anxiolytics;N05BC03 - emylcamate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB01 - megestrol and ethinylestradiol
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA13 - moexipril and diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DC - Estren derivatives -  sex hormones and modulators of the genital system;G03DC02 - norethisterone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AP - Typhoid vaccines;J07AP02 - typhoid -  inactivated -  whole cell
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB03 - ioxaglic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BF - Alpha glucosidase inhibitors -  blood glucose lowering;A10BF01 - acarbose
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AG - Diphenylbutylpiperidine derivatives -  antipsychotics;N05AG02 - pimozide
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AD - Local anesthetics for treatment of hemorrhoids and anal fissures for topical use;C05AD06 - oxetacaine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AA - Softeners -  emollients;A06AA51 - liquid paraffin -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX01 - meclofenoxate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BB - Fibrinogen containing hemostatics;B02BB01 - fibrinogen -  human
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AE - Indole derivatives -  antipsychotic;N05AE04 - ziprasidone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11A - MULTIVITAMINS -  COMBINATIONS;A11AA - Multivitamins with minerals;A11AA03 - multivitamins and other minerals -  incl. combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AA - HMG CoA reductase inhibitors -  plain lipid modifying drugs;C10AA01 - simvastatin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AA - Thiosemicarbazones -  direct acting antivirals;J05AA01 - metisazone
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BA - Esters of aminobenzoic acid for local anesthesia;N01BA04 - chloroprocaine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J02 - ANTIMYCOTICS FOR SYSTEMIC USE;J02A - ANTIMYCOTICS FOR SYSTEMIC USE;J02AC - Triazole derivatives -  systemic antimycotics;J02AC01 - fluconazole
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX08 - pyrrobutamine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08D - ULTRASOUND CONTRAST MEDIA;V08DA - Ultrasound contrast media;V08DA03 - perflenapent
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX10 - zolimidine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK04 - salbutamol and sodium cromoglicate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA07 - trypsin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB17 - methylthioninium chloride
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04C - DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY;G04CA - Alpha-adrenoreceptor antagonists -  benign prostatic hypertrophy;G04CA51 - alfuzosin and finasteride
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IB - Indium-111 tumour detection radiopharmaceuticals;V09IB03 - indium (111In) antiovariumcarcinoma antibody
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX03 - dexpanthenol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA01 - cyclophosphamide
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07D - BETA BLOCKING AGENTS -  THIAZIDES AND OTHER DIURETICS;C07DB - Beta blocking agents -  selective -  thiazides and other diuretics;C07DB01 - atenolol -  thiazides and other diuretics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EE - Prostaglandin analogues -  antiglaucoma drugs and miotics;S01EE05 - tafluprost
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA09 - fosinopril and diuretics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX43 - vismodegib
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA07 - propatylnitrate
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX09 - ezetimibe
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD05 - sulprostone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC12 - brodalumab
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX07 - dimethyl fumarate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA02 - spiramycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CA - Sodium supplements;A12CA01 - sodium chloride
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB16 - mepartricin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR05 - zidovudine -  lamivudine and nevirapine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB07 - ronifibrate
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC12 - fenticonazole
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB21 - bezlotoxumab
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA08 - tocofersolan
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA54 - cyclopentolate -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA05 - betamethasone and antiinfectives
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03G - GONADOTROPINS AND OTHER OVULATION STIMULANTS;G03GA - Gonadotropins;G03GA06 - follitropin beta
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA12 - tolpropamine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AD - Non-watersoluble X-ray contrast media;V08AD03 - propyliodone
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA12 - rifamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB03 - chlorhexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) in ATC;A02BX01 - carbenoxolone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB54 - tiotropium bromide -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EC - Intermediate-acting sulfonamides;J01EC03 - sulfamoxole
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL06 - veralipride
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BB - Pyrazolones -  analgesics and antipyretics;N02BB03 - aminophenazone
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09A - CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09AA - Technetium 99m compounds -  central nervous system diagnostic radiopharmaceuticals;V09AA01 - technetium (99mTc) exametazime
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD11 - pantoprazole -  amoxicillin -  clarithromycin and metronidazole
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC15 - sirukumab
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC51 - buprenorphine -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01B - ANTIINFLAMMATORY AGENTS -  OPHTHALMOLOGIC;S01BC - Antiinflammatory agents -  non-steroidal -  ophthalmologic;S01BC10 - nepafenac
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA15 - ciprofloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AA - Colony stimulating factors;L03AA02 - filgrastim
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB57 - etidocaine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA13 - ticarcillin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA02 - doxycycline
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DB - Other potassium-sparing agents in ATC;C03DB02 - triamterene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XA - Glycopeptide antibacterials;J01XA03 - telavancin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01M - QUINOLONE ANTIBACTERIALS;J01MA - Fluoroquinolone antibacterials -  systemic;J01MA10 - rufloxacin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA08 - methylprednisolone and antiinfectives
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BB - biguanide antimalarials;P01BB01 - proguanil
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK01 - mercuric amidochloride
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA19 - flurbiprofen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF05 - lamivudine
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07C - ANTIVERTIGO PREPARATIONS;N07CA - Antivertigo preparations;N07CA03 - flunarizine
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AF - Carboxamide derivatives -  antiepileptics;N03AF01 - carbamazepine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AX - Other anterior pituitary lobe hormones and analogues in ATC;H01AX01 - pegvisomant
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX14 - edaravone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DB - First-generation cephalosporins;J01DB03 - cefalotin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB14 - proglumetacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CA - Vinca alkaloids and analogues -  antineoplastic;L01CA06 - vintafolide
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE23 - butenafine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX16 - nicorandil
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GX - Other antiallergics in ATC;S01GX02 - levocabastine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC18 - indacaterol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA05 - febarbamate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CX - Hypnotics and sedatives in combination -  excl. barbiturates;N05CX01 - meprobamate -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03C - HIGH-CEILING DIURETICS;C03CA - sulfonamides -  high-ceiling diuretics -  plain;C03CA02 - bumetanide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01A - Tetracycline antibiotics;J01AA - Tetracyclines;J01AA05 - metacycline
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA11 - dexmethylphenidate
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08C - MAGNETIC RESONANCE IMAGING CONTRAST MEDIA;V08CA - Paramagnetic contrast media;V08CA10 - gadoxetic acid
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA13 - lercanidipine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BE - Drugs used in erectile dysfunction;G04BE52 - papaverine -  combinations
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE18 - naproxcinod
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE02 - naproxen
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB05 - physostigmine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AX - Other intestinal antiinfectives in ATC;A07AX02 - acetarsol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AX - Other gynecological antiinfectives and antiseptics in ATC;G01AX11 - povidone-iodine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA05 - procaine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE10 - everolimus
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AX - Other lipid modifying agents in ATC;C10AX13 - evolocumab
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX01 - tirilazad
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA07 - xylometazoline
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA14 - dopexamine
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB01 - doxapram
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD11 - loprazolam
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB09 - valrubicin
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB10 - epanolol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AB - Heparin group antithrombotic drugs;B01AB06 - nadroparin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BA - biguanide blood glucose lower drugs;A10BA03 - buformin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05X - I.V. SOLUTION ADDITIVES;B05XA - Electrolyte solutions;B05XA12 - zinc chloride
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA17 - midodrine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BB - Anticholinergics inhalants for obstructive airway diseases;R03BB07 - umeclidinium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02C - ANTIADRENERGIC AGENTS -  PERIPHERALLY ACTING;C02CC - Guanine derivatives -  peripherally acting antiadrenergic agents;C02CC07 - guanoxabenz
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA01 - ferrous glycine sulfate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AC - Preparations with no effect on uric acid metabolism;M04AC02 - cinchophen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX19 - nesiritide
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC04 - lofexidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA51 - neomycin -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS in ATC;V10XX - Various therapeutic radiopharmaceuticals;V10XX04 - lutetium (177Lu) oxodotreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA03 - oxyphencyclimine and psycholeptics
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX07 - etafenone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD63 - ceftriaxone and beta-lactamase inhibitor
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM11 - bromides
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB52 - phenytoin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11D - VITAMIN B1 -  PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12;A11DA - Vitamin B1 -  plain;A11DA01 - thiamine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BD - Measles vaccines;J07BD52 - measles -  combinations with mumps and rubella -  live attenuated
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF01 - dicloxacillin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03D - PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03DB - Pregnadien derivatives -  progestogens;G03DB02 - megestrol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ14 - tramadol and dexketoprofen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB12 - albinterferon alfa-2b
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED05 - carteolol
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AB - Watersoluble -  nephrotropic -  low osmolar X-ray contrast media;V08AB08 - iopentol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB07 - chondroitin sulfate-iron complex
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA08 - fluocortolone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD04 - moperone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX32 - sequifenadine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD02 - nitrazepam
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CF - Beta-lactamase resistant penicillins;J01CF04 - oxacillin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC07 - nedocromil
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AX - Other alkylating agents in ATC;L01AX01 - mitobronitol
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01B - ANTIFUNGALS FOR SYSTEMIC USE;D01BA - Antifungals for systemic use;D01BA02 - terbinafine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H05 - CALCIUM HOMEOSTASIS;H05B - ANTI-PARATHYROID AGENTS;H05BX - Other anti-parathyroid agents in ATC;H05BX03 - doxercalciferol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BA - Encephalitis vaccines;J07BA01 - encephalitis -  tick borne -  inactivated -  whole virus
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03E - DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION;C03EA - Low-ceiling diuretics and potassium-sparing agents;C03EA07 - cyclopenthiazide and potassium-sparing agents
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD05 - coagulation factor VII
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BA - Folic acid analogs -  antimetabolites;L01BA04 - pemetrexed
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CB - Corticosteroids/antiinfectives/mydriatics in combination;S01CB02 - prednisolone
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB10 - ribostamycin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AJ - Quaternary ammonium compounds -  antiseptics and disinfectants;D08AJ10 - decamethoxine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX14 - histamine dihydrochloride
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA12 - potassium salicylate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CA - Synthetic anticholinergic agents in combination with psycholeptics;A03CA06 - bevonium and psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR01 - ampicillin and beta-lactamase inhibitor
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA15 - carbasalate calcium
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04A - ANTICHOLINERGIC AGENTS;N04AC - Ethers of tropine or tropine derivatives -  anticholinergic;N04AC30 - etybenzatropine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09B - ACE INHIBITORS -  COMBINATIONS;C09BA - ACE inhibitors and diuretics;C09BA03 - lisinopril and diuretics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX03 - chlorbenzoxamine
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AC - Imidazole and triazole derivatives -  topical antifungals;D01AC03 - econazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12C - OTHER MINERAL SUPPLEMENTS in ATC;A12CE - Selenium supplements;A12CE02 - sodium selenite
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX07 - etomidate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CR - Combinations of penicillins -  incl. beta-lactamase inhibitors;J01CR04 - sultamicillin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01ED - Beta blocking agents -  antiglaucoma preparations and miotics;S01ED52 - betaxolol -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06D - ANTI-DEMENTIA DRUGS;N06DA - Anticholinesterase anti-dementia drugs;N06DA03 - rivastigmine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX06 - idanpramine
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA03 - thenalidine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XX - Other antibacterials in ATC;J01XX08 - linezolid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB04 - penthienate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AR - Arsenic compounds -  for amoebiasis and other protozoal diseases;P01AR02 - difetarsone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA05 - dextran
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX02 - pravastatin and acetylsalicylic acid
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB10 - levobupivacaine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AC - Interleukins;L03AC02 - oprelvekin
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06B - CHEMOTHERAPEUTICS FOR TOPICAL USE;D06BB - Antivirals -  topical;D06BB03 - aciclovir
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD16 - cefditoren
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA11 - heptabarbital
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AG - Alpha and beta blocking agents;C07AG01 - labetalol
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AB - Hydantoin derivatives -  antiepileptics;N03AB05 - fosphenytoin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA12 - fidaxomicin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA07 - metreleptin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB23 - piperidione
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC09 - budesonide
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BB - Antiarrhythmics -  class Ib;C01BB02 - mexiletine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EE - Combinations of sulfonamides and trimethoprim -  incl. derivatives;J01EE03 - sulfametrole and trimethoprim
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA08 - fenozolone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX04 - dibutylsuccinate
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX04 - azapropazone
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BD - Diaminopyrimidines -  antimalarials;P01BD01 - pyrimethamine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA30 - dexpanthenol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX07 - benzydamine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CA - Bioflavonoid drugs for capillary stabilizing;C05CA03 - diosmin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BX - Other anxiolytics in ATC;N05BX05 - Lavandulae aetheroleum
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE07 - lapatinib
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AA - Phenothiazines with aliphatic side-chain -  antipsychotics;N05AA03 - promazine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BA - Vitamin K containing hemostatics;B02BA01 - phytomenadione
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD03 - cefsulodin
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CG - gastric secretion test diagnostic agents;V04CG03 - histamine phosphate
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AC - Dichloroacetamide derivative drugs for amoebiasis and other protozoal diseases;P01AC01 - diloxanide
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA05 - clioquinol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC05 - ustekinumab
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AG - Opioids in combination with antispasmodics;N02AG01 - morphine and antispasmodics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD13 - metformin and alogliptin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE28 - ceritinib
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AB - Phenylpiperidine derivatives -  opioid analgesics;N02AB72 - pethidine -  combinations with psycholeptics
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA10 - mezlocillin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB54 - prilocaine -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB04 - phenolphthalein
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01A - ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES;H01AA - ACTH and synthetic analog preparations;H01AA02 - tetracosactide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AH - Meningococcal vaccines;J07AH10 - meningococcus A -  purified polysaccharides antigen conjugated
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09I - TUMOUR DETECTION RADIOPHARMACEUTICALS;V09IA - Technetium 99m compounds -  tumor detection radiopharmaceuticals;V09IA08 - technetium (99mTc) etarfolatide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB30 - capreomycin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA07 - mometasone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB10 - cortisone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AB - Contact laxatives;A06AB07 - cascara
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM08 - ethchlorvynol
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06C - PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION;N06CA - Antidepressants in combination with psycholeptics;N06CA01 - amitriptyline and psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF08 - palifermin
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H03 - THYROID THERAPY DRUGS;H03B - ANTITHYROID PREPARATIONS;H03BB - Sulfur-containing imidazole derivatives -  antithyroid preparations;H03BB02 - thiamazole
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD05 - motretinide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AB - Preparations increasing uric acid excretion;M04AB05 - lesinurad
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03C - ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS;A03CB - Belladonna and derivatives in combination with psycholeptics;A03CB31 - hyoscyamine and psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA02 - fenfluramine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA09 - clorindione
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CC - Selective beta-2-adrenoreceptor agonists -  systemic;R03CC10 - carbuterol
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AJ - Opioids in combination with non-opioid analgesics;N02AJ02 - dihydrocodeine and acetylsalicylic acid
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AC - Pyrethrines -  incl. synthetic compounds -  ectoparasiticides -  incl. scabicides;P03AC02 - bioallethrin
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07B - CORTICOSTEROIDS -  COMBINATIONS WITH ANTISEPTICS;D07BC - Corticosteroids -  potent -  combinations with antiseptics;D07BC02 - fluocinolone acetonide and antiseptics
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX56 - etirinotecan pegol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA36 - ocrelizumab
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA02 - dequalinium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA06 - rabies serum
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA03 - isradipine
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AF - Enzymes -  peripheral vasodilators;C04AF01 - kallidinogenase
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03A - ECTOPARASITICIDES -  INCL. SCABICIDES;P03AA - Sulfur containing product ectoparasiticides;P03AA04 - disulfiram
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC03 - ioglycamic acid
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX01 - oxitriptan
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03B - ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS;D03BA - Proteolytic enzymes for treatment of wounds and ulcers;D03BA03 - bromelains
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB09 - cytomegalovirus immunoglobulin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AA - Caries prophylactic agents;A01AA03 - olaflur
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA08 - calcium glycerylphosphate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD05 - terodiline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CC - Estrogens -  combinations with other drugs;G03CC02 - dienestrol
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA06 - nimodipine
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AC - Watersoluble -  hepatotropic X-ray contrast media;V08AC06 - iopanoic acid
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH05 - asenapine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC17 - tildrakizumab
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA12 - drospirenone and ethinylestradiol
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX23 - pimethixene
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB01 - clofibrate
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors;J05AB01 - aciclovir
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AK - Plague vaccines;J07AK01 - plague -  inactivated -  whole cell
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC04 - carmofur
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CB - Mucolytics;R05CB01 - acetylcysteine
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB32 - glutathione
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH01 - tacrolimus
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX39 - romidepsin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE30 - Beta-lactamase sensitive penicillin combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB17 - cerliponase alfa
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA08 - vinylbital
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA07 - dobutamine
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10A - LIPID MODIFYING AGENTS -  PLAIN;C10AB - Fibrates -  lipid modifying drugs -  plain;C10AB04 - gemfibrozil
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AD - Nitrosoureas -  antineoplastic alkylating agents;L01AD02 - lomustine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX19 - tilorone
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA05 - ioxitalamic acid
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BA - Solutions for parenteral nutrition;B05BA04 - protein hydrolysates
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01G - AMINOGLYCOSIDE ANTIBACTERIALS;J01GB - Other aminoglycosides in ATC;J01GB01 - tobramycin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AB - Alkyl sulfonate alkylating agents;L01AB01 - busulfan
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AX - Other immunosuppressants in ATC;L04AX01 - azathioprine
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE03 - tribromometacresol
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL07 - formoterol and glycopyrronium bromide
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AH - Agents for dermatitis -  excluding corticosteroids;D11AH04 - alitretinoin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD08 - solifenacin
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BA - Dopa and dopa derivatives;N04BA03 - levodopa -  decarboxylase inhibitor and COMT inhibitor
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA15 - camazepam
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA51 - etilefrine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R07 - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07A - OTHER RESPIRATORY SYSTEM PRODUCTS in ATC;R07AB - Respiratory stimulants;R07AB03 - pentetrazol
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX24 - deoxycholic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07A - BACTERIAL VACCINES;J07AE - Cholera vaccines;J07AE02 - cholera -  live attenuated
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AA - Butylpyrazolidines -  antiinflammatory and antirheumatic drugs;M01AA01 - phenylbutazone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA09 - vancomycin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BA - Salicylic acid and derivatives -  analgesics and antipyretics;N02BA59 - dipyrocetyl -  combinations excl. psycholeptics
V - VARIOUS DRUG CLASSES IN ATC;V01 - ALLERGENS;V01A - ALLERGENS;V01AA - Allergen extracts;V01AA09 - textile allergenic extracts
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA05 - sodium edetate
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA79 - codeine -  combinations with psycholeptics
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01C - ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;S01CA - Corticosteroids and antiinfectives in combination -  opthalmologic;S01CA02 - prednisolone and antiinfectives
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD06 - thiazinam
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD52 - prednisolone -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DX - Other systemic drugs for obstructive airway diseases in ATC;R03DX09 - mepolizumab
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AN - Lithium antipsychotics;N05AN01 - lithium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11H - OTHER PLAIN VITAMIN PREPARATIONS in ATC;A11HA - Other plain vitamin preparations in ATC;A11HA05 - biotin
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02B - OTHER ANALGESICS AND ANTIPYRETICS in ATC;N02BG - Other analgesics and antipyretics in ATC;N02BG08 - ziconotide
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB10 - alclometasone
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AL - Benzamide antipsychotics;N05AL03 - tiapride
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX26 - avocado and soyabean oil -  unsaponifiables
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CC - Selective serotonin (5HT1) agonists -  antimigraine drugs;N02CC03 - zolmitriptan
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA18 - ethyl loflazepate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AA - Antibiotics -  ophthalmologic;S01AA07 - framycetin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AX - Other drugs for disorders of the musculo-skeletal system in ATC;M09AX06 - eteplirsen
D - DERMATOLOGICALS;D06 - ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE;D06A - ANTIBIOTICS FOR TOPICAL USE;D06AX - Other antibiotics for topical use in ATC;D06AX13 - retapamulin
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB05 - pheniramine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AA - Corticosteroids -  weak (group I);D07AA03 - prednisolone
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09A - ACE INHIBITORS -  PLAIN;C09AA - ACE inhibitors -  plain;C09AA01 - captopril
M - MUSCULO-SKELETAL SYSTEM DRUGS;M09 - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09A - OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM in ATC;M09AA - Quinine and derivatives for DISORDERS OF THE MUSCULO-SKELETAL SYSTEM;M09AA72 - quinine -  combinations with psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07A - INTESTINAL ANTIINFECTIVES;A07AA - antibiotics -  intestinal;A07AA01 - neomycin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB11 - acemetacin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12B - POTASSIUM SUPPLEMENTS;A12BA - Potassium;A12BA30 - potassium (different salts in combination)
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02A - ANTIADRENERGIC AGENTS -  CENTRALLY ACTING;C02AA - Rauwolfia alkaloids -  centrally acting antiadrenergic;C02AA02 - reserpine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07F - BETA BLOCKING AGENTS -  OTHER COMBINATIONS;C07FB - Beta blocking agents and calcium channel blockers;C07FB03 - atenolol and nifedipine
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA06 - trimipramine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XD - Imidazole derivatives -  antibacterial for systemic use;J01XD01 - metronidazole
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA24 - epinephrine
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CE - liver functional capacity test diagnostic agents;V04CE03 - methacetin (13C)
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08C - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS;C08CA - Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects;C08CA10 - nilvadipine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE12 - oxaprozin
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DE - Fourth-generation cephalosporins;J01DE01 - cefepime
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA02 - carisoprodol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors;J05AF02 - didanosine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A11 - VITAMINS;A11C - VITAMIN A AND D -  INCL. COMBINATIONS OF THE TWO;A11CC - Vitamin D and analogues;A11CC06 - calcifediol
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07X - OTHER NERVOUS SYSTEM DRUGS in ATC;N07XX - Other nervous system drugs in ATC;N07XX11 - pitolisant
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BX - Other psychostimulants and nootropics in ATC;N06BX08 - pirisudanol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES;L01DB - Anthracyclines and related substances;L01DB06 - idarubicin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA39 - emapalumab
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AL - Silver compounds -  antiseptics and disinfectants;D08AL30 - silver
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX01 - etamsylate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BC - Sulfonamides (heterocyclic) -  blood glucose lowering drugs;A10BC01 - glymidine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CB - Salt irrigating solutions;B05CB04 - sodium bicarbonate
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AA - Sympathomimetics -  plain;R01AA04 - phenylephrine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA11 - mephentermine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XC - Selective estrogen receptor modulators;G03XC02 - bazedoxifene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BL - Yellow fever vaccines;J07BL01 - yellow fever -  live attenuated
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AB - Substituted alkylamines -  systemic antihistamines;R06AB52 - dexchlorpheniramine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC15 - reproterol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CC - Antiinflammatory products for vaginal administration;G02CC01 - ibuprofen
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XC - Monoclonal antibodies -  antineoplastic;L01XC07 - bevacizumab
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AC - Oxicams -  antiinflammatory and antirheumatic drugs;M01AC56 - meloxicam -  combinations
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE20 - Other antifungal combinations for topical use in ATC
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AA - Nitrogen mustard analogues;L01AA08 - prednimustine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01F - MYDRIATICS AND CYCLOPLEGICS;S01FA - Anticholinergic mydriatics and cycloplegics;S01FA04 - cyclopentolate
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01H - Local anesthetics -  ophthalmologic;S01HA - Local anesthetics;S01HA02 - oxybuprocaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03X - OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM in ATC;G03XC - Selective estrogen receptor modulators;G03XC05 - ospemifene
J - ANTIINFECTIVES FOR SYSTEMIC USE;J04 - ANTIMYCOBACTERIALS;J04A - DRUGS FOR TREATMENT OF TUBERCULOSIS;J04AB - Antibiotics -  Antitubercular;J04AB03 - rifamycin
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05C - EXPECTORANTS -  EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;R05CA - Expectorants;R05CA08 - creosote
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01B - LOCAL ANESTHETICS;N01BB - Amide local anesthetics;N01BB07 - etidocaine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CC - Antiinflammatory products for vaginal administration;G02CC04 - flunoxaprofen
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BC - Drugs used in opioid dependence;N07BC01 - buprenorphine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EB - Parasympathomimetics -  antiglaucoma preparations and miotics;S01EB02 - carbachol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AE - Propionic acid derivatives -  antiinflammatory and antirheumatic products;M01AE15 - flunoxaprofen
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02B - CONTRACEPTIVES FOR TOPICAL USE;G02BB - Intravaginal contraceptives;G02BB01 - vaginal ring with progestogen and estrogen
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB10 - natamycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AH - Peripheral opioid receptor antagonists;A06AH03 - naloxegol
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA11 - ferrous iodine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD06 - insulin degludec and insulin aspart
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AR - Antivirals for treatment of HIV infections -  combinations;J05AR02 - lamivudine and abacavir
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03B - VITAMIN B12 AND FOLIC ACID;B03BA - Vitamin B12 (cyanocobalamin and analogues);B03BA51 - cyanocobalamin -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BA - Belladonna alkaloids -  tertiary amines for functional gastrointestinal disorders;A03BA01 - atropine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AC - Progestogen systemic hormonal contraceptives;G03AC07 - norgestrienone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A01 - STOMATOLOGICAL PREPARATIONS;A01A - STOMATOLOGICAL PREPARATIONS;A01AB - Antiinfectives and antiseptics for local oral treatment;A01AB13 - tetracycline
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA12 - rokitamycin
D - DERMATOLOGICALS;D04 - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04A - ANTIPRURITICS -  INCL. ANTIHISTAMINES -  ANESTHETICS -  ETC.;D04AA - Antihistamines for topical use;D04AA22 - isothipendyl
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DA - Opium alkaloids and derivatives -  cough suppressants;R05DA10 - thebacon
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BX - Other systemic hemostatics in ATC;B02BX04 - romiplostim
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BX - Other viral vaccines in ATC;J07BX01 - smallpox -  live attenuated
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XA - Corticosteroids -  weak -  other combinations;D07XA01 - hydrocortisone
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AD - Prostaglandins -  oxytocics;G02AD02 - dinoprostone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AD - Phenothiazine derivatives -  systemic antihistamines;R06AD03 - thiethylperazine
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07A - BETA BLOCKING AGENTS;C07AB - Beta blocking agents -  selective;C07AB06 - bevantolol
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC07 - azacitidine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AA - Natural opium alkaloid analgesics;N02AA10 - papaveretum
V - VARIOUS DRUG CLASSES IN ATC;V08 - CONTRAST MEDIA;V08A - X-RAY CONTRAST MEDIA -  IODINATED;V08AA - Watersoluble -  nephrotropic -  high osmolar X-ray contrast media;V08AA08 - iocarmic acid
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA04 - betamethasone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BD - Blood coagulation factors;B02BD02 - coagulation factor VIII
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09C - RENAL SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09CA - Technetium 99m compounds -  renal system diagnostic radiopharmaceuticals;V09CA06 - technetium (99mTc) ethylenedicysteine
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA09 - azilsartan medoxomil
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC04 - antazoline
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AA - Progestogens and estrogen systemic contraceptives -  fixed combinations;G03AA01 - etynodiol and ethinylestradiol
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AN - Medical gases;V03AN04 - nitrogen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA07 - epicillin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05B - IV solutions used in parenteral administration of fluids -  electrolytes and nutrients;B05BB - Solutions affecting the electrolyte balance;B05BB02 - electrolytes with carbohydrates
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AB - Antidotes;V03AB21 - potassium iodide
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AX - Other general anesthetics in ATC;N01AX04 - propanidid
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BA - Folic acid analogs -  antimetabolites;L01BA01 - methotrexate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB14 - pipenzolate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BH - Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering;A10BH02 - vildagliptin
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AB - Halogenated hydrocarbons -  general anesthetics;N01AB05 - trichloroethylene
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05A - BLOOD AND RELATED PRODUCTS;B05AA - Blood substitutes and plasma protein fractions;B05AA02 - other plasma protein fractions
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AK - Adrenergics inhalants in combination with corticosteroids or other drugs -  excl. anticholinergics;R03AK11 - formoterol and fluticasone
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX10 - enoxolone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01C - HYPOTHALAMIC HORMONES;H01CB - Somatostatin and analogues;H01CB04 - vapreotide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07E - INTESTINAL ANTIINFLAMMATORY AGENTS;A07EA - Corticosteroids acting locally;A07EA07 - beclometasone
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX51 - itramin tosilate -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA12 - nadolol and thiazides
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX14 - orgotein
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA04 - oxyphenbutazone
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE05 - levofloxacin
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA02 - muromonab-CD3
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA01 - levocarnitine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD10 - cefetamet
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC26 - vorapaxar
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AX - Other antiepileptics in ATC;N03AX17 - stiripentol
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AC - Antiallergic nasal preparations for topical use -  excl. corticosteroids;R01AC51 - cromoglicic acid -  combinations
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02C - Corticosteroids and antiinfectives in combination -  otologic;S02CA - Corticosteroids and antiinfectives in combination;S02CA05 - fluocinolone acetonide and antiinfectives
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01A - ALKYLATING AGENTS;L01AC - Ethylene imines -  antineoplastic alkylating drugs;L01AC02 - triaziquone
C - CARDIOVASCULAR SYSTEM DRUGS;C04 - PERIPHERAL VASODILATORS;C04A - PERIPHERAL VASODILATORS;C04AX - Other peripheral vasodilators in ATC;C04AX27 - cinepazide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB30 - Insulins and analogs for injection -  fast-acting combinations
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG04 - vigabatrin
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09H - INFLAMMATION AND INFECTION DETECTION;V09HA - Technetium 99m compounds -  inflammation and infection detection radiopharmaceuticals;V09HA03 - technetium (99mTc) antigranulocyte antibody
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DD - Third-generation cephalosporins;J01DD13 - cefpodoxime
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AE - Fluoroquinolone antiinfectives -  ophthalmologic;S01AE08 - besifloxacin
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AX - Other antiinflammatory and antirheumatic agents -  non-steroids in ATC;M01AX01 - nabumetone
N - NERVOUS SYSTEM DRUGS;N04 - ANTI-PARKINSON DRUGS;N04B - DOPAMINERGIC AGENTS;N04BX - Other dopaminergic agents in ATC;N04BX03 - budipine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M02 - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02A - TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN;M02AA - Antiinflammatory preparations -  non-steroids for topical use;M02AA07 - piroxicam
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AB - Thiazides and potassium in combination;C03AB07 - cyclopenthiazide and potassium
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06B - PSYCHOSTIMULANTS -  AGENTS USED FOR ADHD AND NOOTROPICS;N06BA - Centrally acting sympathomimetics;N06BA05 - pemoline
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GX - Other cardiovascular system diagnostic radiopharmaceuticals in ATC;V09GX03 - chromium (51Cr) chromate labelled cells
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC19 - difluprednate
V - VARIOUS DRUG CLASSES IN ATC;V09 - DIAGNOSTIC RADIOPHARMACEUTICALS;V09G - CARDIOVASCULAR SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS;V09GB - Iodine I-125 compounds -  cardivascular system diagnostic radiopharmaceuticals;V09GB01 - fibrinogen (125I)
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX01 - aluminium chloride
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BA - Aminoquinoline antimalarials;P01BA06 - amodiaquine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XC - Corticosteroids -  potent -  other combinations;D07XC04 - diflucortolone
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AB - Acetic acid derivatives and related substances;M01AB02 - sulindac
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AC - Corticosteroids -  potent (group III);D07AC06 - diflucortolone
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB20 - other cough suppressant combinations in ATC
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09C - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  PLAIN;C09CA - Angiotensin II receptor blockers (ARBs) -  plain;C09CA10 - fimasartan
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P03 - ECTOPARASITICIDES -  INCL. SCABICIDES -  INSECTICIDES AND REPELLENTS;P03B - INSECTICIDES AND REPELLENTS;P03BX - Other insecticides and repellents in ATC;P03BX01 - diethyltoluamide
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AX - Other anti-acne preparations for topical use in ATC;D10AX04 - aluminium oxide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AA - Amino acids and derivatives;A16AA04 - mercaptamine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05B - ANTIVARICOSE THERAPY DRUGS;C05BB - Sclerosing agents for local injection;C05BB05 - phenol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DI - Other cephalosporins and penems in ATC;J01DI02 - ceftaroline fosamil
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA27 - fingolimod
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02 - ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L02B - HORMONE ANTAGONISTS AND RELATED AGENTS;L02BX - Other hormone antagonists and related agents in ATC;L02BX03 - abiraterone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AC - Bulk-forming laxatives;A06AC05 - linseed
C - CARDIOVASCULAR SYSTEM DRUGS;C08 - CALCIUM CHANNEL BLOCKERS;C08G - CALCIUM CHANNEL BLOCKERS AND DIURETICS;C08GA - Calcium channel blockers and diuretics;C08GA01 - nifedipine and diuretics
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AD - Butyrophenone derivatives -  antipsychotics;N05AD01 - haloperidol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01B - ANTIARRHYTHMICS -  CLASS I AND III;C01BC - Antiarrhythmics -  class Ic;C01BC09 - ethacizine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AA - Corticosteroids -  topical for treatment of hemorrhoids and anal fissures;C05AA05 - betamethasone
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03D - OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES in ATC;R03DA - Xanthines -  systemic for obstructive airway disease;R03DA54 - theophylline -  combinations excl. psycholeptics
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AB - Iron trivalent -  oral antianemic preparations;B03AB04 - ferric hydroxide
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AB - Zinc bandages;D09AB01 - zinc bandage without supplements
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DX - Other vasodilators used in cardiac diseases in ATC;C01DX04 - benziodarone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA05 - niperotidine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;B05C - IRRIGATING SOLUTIONS -  BLOOD SUBSTITUTES AND PERFUSION;B05CA - Antiinfective irrigating solutions;B05CA07 - noxytiolin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03B - OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES -  INHALANTS in ATC;R03BA - Glucocorticoid inhalants for obstructive airway disease;R03BA04 - betamethasone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX53 - vosaroxin
V - VARIOUS DRUG CLASSES IN ATC;V04 - DIAGNOSTIC AGENTS;V04C - OTHER DIAGNOSTIC AGENTS in ATC;V04CK - pancreatic function test diagnostic agents;V04CK01 - secretin
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BB - Drugs used in alcohol dependence;N07BB01 - disulfiram
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CB - Prolactine inhibitors;G02CB04 - quinagolide
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CM - Other hypnotics and sedatives in ATC;N05CM05 - scopolamine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M04 - ANTIGOUT PREPARATIONS;M04A - ANTIGOUT PREPARATIONS;M04AB - Preparations increasing uric acid excretion;M04AB02 - sulfinpyrazone
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07B - DRUGS USED IN ADDICTIVE DISORDERS;N07BB - Drugs used in alcohol dependence;N07BB04 - naltrexone
C - CARDIOVASCULAR SYSTEM DRUGS;C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM;C09D - ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs) -  COMBINATIONS;C09DA - Angiotensin II receptor blockers (ARBs) and diuretics;C09DA08 - olmesartan medoxomil and diuretics
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03A - HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE;G03AB - Progestogens and estrogens systemic contraceptives -  sequential preparations;G03AB07 - chlormadinone and ethinylestradiol
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA12 - hexylresorcinol
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03A - MUSCLE RELAXANTS -  PERIPHERALLY ACTING AGENTS;M03AC - Other quaternary ammonium compounds in ATC -  muscle relaxants -  peripherally acting;M03AC10 - mivacurium chloride
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE - Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AE03 - diltiazem
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX11 - mirtazapine
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC05 - rimiterol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06B - IMMUNOGLOBULINS;J06BB - Specific immunoglobulins;J06BB06 - rubella immunoglobulin
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03C - ADRENERGICS FOR SYSTEMIC USE;R03CB - Non-selective beta-adrenoreceptor agonists for systemic use;R03CB51 - isoprenaline -  combinations
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XX - Other antineoplastic agents in ATC;L01XX49 - belinostat
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05A - ANTIPSYCHOTICS;N05AH - Diazepines -  oxazepines -  thiazepines and oxepines antipsychotic drugs;N05AH02 - clozapine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BA - Histamine H2 receptor antagonists for peptic ulcer and GORD;A02BA08 - lafutidine
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AD - Enzymes -  antithrombotic;B01AD07 - reteplase
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX09 - rosuvastatin and amlodipine
M - MUSCULO-SKELETAL SYSTEM DRUGS;M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS;M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS -  NON-STEROIDS;M01AG - Fenamates -  antiinflammatory and antirheumatic drugs;M01AG03 - flufenamic acid
J - ANTIINFECTIVES FOR SYSTEMIC USE;J06 - IMMUNE SERA AND IMMUNOGLOBULINS;J06A - IMMUNE SERA SYSTEMIC ANTIINFECTIVES;J06AA - Immune sera;J06AA03 - snake venom antiserum
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AX - Other antivirals in ATC;J05AX13 - umifenovir
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BB - Purine analogs -  antimetabolites antineoplastic;L01BB07 - nelarabine
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX02 - clonidine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AB - Estren derivatives -  systemic;A14AB01 - nandrolone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AX - Other immunostimulants in ATC;L03AX02 - roquinimex
D - DERMATOLOGICALS;D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE;D01A - ANTIFUNGALS FOR TOPICAL USE;D01AE - Other antifungals for topical use in ATC;D01AE13 - selenium sulfide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BA - Carbamic acid esters -  centrally acting muscle relaxants;M03BA52 - carisoprodol -  combinations excl. psycholeptics
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A02 - DRUGS FOR ACID RELATED DISORDERS;A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD);A02BD - Combinations for eradication of Helicobacter pylori;A02BD09 - lansoprazole -  clarithromycin and tinidazole
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA01 - etilefrine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB11 - taliglucerase alfa
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BD - Drugs for urinary frequency and incontinence;G04BD02 - flavoxate
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CA - Barbiturates -  hypnotics and sedatives -  plain;N05CA05 - aprobarbital
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AB - Enzymes for ALIMENTARY TRACT AND METABOLISM;A16AB14 - sebelipase alfa
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CA - Adrenergic and dopaminergic cardiac stimulants;C01CA04 - dopamine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA06 - lanatoside C
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02C - ANTIMIGRAINE PREPARATIONS;N02CX - Other antimigraine preparations in ATC;N02CX05 - dimetotiazine
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA08 - carbinoxamine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XE - Protein kinase inhibitors -  antineoplastic drugs;L01XE42 - ribociclib
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AC - Selective beta-2-adrenoreceptor agonist inhalants;R03AC08 - pirbuterol
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AF - Barbiturates for general anesthesia -  plain;N01AF03 - thiopental
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01B - ANTIMETABOLITES;L01BC - Pyrimidine analogues -  antineoplastic antimetabolites;L01BC01 - cytarabine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AE - Protease inhibitors -  direct acting antivirals;J05AE02 - indinavir
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01A - CARDIAC GLYCOSIDES;C01AA - Digitalis glycosides;C01AA09 - gitoformate
R - RESPIRATORY SYSTEM DRUGS;R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES;R03A - ADRENERGICS -  INHALANTS;R03AL - Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids;R03AL04 - indacaterol and glycopyrronium bromide
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03A - LOW-CEILING DIURETICS -  THIAZIDES;C03AX - Thiazides -  combinations with other drugs;C03AX01 - hydrochlorothiazide -  combinations
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A07 - ANTIDIARRHEALS -  INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;A07D - ANTIPROPULSIVES;A07DA - Antipropulsives;A07DA02 - opium
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CA - Penicillins with extended spectrum;J01CA20 - Penicillins with extended spectrum combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01EB - Short-acting sulfonamides;J01EB03 - sulfadimidine
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES;H01B - POSTERIOR PITUITARY LOBE HORMONES;H01BB - Oxytocin and analogues;H01BB02 - oxytocin
D - DERMATOLOGICALS;D08 - ANTISEPTICS AND DISINFECTANTS;D08A - ANTISEPTICS AND DISINFECTANTS;D08AK - Mercurial antiseptic and disinfectant products;D08AK30 - mercuric iodide
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07B - VIRAL VACCINES;J07BF - Poliomyelitis vaccines;J07BF02 - poliomyelitis oral -  trivalent -  live attenuated
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BX - HMG CoA reductase inhibitors -  other combinations;C10BX10 - rosuvastatin and valsartan
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD23 - metformin and ertugliflozin
C - CARDIOVASCULAR SYSTEM DRUGS;C02 - ANTIHYPERTENSIVES;C02K - OTHER ANTIHYPERTENSIVES in ATC;C02KX - Antihypertensives for pulmonary arterial hypertension;C02KX02 - ambrisentan
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AA - Aminoalkyl ethers -  systemic antihistamines;R06AA52 - diphenhydramine -  combinations
C - CARDIOVASCULAR SYSTEM DRUGS;C03 - DIURETICS;C03D - POTASSIUM-SPARING DIURETICS;C03DA - Aldosterone antagonists;C03DA02 - potassium canrenoate
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FB - Progestogens and estrogens -  sequential preparations;G03FB07 - medrogestone and estrogen
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA14 - isosorbide mononitrate
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AA - Vitamin K antagonists;B01AA03 - warfarin
V - VARIOUS DRUG CLASSES IN ATC;V03 - ALL OTHER THERAPEUTIC PRODUCTS;V03A - ALL OTHER THERAPEUTIC PRODUCTS;V03AF - Detoxifying agents for antineoplastic treatment;V03AF05 - amifostine
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BX - Other blood glucose lowering drugs -  excl. insulins in ATC;A10BX03 - nateglinide
D - DERMATOLOGICALS;D10 - ANTI-ACNE PREPARATIONS;D10A - ANTI-ACNE PREPARATIONS FOR TOPICAL USE;D10AD - Retinoids for topical use in acne;D10AD02 - retinol
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01E - OTHER CARDIAC PREPARATIONS in ATC;C01EB - Other plain cardiac preparations in ATC;C01EB17 - ivabradine
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AD - Corticosteroids -  very potent (group IV);D07AD01 - clobetasol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AD - Insulins and analogues for injection used in Diabetes -  intermediate- or long-acting combined with fast-acting;A10AD30 - Insulins and analogs for injection -  intermediate-acting combined with fast-acting- combinations
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02B - CONTRACEPTIVES FOR TOPICAL USE;G02BA - Intrauterine contraceptives;G02BA01 - plastic IUD
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AG - Enema for Constipation;A06AG03 - dantron -  incl. combinations
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01A - AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES;P01AA - Hydroxyquinoline derivatives for amoebiasis and other protozoal diseases;P01AA01 - broxyquinoline
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AC - Interleukin inhibitors;L04AC02 - basiliximab
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01X - OTHER OPHTHALMOLOGICALS IN ATC;S01XA - Other ophthalmologicals in ATC;S01XA24 - cenegermin
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05C - HYPNOTICS AND SEDATIVES;N05CD - Benzodiazepine derivative hypnotics and sedatives;N05CD09 - brotizolam
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02C - OTHER GYNECOLOGICALS in ATC;G02CX - Other gynecologicals in ATC;G02CX03 - Agni casti fructus
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03C - ESTROGENS -  SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03CA - Natural and semisynthetic estrogens -  plain;G03CA09 - promestriene
S - SENSORY ORGAN DRUGS;S02 - OTOLOGICALS;S02A - ANTIINFECTIVE DRUGS -  OTOLOGIC;S02AA - Antiinfectives;S02AA02 - nitrofural
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BC - Methanolquinolines -  antimalarial;P01BC01 - quinine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01E - SULFONAMIDES AND TRIMETHOPRIM ANTIBACTERIALS FOR SYSTEMIC USE;J01ED - Long-acting sulfonamides;J01ED03 - sulfametomidine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA06 - hachimycin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD04 - chlorobutanol
J - ANTIINFECTIVES FOR SYSTEMIC USE;J05 - ANTIVIRALS FOR SYSTEMIC USE;J05A - DIRECT ACTING ANTIVIRALS;J05AG - Non-nucleoside reverse transcriptase inhibitors;J05AG02 - delavirdine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L03 - IMMUNOSTIMULANTS;L03A - IMMUNOSTIMULANTS;L03AB - Interferons;L03AB02 - interferon beta natural
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB02 - insulin (beef)
R - RESPIRATORY SYSTEM DRUGS;R02 - THROAT PREPARATIONS;R02A - THROAT PREPARATIONS;R02AA - Antiseptic throat preparations;R02AA09 - benzethonium
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AB - Insulins and analogues for injection -  fast-acting;A10AB05 - insulin aspart
D - DERMATOLOGICALS;D11 - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11A - OTHER DERMATOLOGICAL PREPARATIONS in ATC;D11AX - OTHER DERMATOLOGICAL PREPARATIONS IN ATC;D11AX12 - pyrithione zinc
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE53 - cyclizine -  combinations
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AX - Other antidepressants in ATC;N06AX08 - bifemelane
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AD - Osmotically acting laxatives;A06AD17 - sodium phosphate
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS -  ANTINEOPLASTIC DRUGS;L01CD - Taxanes -  antineoplastic;L01CD04 - cabazitaxel
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L01 - ANTINEOPLASTIC AGENTS;L01X - OTHER ANTINEOPLASTIC AGENTS in ATC;L01XD - Sensitizers used in photodynamic/radiation therapy;L01XD07 - padeliporfin
P - ANTIPARASITIC PRODUCTS -  INSECTICIDES AND REPELLENTS;P01 - ANTIPROTOZOALS;P01B - ANTIMALARIALS;P01BF - Artemisinin and derivatives -  combinations;P01BF02 - artesunate and mefloquine
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05C - CAPILLARY STABILIZING AGENTS;C05CX - Other capillary stabilizing agents in ATC;C05CX03 - Hippocastani semen
C - CARDIOVASCULAR SYSTEM DRUGS;C05 - VASOPROTECTIVES;C05A - AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;C05AX - Other agents for treatment of hemorrhoids and anal fissures for topical use in ATC;C05AX05 - tribenoside
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB04 - methylprednisolone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A06 - DRUGS FOR CONSTIPATION;A06A - DRUGS FOR CONSTIPATION;A06AX - Other drugs for constipation in ATC;A06AX07 - plecanatide
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA01 - framycetin
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A12 - MINERAL SUPPLEMENTS;A12A - CALCIUM SUPPLEMENTS;A12AA - Calcium;A12AA30 - calcium laevulate
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AA - Non-selective monoamine reuptake inhibitors;N06AA21 - maprotiline
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC16 - eptifibatide
M - MUSCULO-SKELETAL SYSTEM DRUGS;M03 - MUSCLE RELAXANTS;M03B - MUSCLE RELAXANTS -  CENTRALLY ACTING AGENTS;M03BB - Oxazol -  thiazine -  and triazine derivatives centrally acting muscle relaxants;M03BB02 - chlormezanone
N - NERVOUS SYSTEM DRUGS;N02 - ANALGESICS;N02A - OPIOID ANALGESICS;N02AE - Oripavine derivatives analgesics;N02AE01 - buprenorphine
N - NERVOUS SYSTEM DRUGS;N05 - PSYCHOLEPTICS;N05B - ANXIOLYTICS;N05BA - Benzodiazepine derivative anxiolytics;N05BA03 - medazepam
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AE - Direct thrombin inhibitors;B01AE04 - melagatran
N - NERVOUS SYSTEM DRUGS;N06 - PSYCHOANALEPTICS;N06A - ANTIDEPRESSANTS;N06AB - Selective serotonin reuptake inhibitors;N06AB09 - etoperidone
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA21 - efalizumab
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01R - COMBINATIONS OF ANTIBACTERIALS;J01RA - Combinations of antibacterials;J01RA13 - norfloxacin and tinidazole
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10B - BLOOD GLUCOSE LOWERING DRUGS -  EXCL. INSULINS;A10BD - Combinations of oral blood glucose lowering drugs;A10BD01 - phenformin and sulfonylureas
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AG - Fatty acid derivatives -  antiepileptics;N03AG01 - valproic acid
D - DERMATOLOGICALS;D09 - MEDICATED DRESSINGS;D09A - MEDICATED DRESSINGS;D09AA - Medicated dressings with antiinfectives;D09AA04 - phenylmercuric nitrate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A10 - DRUGS USED IN DIABETES;A10A - INSULINS AND ANALOGUES;A10AE - Insulins and analogues for injection -  long-acting;A10AE06 - insulin degludec
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B01 - ANTITHROMBOTIC AGENTS;B01A - ANTITHROMBOTIC AGENTS;B01AC - Platelet aggregation inhibitors excl. heparin;B01AC19 - beraprost
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01C - BETA-LACTAM ANTIBACTERIALS -  PENICILLINS;J01CE - Beta-lactamase sensitive penicillins;J01CE01 - benzylpenicillin
G - GENITO URINARY SYSTEM AND SEX HORMONES;G01 - GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;G01A - ANTIINFECTIVES AND ANTISEPTICS -  EXCL. COMBINATIONS WITH CORTICOSTEROIDS;G01AA - Antibiotics -  Gynecological;G01AA09 - mepartricin
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AD - Corticosteroid nasal preparations for topical use;R01AD05 - budesonide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03X - OTHER ANTIANEMIC PREPARATIONS in ATC;B03XA - Other antianemic preparations in ATC;B03XA05 - roxadustat
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03F - PROPULSIVES;A03FA - Propulsives;A03FA01 - metoclopramide
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B03 - ANTIANEMIC PREPARATIONS;B03A - IRON ANTIANEMIC PREPARATIONS;B03AA - Iron bivalent -  oral antianemic preparations;B03AA07 - ferrous sulfate
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A08 - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08A - ANTIOBESITY PREPARATIONS -  EXCL. DIET PRODUCTS;A08AA - Centrally acting antiobesity products;A08AA56 - ephedrine -  combinations
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA01 - diphtheria-poliomyelitis-tetanus
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A04 - ANTIEMETICS AND ANTINAUSEANTS;A04A - ANTIEMETICS AND ANTINAUSEANTS;A04AD - Other antiemetics in ATC;A04AD51 - scopolamine -  combinations
R - RESPIRATORY SYSTEM DRUGS;R05 - COUGH AND COLD PREPARATIONS;R05D - COUGH SUPPRESSANTS -  EXCL. COMBINATIONS WITH EXPECTORANTS;R05DB - Other cough suppressants in ATC;R05DB10 - clofedanol
G - GENITO URINARY SYSTEM AND SEX HORMONES;G04 - UROLOGICALS;G04B - UROLOGICALS;G04BX - Other urologicals in ATC;G04BX11 - collagen
R - RESPIRATORY SYSTEM DRUGS;R01 - NASAL PREPARATIONS;R01A - DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE;R01AB - Sympathomimetics -  combinations excl. corticosteroids;R01AB07 - oxymetazoline
C - CARDIOVASCULAR SYSTEM DRUGS;C10 - LIPID MODIFYING AGENTS;C10B - LIPID MODIFYING AGENTS -  COMBINATIONS;C10BA - HMG CoA reductase inhibitors in combination with other lipid modifying agents;C10BA06 - rosuvastatin and ezetimibe
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AX - Other antihistamines for systemic use in ATC;R06AX17 - ketotifen
C - CARDIOVASCULAR SYSTEM DRUGS;C07 - beta-Adrenergic Blocking Agents;C07B - BETA BLOCKING AGENTS AND THIAZIDES;C07BA - Beta blocking agents -  non-selective -  and thiazides;C07BA05 - propranolol and thiazides
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02B - VITAMIN K AND OTHER HEMOSTATICS;B02BC - Local hemostatics;B02BC02 - oxidized cellulose
D - DERMATOLOGICALS;D03 - PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS;D03A - CICATRIZANTS;D03AX - Other cicatrizants in ATC;D03AX12 - trolamine
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01E - ANTIGLAUCOMA PREPARATIONS AND MIOTICS;S01EC - Carbonic anhydrase inhibitors -  antiglaucoma drugs and miotics;S01EC05 - methazolamide
G - GENITO URINARY SYSTEM AND SEX HORMONES;G02 - OTHER GYNECOLOGICALS in ATC;G02A - UTEROTONICS;G02AB - Ergot alkaloid oxytocics;G02AB01 - methylergometrine
L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;L04 - IMMUNOSUPPRESSANTS;L04A - IMMUNOSUPPRESSANTS;L04AA - Selective immunosuppressants;L04AA24 - abatacept
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01F - MACROLIDES -  LINCOSAMIDES AND STREPTOGRAMINS;J01FA - Macrolides;J01FA08 - troleandomycin
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B02 - ANTIHEMORRHAGICS;B02A - ANTIFIBRINOLYTICS;B02AB - Proteinase inhibitors -  antifibrinolytic;B02AB02 - alfa1 antitrypsin
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01G - DECONGESTANTS AND ANTIALLERGICS;S01GA - Sympathomimetics used as decongestants;S01GA02 - tetryzoline
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03B - BELLADONNA AND DERIVATIVES CONTAINING DRUGS -  PLAIN FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03BB - Belladonna alkaloids -  semisynthetic -  quaternary ammonium compounds for functional gastrointestinal disorders;A03BB04 - fentonium
N - NERVOUS SYSTEM DRUGS;N07 - OTHER NERVOUS SYSTEM DRUGS in ATC;N07A - PARASYMPATHOMIMETICS;N07AX - Other parasympathomimetics in ATC;N07AX01 - pilocarpine
G - GENITO URINARY SYSTEM AND SEX HORMONES;G03 - SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM;G03F - PROGESTOGENS AND ESTROGENS IN COMBINATION;G03FA - Progestogens and estrogens -  fixed combinations;G03FA16 - trimegestone and estrogen
J - ANTIINFECTIVES FOR SYSTEMIC USE;J07 - VACCINES;J07C - BACTERIAL AND VIRAL VACCINES -  COMBINED;J07CA - Bacterial and viral vaccines -  combined;J07CA04 - hemophilus influenzae B and poliomyelitis
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01X - OTHER ANTIBACTERIALS in ATC;J01XE - Nitrofuran derivatives -  antibacterials for systemic use;J01XE51 - nitrofurantoin -  combinations
V - VARIOUS DRUG CLASSES IN ATC;V10 - THERAPEUTIC RADIOPHARMACEUTICALS;V10A - ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS;V10AX - Other antiinflammatory therapeutic radiopharmaceuticals in ATC;V10AX01 - phosphorous (32P) chromicphosphate colloid
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07X - CORTICOSTEROIDS -  OTHER COMBINATIONS;D07XB - Corticosteroids -  moderately potent -  other combinations;D07XB04 - fluorometholone
R - RESPIRATORY SYSTEM DRUGS;R06 - ANTIHISTAMINES FOR SYSTEMIC USE;R06A - ANTIHISTAMINES FOR SYSTEMIC USE;R06AE - Piperazine derivatives -  systemic antihistamines;R06AE06 - oxatomide
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AX - Other drugs for functional gastrointestinal disorders in ATC;A03AX10 - isometheptene
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AA - Synthetic anticholinergics -  esters with tertiary amino group for functional gastrointestinal disorders;A03AA04 - mebeverine
J - ANTIINFECTIVES FOR SYSTEMIC USE;J01 - ANTIBACTERIALS FOR SYSTEMIC USE;J01D - OTHER BETA-LACTAM ANTIBACTERIALS in ATC;J01DC - Second-generation cephalosporins;J01DC13 - cefbuperazone
B - BLOOD AND BLOOD FORMING ORGAN DRUGS;B06 - OTHER HEMATOLOGICAL AGENTS in ATC;B06A - OTHER HEMATOLOGICAL AGENTS in ATC;B06AA - Enzymes -  hematological;B06AA10 - desoxyribonuclease
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS in ATC;A16AX - Various alimentary tract and metabolism products;A16AX04 - nitisinone
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A14 - ANABOLIC AGENTS FOR SYSTEMIC USE;A14A - ANABOLIC STEROIDS;A14AA - Androstan derivatives;A14AA09 - norethandrolone
N - NERVOUS SYSTEM DRUGS;N03 - ANTIEPILEPTICS;N03A - ANTIEPILEPTICS;N03AA - Barbiturates and derivatives;N03AA02 - phenobarbital
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01C - CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;C01CE - Phosphodiesterase inhibitors -  cardiac stimulant;C01CE02 - milrinone
N - NERVOUS SYSTEM DRUGS;N01 - ANESTHETICS;N01A - ANESTHETICS -  GENERAL;N01AH - Opioid anesthetics;N01AH03 - sufentanil
D - DERMATOLOGICALS;D07 - CORTICOSTEROIDS -  DERMATOLOGICAL PREPARATIONS;D07A - CORTICOSTEROID DERMATOLOGICAL PREPARATIONS -  PLAIN;D07AB - Corticosteroids -  moderately potent (group II);D07AB06 - fluorometholone
H - SYSTEMIC HORMONAL PREPARATIONS -  EXCL. SEX HORMONES AND INSULINS;H02 - CORTICOSTEROIDS FOR SYSTEMIC USE;H02A - CORTICOSTEROIDS FOR SYSTEMIC USE -  PLAIN;H02AB - Glucocorticoids -  Systemic;H02AB17 - cortivazol
A - ALIMENTARY TRACT AND METABOLISM DRUGS;A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03A - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS;A03AB - Synthetic anticholinergics -  quaternary ammonium compounds for functional gastrointestinal disorders;A03AB11 - poldine
C - CARDIOVASCULAR SYSTEM DRUGS;C01 - CARDIAC THERAPY DRUGS;C01D - VASODILATORS USED IN CARDIAC DISEASES;C01DA - Organic nitrates used in cardiac disease;C01DA63 - eritrityl tetranitrate -  combinations
S - SENSORY ORGAN DRUGS;S01 - OPHTHALMOLOGICALS;S01A - ANTIINFECTIVE OPHTHALMOLOGICS;S01AD - Antivirals -  ophthalmologic;S01AD08 - fomivirsen
